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ABSTRACT 
The  exposure  of  cells  to  environmental  stresses,  including  heat  shock, 
heavy metals, alcohols or oxidative stress results in the cellular accumulation of 
a number of chaperones, commonly known as heat shock proteins (Hsps). Hsps 
maintains  the  correct  folding  and  conformation  of  proteins  and  are  vital  in 
regulating the stability between protein synthesis and degradation. Hsps are not 
only  fundamental  in  the  cellular  stress  response  but  are  also  important  in 
regulating numerous important normal functions, such as cell proliferation and 
apoptosis. The results presented in the thesis focus on Hsp90 in nematodes, its 
possible roles in acquired drug resistance and further characterisation of Brugia 
pahangi Hsp90. 
Hsp90 plays a key role in the cellular stress response by interacting with 
proteins after their native conformation has been altered by stress.  Hsp90 is 
essential in all eukaryotes and plays a central role in multiple cellular processes. 
Since knock out of hsp90 is lethal to most eukaryotes, inhibitors of Hsp90 have 
been  widely  used  to  study  its  function.  The  most  widely  used  inhibitor  is 
geldanamycin (GA). GA binds to the N terminal/ATP binding site of Hsp90 which 
results  in  conformational  changes  and  the  degradation  of  client  proteins. 
Although  the  gene  encoding  hsp90  has  been  characterized,  little  is  known 
regarding its function in parasitic nematodes. Previous studies have shown that 
Caenorhabditis elegans Hsp90 is unique amongst eukaryotes because it fails to 
binds GA. This was suggested as an example of ‘adaptive evolution’ because C. 
elegans  inhabits  the  same  ecological  niche  of  the  soil  as  the  Streptomyces 
species which produces GA. In contrast B. pahangi Hsp90 does bind to GA. The 
first objective of this project was to determine whether the resistance of C. 
elegans Hsp90 to GA is the norm or the exception amongst nematodes and to 
determine  whether  GA  binding  is  associated  with  particular  clades  of 
nematodes. The results showed that the ability of Hsp90 to bind GA is associated 
with the life cycle of the nematode. Free living species or those that have a 
free living larval stage in the soil do not bind GA, while those species which are 
obligate parasites (Trichinella  and the filarial worms),  or which are enclosed 
within a protective  egg shell while in  the environment (Ascarids),  possess  an 
Hsp90 that binds GA. These data support the adaptive evolution hypothesis. iv 
Further  characterisation  of  B.  pahangi  Hsp90  showed  that  it  was 
expressed  in  all  life cycle  stages  but  in  the  pull down  assay,  only  adult  B. 
pahangi Hsp90 bound to GA, not Hsp90 from L3 or Mf. The inability to detect L3 
or Mf Hsp90 binding to GA beads could perhaps reflect a lack of sensitivity of the 
assay, or alternatively may suggest that Hsp90 from these stages is processed in 
such way that it fails to bind to GA. In addition, only a small amount (6.3%) of B. 
pahangi Hsp90 bound to GA after a series of pull down assays. Whether these 
data represents an accurate reflection of the amount of Hsp90 that can bind to 
GA is not known, but if correct, the results suggest that it might be necessary to 
inhibit only a small percentage of total Hsp90 to kill the worm.  
Attempts  were  make  to  identify  proteins  that  associate  with  Hsp90  by 
comparing the proteome of GA treated adult B. pahangi with control worms. In 
this analysis, several proteins with structural functions were identified. These 
proteins were down regulated after exposure to GA at 1.0  M. Comparison of 
Hsp90 levels in B. pahangi and C. elegans showed that Hsp90 was expressed at 
relatively  higher  levels  in  B.  pahangi  (p<0.05)  but  there  was  no  significant 
difference in the affinity of B. pahangi or C. elegans for Hsp90 binding to ATP 
beads. Results in Chapter 4 showed that the binding of Hsp90 to GA beads was 
competed by free GA or ATP. In addition, novobiocin, another Hsp90 inhibitor 
which binds at C terminal domain of Hsp90 also inhibited binding of B. pahangi 
Hsp90 to GA beads, suggesting an interaction between the N terminal and C 
terminal of Hsp90.    
Hsp90  has  also  been  shown  to  be  involved  in  the  acquisition  of  drug 
resistance in fungi. A previous study on fungi showed  that the  emergence of 
fluconazole resistance depended on high levels of Hsp90 and was abolished when 
Hsp90 expression was reduced. So, given the conservation of Hsp90 it is possible 
that  Hsp90  may  be  involved  in  the  acquired  resistance  of  nematodes  to 
anthelmintic. The analysis carried out did not produce any correlation between 
expression levels of Hsp90 and drug resistance in nematodes. RNAi experiments 
were carried out to reduce Hsp90 levels in C. elegans and to investigate whether 
Hsp90  may  play  a  role  in  the  tolerance  of  ivermectin resistant  C.  elegans  to 
drug.  Results  showed  that  reducing  Hps90  levels  altered  the  sensitivity  of 
ivermectin resistant C. elegans to drug.   v 
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 g      microgram 
 l      microlitre 
 M      micromolar 
17 AAG    17 allylamino 17 demethoxygeldanamycin 
17 DMAG    17 demethoxy 17 N,N dimethylamino ethylamino geldanamycin 
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1  Introduction 
1.1 Heat shock proteins 
In  1962,  Ritossa  reported  the  effects  of  evelated  temperature  on  the 
puffing  patterns  of  the  salivary  gland  chromosomes  of  Drosophila  busckii 
(Ritossa,  1962).  An  increase  in  incubation  temperature  resulted  in  the 
development  of  a  defined  set  of  new  transcription  loci  on  the  polytene 
chromosomes.  Similar  effects  were  also  observed  after  treatment  with  2,4 
dinitrophenol and sodium salicylate in Drosophila melanogaster larvae (Ritossa, 
1963). These observations indicated that elevated temperatures and chemical 
compounds induced the expression of certain genes. However, the term ‘heat 
shock protein’ only emerged in 1974 when Tissieres and co workers identified 
the first gene products representing this protein group in the salivary glands of 
D.  melanogaster.  These  proteins  not  only  appeared  in  salivary  glands  of  D. 
melanogaster but also in the brain, Malphighian tubules and wing imaginal disc, 
indicating  that  the  response  was  not  tissue  specific.  Besides  that,  a  similar 
effect of ecdysterone treatment was also observed in salivary glands but the 
induction was much less compared to that following heat shock. These unique 
proteins were referred to as heat shock proteins because of the nature of the 
stimulus that caused their induction. The remarkable discovery of heat shock 
proteins (Hsps) led to numerous subsequent studies in which Hsps were shown to 
be  present  in  all  species  tested  and  to  be  well  conserved  (as  reviewed  by 
Lindquist & Craig, 1988).  
As their name implies, Hsps respond to an increase in temperature but they 
are also induced when a cell undergoes various types of other stresses. Almost 
any  abrupt  change  in  cellular  environment  will  induce  the  synthesis  of  heat Chapter 1        3 
shock,  or  stress,  proteins  (Csermely  et  al.,  1998).  Some  Hsp  members  are 
constitutively expressed while some are only expressed after stress (Samali & 
Orrenius,  1998).  There  are  a  number  of  conditions  that  can  induce  the  heat 
shock  response  in  cells  including  environmental  stresses,  toxins, 
pathophysiological and disease states. In addition, Hsps can be induced under 
non stress  conditions  such  as  cell  growth  and  development  and  at  particular 
phases of the cell cycle etc. (Morimoto, 1998)(Figure 1.1).  
A consequence of exposure to stress is the accumulation of misfolded or 
denatured proteins. Hsps bind to damaged polypeptides and either help to refold 
them or facilitate their degradation by the ubiquitin proteasome pathway. Hsp 
induction  requires  the  activation  of  heat  shock  factor  (HSF)(Lis  &  Wu,  1993; 
Morimoto,  1993;  Morimoto,  1998).  HSF  is  a  transcription  factor  that  is 
responsible for regulating Hsp expression (Yamamoto et al., 2009). Up to now 
four HSFs have been characterised from animals namely, HSF 1, HSF 2, HSF 3 
and  HSF 4  (Morimoto,  1998).  HSF 3  was  shown  to  be  only  present  in  avian 
species  while,  HSF 1,  HSF 2  and  HSF 4  were  shown  to  be  present  in  human, 
mouse  and  chicken.  There  are  multiple  HSFs  in  plants.    HSF 1  is  the  major 
regulator of Hsps (Sreedhar & Csermely, 2004). Following activation, HSF 1 binds 
to heat shock elements (HSEs), stress responsive promoter elements essential for 
heat shock inducibility. These contain multiple adjacent inverted arrays of the 
binding  site  (5’ nGAAn 3’)(Fernandes  et  al.,  1994),  and  binding  of  HSF 1 
activates the transcription of Hsps (Wu, 1995; Morimoto, 1998). The induction of 
Hsps helps to repair damaged proteins and assists in the recovery of the cells. 
Then,  when  the  stress  is  removed,  Hsp  levels  drop  back  to  normal.  This 
adaptation is vital for cells to restore homeostasis and improves survival. Chapter 1        4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Conditions that induce the heat shock response (after Morimoto, 1998). 
  
Hsps respond to environmental stress, pathophysiological stress and non-stress conditions 
following activation of heat shock factor (HSF) that binds to heat shock elements (HSEs) 
and activates transcription of Hsps. 
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1.1.1 The heat shock protein family and their functions 
The major function of all Hsps is in molecular chaperoning. According to 
Hartl (1996), molecular chaperones can be defined as ‘proteins that bind to and 
stabilize an otherwise unstable conformer of another protein and by controlled 
binding and release, facilitate its correct fate in vivo: be it folding, oligomeric 
assembly,  transport  to  a  particular  sub cellular  compartment,  or  disposal  by 
degradation’. Molecular chaperones assist or mediate the correct assembly of 
other  polypeptides  but  are  not  a  component  of  the  final  fold  (Ellis  & 
Hemmingsen,  1989).  As  molecular  chaperones,  Hsps  help  in  protein  folding, 
refolding and in the stabilization of unstable proteins. After cells are exposed to 
stresses such as heat shock, proteins become less stable and may become locally 
unfolded or misfolded. In response to the stress, transcription of Hsps is induced 
to  protect  cells  from  further  damage.  Hsps  facilitate  the  unfolded/misfolded 
proteins to  acquire  their  native  state. This mechanism  helps to maintain  the 
protein levels in response to stresses. Hsps are also involved in the translocation 
of protein across intracellular membranes (Phillips & Silhavy, 1990; Hannavy et 
al., 1993). The other important aspect of Hsps as molecular chaperones is their 
function to prevent the aggregation of proteins. This function is vital to ensure 
proper folding of polypeptides especially for newly synthesised polypeptides.  
Hsps  are  classified  into  different  families,  based  on  their  molecular 
weight, structure and function.  Those families include Hsp100, Hsp90, Hsp70, 
Hsp60,  Hsp40 and  the  small  heat shock  protein  family  (sHsp)  (reviewed  by 
Johnson  &  Craig,  1997).  Table  1.1  shows  the  major  families  of  heat  shock 
proteins and their functions. Hsp100 is a member of the AAA (ATPase associated 
with  various  cellular  activities)  superfamily  (Neuwald  et  al.,  1999).  The  AAA Chapter 1        6 
superfamily is a diverse family of enzymes that act on other macromolecules and 
catalyze  processes  (Maurizi  &  Xia,  2004).  Hsp90  is  a  member  of  the  gyrase 
Hsp90 histidine kinase MutL (GHKL) family of ATPases (Ban et al., 1999). It is 
essential in eukaryotes and involved in multiple cellular processes especially in 
maturation  of  substrate  or  client  proteins  engaged  in  signalling  pathways 
(reviewed by Pearl & Prodromou, 2006). Hsp90 is discussed further in Section 
1.2.  
Hsp70 has various functions in cells. It assists in protein folding, refolding 
aggregated proteins, assembly of newly synthesized proteins, and is involved in 
the transportation of proteins across membranes (Fujihara & Nedler, 1999). In 
the  free living  nematode,  Caenorhabditis  elegans,  hsp70  constitutes  a  multi 
gene  family  (Heschl  &  Baillie,  1989)  with  different  temporal  and  spatial 
expression  patterns.  In  addition,  some  Hsp70s  have  been  characterised  from 
various parasitic nematodes, including Brugia malayi (Selkirk et al., 1989) and 
Parastrongyloides trichosuri (Newton Howes et al., 2006). However, the exact 
function of the hsp70 gene family in parasitic nematodes remains uncertain. 
Hsp60 is considered to be a typical mitochondrial chaperone (also known 
as Cpn60) and in eukaryotes, can be found in mitochondria, the cytosol and at 
the cell surface. In plants, Hsp60 is localised to the chloroplast (Cappello et al., 
2008). Hsp60 plays an essential role in the transportation and maintenance of 
mitochondrial  proteins  (Koll  et  al.,  1992)  as  well  as  the  transmission  and 
replication of mitochondrial DNA (Smiley et al., 1992) The intracellular Hsp60, 
which  resides  in  mitochondria  and  chloroplasts,  was  shown  to  interact  with 
Hsp10 (or Cpn10) to  assist newly synthesised proteins to achieve their native 
conformation (Cheng et al., 1989; Richardson et al., 2001). Besides that, Hsp60 Chapter 1        7 
was shown to be present on the surface of normal (Soltys & Gupta, 1997) and 
tumour cells (Piselli et al., 2000; Feng et al., 2002; Shin et al., 2003) and has 
been suggested to be a danger signal for the immune system for the activation 
of anti tumour T cell responses (Feng  et  al., 2002; Osterloh  et al., 2004). In 
addition, mutations in GroEL (a homologue of Hsp60 in bacteria) blocked the 
export  of  some  proteins  (Kusukawa  et  al.,  1989),  which  suggested  a  role  for 
Hsp60 in protein transportation. In the parasitic nematode, Trichinella spiralis, 
the induction of Hsp60 was suggested to be involved in maintenance of tolerance 
to the toxic oxidant H2O2 (Martinez et al., 2002).  
Hsp40  is  categorized  based  on  homology  to  the  founding  member  in 
Escherichia  coli,  DnaJ  (Ohtsuka  et  al.,  1990;  Hattori  et  al.,  1993;  Ohtsuka, 
1993).  The  key  factor  of  Hsp40  function  resides  in  the  J domain.  This  well 
conserved domain is thought to promote the function of Hsp40 by recruiting an 
Hsp70 (Sugito et al., 1995; Minami et al., 1996).   
Small  Hsps  (sHsps)  are  a  varied  group  and  widely  distributed  in  both 
prokaryotes  and  eukaryotes.  sHsps  range  in  size  from  12  to  43  kDa  with  the 
majority  between 14 and 27 kDa (Garofalo  et al., 2009). Different organisms 
have different numbers of sHsps, ranging from one in Saccharomyces cerevisiae 
(Petko & Lindquist, 1986) to 30 in higher plants (Mansfield & Key, 1987).  In 
plants,  the  sHsps  are  localized  to  the  chloroplast,  cytoplasm,  nucleus, 
endoplasmic  reticulum  and  mitochondria  (Garofalo  et  al.,  2009).  sHsps  are 
involved  in  stabilization  of  misfolded  proteins  and  thermotolerance. 
Furthermore,  a  well  conserved  domain  in  sHsps,  known  as  the  α crystallin 
domain  is  an  important  component  of  the  eye  lens  which  functions  for  the 
lifespan of an organism and is essential for vision (Ingolia & Craig, 1982). hsp16 Chapter 1        8 
is a multi gene family in the free living nematode C. elegans. Over expression of 
hsp16.2, the most stress inducible of the family, resulted in increased longevity 
and resistance to a variety of stresses (Walker & Lithgow, 2003). According to 
Halaschek Wiener et al (2005), genes of the hsp16 family were shown to be very 
highly up regulated in long lived daf 2 mutants.  
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Table 1.1: Hsp families and their major functions 
 
Hsp families  Major functions 
 
 
 
Hsp100 
 
Hsp90 
 
 
Hsp70 
 
Hsp60 
 
Hsp40 
 
Small Hsp 
 
Protein disaggregation, thermotolerance 
 
Regulatory interactions with signaling proteins, stabilization 
of misfolded proteins 
 
Protein folding, membrane transport of proteins 
 
Protein folding (limited substrates in eukaryotic cytoplasm) 
 
Protein folding, co chaperone for Hsp70 
 
Stabilization of misfolded proteins, thermotolerance, eye 
lens structural proteins 
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1.2 Hsp90 
  The  90  kDa  heat  shock  protein  (Hsp90)  is  one  of  the  most  abundant 
proteins in the cytosol of both eukaryotic and prokaryotic cells. It can constitute 
up to 1 2% of the cellular protein under normal conditions (Welch & Feramisco, 
1982).  The  concentration  of  Hsp90  increases  even  more  upon  sudden 
temperature upshifts. Hsp90 is a unique molecular chaperone that is involved in 
cellular regulatory processes. To date members of the Hsp90 family have been 
found in the cytosol, the endoplasmic reticulum and chloroplasts (Rebbe et al., 
1987; Felts et al., 2000; Krishna & Gloor, 2001). Hsp90 is essential in all cells 
because of the nature of the proteins which it chaperones. Unlike other Hsps, 
Hsp90 chaperones specific client proteins that associate together for folding and 
degradation. Hsp90 keeps proteins on the correct folding pathway and at the 
same  time  prevents  possible  non specific  interactions  with  other  proteins. 
Because of the importance of Hsp90 in cells it has been extensively studied, but 
much  of  the  information  on  Hsp90  interactions  comes  from  studies  on 
mammalian cell lines and yeast.   
1.2.1 Hsp90 structure and conformation 
  Hsp90 is a hydrophobic protein and its hydrophobicity further increases 
after heat shock (Iwasaki et al., 1989; Yamamoto et al., 1991).  The first report 
of  the  crystallization  of  the  full length  yeast  Hsp90  was  published  nearly  14 
years ago by Prodromou et al (1996).  Based on proteolysis data (Nemoto et al., 
1997; Young et al., 1997), Hsp90 consists of three domains: a 25 kDa N terminal, 
a 35 kDa middle domain (M) and a 12 kDa C terminal domain (see Figure 1.3 for 
outline  drawing  representing  the  Hsp90  structural  domains).  The  N terminal 
domain  is  linked  to  the  M domain  by  a  charged  region  (CR).  The  25  kDa  N Chapter 1        11 
terminal domain of Hsp90 is the binding site for ATP (Prodromou et al., 1997) 
and geldanamycin (GA)(Whitesell et al., 1994) and is highly conserved across all 
species.  GA is a specific inhibitor of Hsp90 (Prodromou et al., 1997; Whitesell et 
al., 1994; Roe et al., 1999)(Section 1.3.1). The N terminus is the binding site for 
another Hsp90 inhibitor, radicicol (Soga et al., 1998). The N terminal domain 
contains an unusual adenine nucleotide binding pocket known as a Bergerat fold 
(Dutta & Inouye, 2000). It is unusual because it has no similarity to ATP binding 
domains found in other kinases or the chaperone Hsp70 (Whitesell & Lindquist, 
2005) even though it belongs to the GHKL superfamily. The middle domain (M 
domain)  of  yeast  Hsp90  (amino  acids  272 617)  was  found  to  mediate  the 
interaction  with  Aha1  and  Hch1  (Lotz  et  al.,  2003).  Aha1  and  Hch1  are  two 
Hsp90 associated proteins required by Hsp90 for full activation. The M domain is 
a  major  site  for  client  protein  interactions  (Fontana  et  al.,  2002).  The  C 
terminus  functions  as  a  dimerisation  domain  (Minami  et  al.,  1994).  The  C 
terminal  domain  is  also  supposed  to  possess  an  alternative  ATP binding  site, 
which becomes accessible when the N terminal pocket is occupied (Marcu et al., 
2000b; Soti et al., 2002).  
CR refers to the charged region which serves as a flexible linker between 
the N terminal and M domains (see Figure 1.2). All cytosolic eukaryotic Hsp90 
proteins have a charged region of varying size. The CR is possibly involved in 
regulatory  function  and  participates  in  the  association  of  the  protein  with 
steroid  receptors  (Dao Phan  et  al.,  1997)  and  with  the  protein  kinase  CK II 
(Miyata  &  Yahara,  1995).  However,  genetic  studies  show  that  the  CR  is  not 
fundamental for the life sustaining functions of Hsp90 in yeast, because deletion 
of the CR did not demonstrate any noticeable phenotypes in vivo (Louvion et al., 
1996). However, it may be involved in some “back up” or regulatory functions Chapter 1        12 
(Csermely et al., 1998). Figure 1.3 shows the dimer of Hsp90 and its biochemical 
functions.  
 
 
 
 
 
 
Figure 1.2: Structural domains of yeast Hsp90 (after Pearl & Prodromou, 2006) 
 
N = The N-terminal domain 
M = The middle domain 
C = The C-terminal domain 
   = The charged region links the N-terminal domain to the M-domain 
 Numbers denote the amino acid positions of different domains of yeast Hsp90. 
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Figure 1.3: Structure of Hsp90 dimer and its biochemical functions  
 
The N-terminal domain of Hsp90 is a binding site for ATP/GA. The M-domain functions as a 
binding  site  for  co-chaperones  and  client  proteins.  It  is  also  required  for  the  ATPase 
activation. The C-domain is vital for the dimerization of Hsp90. The CR links the N-domain to 
the M-domain (after Whitesell & Lindquist, 2005). 
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1.2.2 Classification of Hsp90 
Hsp90 exists in all organisms but is absent in the Archaebacteria (Tanaka 
&  Nakamoto,  1999;  Stechmann  &  Cavalier Smith,  2004).  Chen  et  al  (2006) 
divided the Hsp90 gene family into five sub families, namely HSP90A, HSP90B, 
HSP90C, TRAP and HTPG, which differ in their cellular localisation. The Hsp90 
homologue,  HTPG  (high  temperature  protein  G)  is  the  shortest  in  the  Hsp90 
family,  with  a  molecular  mass  between  66.7–78.0  kDa  and  it  exists  in  the 
Eubacteria but not in the Archaebacteria. Deletion of HTPG in Eubacteria is not 
lethal  but  results  in  a  slight  growth  disadvantage  (Bardwell  &  Craig,  1988). 
HSP90A, which exists in all the eukaryotic kingdoms, can be further divided into 
two  different  classes  in  vertebrates,  Hsp90 alpha  (Hsp90α)  and  Hsp90 beta 
(Hsp90β). These both exist in the cytosol where Hsp90α is the inducible form and 
Hsp90β, the constitutive form (Rebbe et al., 1987; Hoffmann & Hovemann 1988). 
HSP90B exists in all species of Protista, Plantae and Animalia, and some species 
of  Fungi.  HSP90B  is  an  Hsp90  homologue  which  resides  in  the  endoplasm 
reticulum and is also known as Grp94 (94 kDa glucose regulated protein). HSP90C 
is an Hsp90 homologue which can be found in chloroplasts and is only present in 
Plantae.  HSP90C  has  duplicated  into  Hsp90C1  and  Hsp90C2  in  higher  plants. 
TRAP (tumor necrosis factor receptor associated protein) is an Hsp90 homologue 
which  resides  in  the  mitochondria  and  is  most  closely  related  to  HTPG 
(Stechmann & Cavalier Smith, 2004). Refer to Table 1.2 for details of the Hsp90 
family. 
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Table 1.2: Members of the Hsp90 molecular chaperone family 
 
Name  Subgroup  Characteristic 
localization 
Kingdom 
HTPG 
 
 
HtpG A 
HtpG B 
HtpG C 
Cytoplasm 
 
 
Bacteria but absent in 
Archaebacteria 
 
HSP90A  Hsp90α 
Hsp90β 
Cytoplasm  Exists in all eukaryotic 
kingdom 
HSP90B  Also known as 
Grp94 
 
Endoplasmic reticulum  Exists in all eukaryotic 
kingdom 
HSP90C  Hsp90C1 
Hsp90C2 
Chloroplast  Plantae 
TRAP    Mitochondrial  Animalia and some 
species in  Protista 
(Alveolata, 
Englenozoa) 
       
 
 
(Adapted from Chen et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 1        16 
1.2.3 Hsp90 functions 
  As its  name implies,  Hsp90 responds to  environmental changes  such  as 
elevated  temperature,  oxidation,  pH  etc.  This  response  is  important  for 
maintaining a favourable environment which is suitable for cells to cope with 
environmental changes. Hsp90 plays a fundamental role in all cells. It has been 
suggested  to  play  a  central  role  in  the  assembly  (Jackson  et  al.,  2004)  and 
disassembly  machine  (Wegele  et  al.,  2004).  This  unique  chaperone  works 
together with Hsp40, Hsp70 and other co chaperones such as the TPR proteins 
etc.  in  activation  or  maturation  of  a  wide  range  of  client  proteins  and 
substrates, including some important protein kinases and transcription factors. 
Because of the nature of its client proteins, it is involved in cell cycle, growth, 
apoptosis, endocrine function, plant immunity and also in evolution (Figure 1.4).  
In  vitro  Hsp90  alone  can  prevent  protein  aggregation  and  promote 
refolding  (Welch  et  al.,  1992)  but  in  vivo  Hsp90  functions  with  associated 
proteins known as co chaperones (see Table 1.3). For example the v Src tyrosine 
kinase has been reported to form stable complexes with Hsp90 (Blankenship & 
Matsumura, 1997), where Hsp90 maintains the kinase in an inactive form and 
helps  in  its  membrane  recruitment.  However,  this  requires  association  with 
other  co chaperones  to  complete  the  whole  processes.  Table  1.3  shows  the 
important components of the Hsp90 chaperone machine (adapted from Whitesell 
& Lindquist, 2005).  
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Figure 1.4: Hsp90 has a central role in the assembly of various proteins involved in many 
cellular processes.   
 
Cytosolic  Hsp90  and  its  homologues,  Grp94,  HtpG,  Hsp90-α  and  TRAP  along  with  co-
chaperones form the cellular assembly machine.  This assembly machine acts on a range of 
client  proteins  for  their  maturation  and  activation,  thereby  controlling  multiple  cellular 
processes e.g. cell cycle, apoptosis and stress recovery (after Jackson et al., 2004).  
 
 
 
 
 
 
 
 
 Chapter 1        18 
 
Table 1.3: Hsp90 and the important components of the chaperone machinery 
 
Protein Family  Classification  Function 
Hsp90  Chaperone  Supports meta stable protein 
conformations, especially in signal 
transducers 
Hsp70  Chaperone  Helps fold nascent polypeptide chains; 
participates in assembly of multiprotein 
complexes  
Hsp40  Co chaperone  Stimulates Hsp70 ATPase activity 
HIP, HOP  Adapters  Mediates interaction of Hsp90 and 
Hsp70 
Cdc37/p50  Co chaperone  Modulates interactions with kinase 
AHA1  Co chaperone  Stimulates Hsp90 ATPase activity 
p23  Co chaperone  Stabilizes Hsp90 association with clients 
Immunophilin  Prolyl isomerase  Modulates interactions with hormone 
receptors 
     
HOP – Hsp70/Hsp90-organizing protein, HIP – Hsp70-interacting protein, Cdc37 – cell 
division cycle 37 homologue, AHA1 – activator of Hsp90 ATPase homologue.  
(Adapted from Whitesell & Lindquist, 2005) 
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In  the  process  of  protein  folding  by  Hsp90,  Hsp70 Hip  will  initiate  the 
binding to an unstructured target protein. This process is aided by the Hsp70 co 
chaperone, Hsp40. Hsp90 then forms a structure with Hop which is responsible 
for  linking  Hsp70  to  Hsp90.  Then,  immunophilins  and  p23  are  added  to  the 
conformation and parallel with this, Hsp70 Hip and Hop are released from the 
mature  complex  (Figure  1.5).  p23  binding  is  an  important  process  because  it 
allows the completion of folding (Dittmar et al., 1997).  According to Ali et al 
(2006), p23 is required to stabilise Hsp90 in the ATP bound form. Furthermore, 
p23 binding is vital to extend the time Hsp90 is in the appropriate conformation 
for client  protein  activation. Finally the mature  target  protein is released to 
complete the whole process. Any disruption by Hsp90 inhibitors leads to multiple 
physiologic  defects  in  live  cells.  For  example,  for  protein  kinases,  Hsp90  is 
thought to stabilize the exposed catalytic domains before assembly of the kinase 
into  the  final  signalling  complex  (Xu  &  Lindquist,  1993;  Alique  et  al.,  1994; 
Stepanova et al., 1996), and the interruption of the conformation with Hsp90 
inhibitors will lead to failure of the final fold.  
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Figure 1.5: Hsp90 in the folding process.  
 
(a) Unfolded target protein. Hsp70-Hip initiates the binding to the target protein aided by 
Hsp40.  
(b) Hsp90-Hop conformation binds to the Hsp70-Hip-target protein.  
(c) The binding of immunophilin aids the maturation of the complex. The binding of p23 to 
the complex allows the completion of the folding.  
(d) Hip-Hsp70-Hop is released from the mature complex. 
(e) Target protein is released in its mature and stable conformation  
(Adapted from Csermely et al., 1998).  
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1.3 Hsp90 inhibitors 
The  realisation  that  Hsp90  chaperones  proteins  required  for  cellular 
viability opened up a new direction in the development of drugs that alter Hsp90 
function. GA, the first Hsp90 inhibitor that was recognised, belongs to the family 
of benzoquinone ansamycins. GA binds to the N terminal domain of Hsp90, while 
other inhibitors such as novobiocin bind to the C terminal domain. The binding 
of inhibitor to the N terminus or C terminus of Hsp90 alters the conformation of 
the molecule and at the same time prevents association with client proteins that 
may be required for viability. The use of Hsp90 specific inhibitors results in a 
decline in client protein activity in vivo and in the degradation of vital signalling 
proteins  that  are  involved  in  cell  proliferation,  cell  cycle  regulation  and 
apoptosis  (reviewed  by  Maloney  &  Workman,  2002).  As  an  outcome  of  this, 
several Hsp90 inhibitors have been developed and some of them are already in 
clinical  trials.  Table  1.4  shows  some  of  the  Hsp90  inhibitors  (reviewed  by 
Sreedhar et al., 2004). 
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Table 1.4: Hsp90 inhibitors  
 
Domain targeted  Inhibitors 
 
N terminal 
 
 
 
C terminal 
 
 
Geldanamycin and analogues (17 AAG, 17 DMAG) 
Radicicol and its analogues (aigialomycin D, pochonin D) 
Purine scaffold Hsp90 binders, PU3 
 
Cisplatin 
Novobiocin 
 
     
   
 
(Adapted from Sreedhar et al., 2004) 
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1.3.1 Geldanamycin  
GA,  which  belongs  to  the  family  of  benzoquinone  ansamycins,  is  an 
antibiotic that specifically inhibit the cytosolic chaperone Hsp90 (Pratt, 1998; 
Neckers,  et  al.,  1999)  GA  was  first  purified  from  the  broth  of  Streptomyces 
hygroscopicus (DeBoer et al., 1970), a soil bacterium. GA is soluble in alcohols, 
aliphatic chlorinated solvents, acetone, benzene and ethyl acetate but poorly 
soluble  in  water  (DeBeor  et  al.,  1970).  GA  consists  of  a  quinone  ring  and 
hydrophobic  ansa  bridge  (Rinehart  &  Shield,  1976)  (see  Figure  1.6  for  the 
chemical structural of GA). At first GA was thought to be an inhibitor of tyrosine 
kinases  (Uehara  et  al.,  1989),  as  it  was  shown  that  GA  abolishes  Src  kinase 
activity in whole cell assays (Uehara et al., 1988). However, in other studies, GA 
was shown to be unable to directly inhibit the kinase activity of the purified 
recombinant  protein  (Whitesell  et  al.,  1992).  It  was  then  suggested  that  GA 
indirectly inhibits Src kinase activity by binding to unrecognised Src associated 
proteins. Subsequently by an affinity isolation method using GA immobilised on 
agarose beads, it was shown that GA specifically binds to Hsp90 (Whitesell et 
al., 1994). In addition, it was observed that levels of src Hsp90 were reduced as 
the GA concentrations were increased. This early experiment demonstrated that 
GA not only binds to Hsp90 but also interrupted the chaperone function of Hsp90 
and its associated kinase proteins.  
The first co crystal structure of Hsp90 bound to GA was published in 1997 
(Prodromou  et  al.,  1997).  Subsequent  affinity  chromatography  experiments 
together with co crystal structures provided evidence that GA inhibits Hsp90 by 
binding to its N terminal ATP binding site (Whitesell et al., 1994; Prodromou et 
al., 1997; Roe et al., 1999). These studies resulted in a re interpretation of the Chapter 1        24 
effect of GA on kinases.  In the presence of GA, the immature kinase undergoes 
rapid degradation as a consequence of ubiquitination and subsequent catabolism 
by the proteasome.  As a result, the depletion of the mature kinase can cause 
cell death.  
Recently, GA has been used intensively to study the effects of inhibiting 
Hsp90 in tumour cells. However, GA is poorly soluble in aqueous solution and its 
hepatotoxicity proved problematic in clinical trials (Supko et al., 1995). Studies 
by  Dikalov  and  co workers  (2002)  showed  that  incubation  of  GA  with  flavin 
dependent reductase enzymes transformed GA quinone into a semiquinone. The 
semiquinone reacts with molecular oxygen to produce superoxide radicals which 
can cause toxicity (Dikalov et al., 1992) and this causes cell death. By inserting a 
stronger  electron donating  group  into  the  17 position  of  GA,  it  stabilized  the 
quinone and decreased its redox active potential (Blagg & Kerr, 2006). This new 
analogue  17 allylamino 17 demethoxygeldanamycin  (17 AAG)  seems  to  behave 
significantly better than GA (Barzilay et al., 2005). 17 AAG has entered Phase I 
and Phase II clinical trials for cancer chemotherapy. Even though 17 AAG shows 
promising results in chemotherapy, this analogue still produces hepatotoxicity 
and its water insolubility makes it difficult to formulate (Jez et al., 2003). In 
order to improve the solubility of 17 AAG, an extra tertiary amine group was 
incorporated into 17 AAG which led to the development of 17 demethoxy 17 
N,N dimethylamino ethylamino geldanamycin  (17 DMAG)(Jez  et  al.,  2003).  17 
DMAG  is  much  more  water  soluble  and  has  entered  Phase  I  clinical  trials 
(reviewed in Bagatell & Whitesell, 2004). Refer to Figure 1.6 for the chemical 
structure of GA, 17 AAG and 17 DMAG. 
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Figure 1.6: Geldanamycin and its analogues 
 
a)  Geldanamycin  (C29H40N2O9).  As  a  member  of  the  benzoquinone  ansamycin  family,  GA 
consists of a quinone ring and hydrophobic ansa bridge. 
b) Chemical structure of 17-AAG shows the new substituted group in 17-position of GA (17-
AAG, (CH2=CHCH2NH-).  
c) 17-DMAG chemical structure shows an extra tertiary amine group inserted in 17-position of 
GA to produce 17-DMAG  (CH3)2NCH2CH2NH-) 
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1.3.2 Radicicol 
Radicicol  is  a  macrocyclic  antibiotic  that  was  first  isolated  from 
Monosporium  bonarden  (Delmotte  &  Delmotte Plaque,  1953)(see  Figure  1.7). 
Kwon et al (1992a) reported that radicicol contributed to the inhibition of the 
oncogenic kinase Src.  Then, it was revealed by Kwon et al (1992b) that it is a 
specific inhibitor of Hsp90. In 1999, the crystal structure of radicicol bound to 
yeast Hsp90 was solved (Roe et al., 1999). Even though radicicol does not have a 
similar structure to GA, it also inhibits Hsp90 by binding to the N terminal ATP 
pocket (Prodromou et al., 1997) and it binds with greater affinity compared to 
GA and 17 AAG (Roe et al., 1999). It has been shown to compete with ATP for 
the binding site of Hsp90 (Roe et al., 1999). Radicicol is also known to suppress 
the activity of various oncogenic proteins  such  as  Ras, Raf and v src tyrosine 
kinase (Kwon et al., 1997). Furthermore radicicol has been shown to be active 
against  retinoblastoma  cells  that  are  resistant  to  17 AAG  (Yamamoto  et  al., 
2003).  However,  radicicol  lacks  anti tumour  activity  in  vivo  in  experimental 
models because of its instability (Vogen et al., 2002). Besides that there are two 
analogues of radicicol that show a good affinity for binding to Hsp90 namely, 
aigialomycin D (Yang et al., 2004) and pochonin D (Moulin et al., 2005).                                                                                
                       
1.3.3 Novobiocin 
Novobiocin  is  a  coumarin  antibiotic  that  has  been  isolated  from 
Streptomyces strains and has a potent activity against Gram positive bacteria 
(Yu  et  al.,  2004)(see  Figure  1.7).  It  has  been  shown  to  inhibit  the  enzyme 
catalyzed hydrolysis of ATP and binds to type II topoisomerases including DNA 
gyrase (Lewis et al., 1996; Holdgate et al., 1997) and because of that it has Chapter 1        28 
been used for the treatment of bacterial infection. Novobiocin consists of three 
distinct  parts  namely  the  benzamide  side  chain,  the  coumarin  core  and  the 
noviose sugar (Donnelly & Blagg, 2008). The observation that novobiocin inhibits 
Hsp90  was  proposed  by  Marcu  et  al  (2000a).  They  showed  that  cell  lysates 
incubated with novobiocin Sepharose  bound  to Hsp90, and  demonstrated  that 
the novobiocin binding site correlated to residues 538 728 of Hsp90. Removal of 
amino  acids  657 677  from  the  538 728  peptide  fragment  of  chicken  Hsp90, 
resulted in a  decline in novobiocin binding which demonstrated that residues 
657 677  were  essential  for  novobiocin  binding.  However,  subsequent  studies 
suggested that the binding of Hsp90 to novobiocin Sepharose was non specific 
(Whitesell pers. comm. to E. Devaney). Novobiocin was shown to disrupt Hsp90 
functions  (Marcu  et  al.,  2000b)  and  cause  the  destabilization  and  proteolytic 
degradation  of  a  number  of  proteins.    Allan  and  co workers  proposed  that 
novobiocin may lead to substrate release by inducing a conformational change 
that result in separation of homodimeric C terminal domains (Allan et al., 2006). 
In  vitro,  incubation  of  SkBr3  (human  breast  cancer  cells)  with  increasing 
concentrations of novobiocin caused  the  degradation of Hsp90  client proteins 
(Marcu et al., 2000b). 
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Figure 1.7: Chemical structure of selected Hsp90 inhibitors  
 
a) Chemical structure of radicicol (C18H17ClO6).  
b)  Chemical  structure  of  novobiocin  (C31H36N2O11)  consists  of  three  distinct  parts;  the 
benzamide side chain, the coumarin core and the noviose sugar. 
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1.3.4 Hsp90 inhibitors: Mode of action 
Under  normal  circumstances,  Hsp90  acts  as  a  chaperone,  aiding  the 
maturation of important client proteins. The binding and hydrolysis of ATP is the 
key factor for Hsp90 function (Meyer et al., 2003; Pearl & Prodromou, 2006). 
According to Prodromou et al (2000), the Hsp90 N terminal domains transiently 
binds ATP so that the ATPase cycle is intimately coupled to the opening and 
closing of a molecular clamp (Figure 1.8). For the N terminal hydrolysis of ATP, 
dimerization of Hsp90 is required. According to Pearl & Prodromou (2006), the 
two halves of the Hsp90 dimer cooperate to achieve a conformation that is able 
to hydrolyse ATP. ATP binds to Hsp90 and it stabilizes ‘a tense conformation’ 
and the functional state of Hsp90, because Hsp90 depends on the presence of 
the γ phosphate of ATP. Energy produced by ATP hydrolysis is used to facilitate 
a  conformational  change  within  Hsp90  that  clamps  Hsp90  around  the  bound 
client proteins which leads to proper folding of the client proteins. Hydrolysis of 
bound ATP releases the polypeptide by opening up the Hsp90 dimer (Young et 
al., 2001).  According to Young & Hartl (2000), GA can inhibit the chaperone 
mediated  folding  of  Hsp90  client  proteins  by  blocking  their  ATP dependent 
dissociation from Hsp90. It has also been suggested that by binding to inhibitors 
the  formation  of  closed  clamps  around  the  bound client  proteins  is  inhibited 
(Blagg  &  Kerr,  2006).  As  a  result,  client  proteins  are  released  from  Hsp90 
without  achieving  their  active  or  mature  conformation.  These  unprocessed 
chaperone client  protein  complexes  accumulate  within  the  cell  leading  to 
recruitment  of  E3  ubiquitin  ligases  that  target  Hsp90  client  proteins  for 
degradation in the proteasome (Sepp Lorenzino et al., 1995; Mimnaugh et al., 
1996).          Chapter 1        31 
 
    
Figure 1.8: Schematic of current model for the conformational changes that accompany 
binding and hydrolysis of ATP (adapted from Pearl & Prodromou, 2006).  
 
N represents N-terminal, M for M-domain and C for C-terminal domain. Red represents client 
proteins. 
a)  Open  conformation  of  Hsp90  clamp.  Client  proteins  can  bind  to  Hsp90  without  the 
presence of ATP. However to achieve the full activation it requires ATP hydrolysis. 
b) Closed conformation of Hsp90 dimer in the presence of ATP. In the presence of inhibitor, 
in the ATP binding pocket, Hsp90 cannot form a closed clamp around bound client proteins 
leading to degradation of client proteins. 
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1.4 Hsp90 as a target for anti-tumour drugs 
Presently, there is growing evidence that Hsp90 plays a fundamental role in 
the progress of malignant diseases. Previous studies have shown that Hsp90 was 
expressed  at  two   to  10 fold  higher  levels  in  tumour  cells  (lung  carcinomas, 
melanomas  and  hepatoma)  compared  to  normal  cells  (peripheral blood 
lymphocytes, human umbilical endothelial cells and fibroblasts) and Hsp90 was 
suggested  to  play  an  important  role  in  tumour  cell  survival  (Ferrarini  et  al., 
1992). Hsp90  and its  homologue, Grp94, were shown to be over expressed in 
human breast cancer (Jameel et al., 1992; Haverty et al., 1997). Furthermore, 
in  tumour  cells  Hsp90  co chaperones  were  observed  to  be  over expressed, 
suggesting that a greater amount of Hsp90 in tumour cells might be engaged in 
active chaperoning (Kamal et al., 2003).  
There  are  several  Hsp90  client  proteins  that  are  important  as  possible 
anti cancer targets. Most of these require Hsp90 association for their activation. 
They are mutated p53 (Blagosklonny et al., 1995), Src family kinases (Hatson and 
Matts,  1994),  Wee1  kinase  (Alique  et  al.,  1994),  transmembrane  receptor 
tyrosine kinases (Chavany et al., 1996), Raf 1 kinase, CK II (Miyata & Yahara, 
1995),  Cdk4/Cdk6  (Stepanova  et  al.,  1996),  subunits  of  trimeric  GTP binding 
proteins (Inanobe et al., 1994), tumour necrosis factor receptor, retinoblastoma 
protein  and  focal  adhesion  kinase  (Song  et  al.,  1995;  Chen  et  al.,  1996).  In 
addition, certain client proteins that interact with Hsp90 for their stability are 
oncogenic e.g. ErbB2 transmembrane kinase, Bcr Abl kinase, Akt kinase, PLK 1, 
hypoxia inducible  factor  1α  and  C RAF  (Powers  and  Workman, 2006).  Most  of 
these  client  proteins  represent  a  group  which  contribute  to  the  hallmark  of 
cancer (Hanahan & Weinberg, 2000; Powers & Workman, 2006)(Figure 1.9). For Chapter 1        33 
example, Akt kinase is one protein associated with Hsp90. It was shown to be 
involved in a signal transduction pathway which is responsible for the growth 
signal, evasion of apoptosis and sustained angionesis (Donnelly & Blagg, 2008). 
Akt kinase acts as a modulator for phosphatidylinositol 3 kinase (PI 3K) which is 
responsible for the cell survival signal pathway and the interaction between Akt 
kinase and PI 3K has been targeted by various anti cancer drugs (Tsurou et al., 
2003).   
 
 
 
Figure 1.9: Hsp90 and six hallmark traits of cancer. 
 
Hsp90 is essential for stability and function of oncogenic client proteins, which contribute 
to the hallmark of cancer.  
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In  tumour  cells,  Hsp90  was  found  to  accumulate  in  multiprotein 
complexes bound to client and partner proteins while in normal cells Hsp90 was 
found  as  a  homodimeric  protein  unbound  to  partner  proteins  (Kamal  et  al., 
2003). In addition, Hsp90 in tumour cells has a high ATPase activity and a high 
affinity for inhibitors such as GA compared to normal cells (Kamal et al., 2003). 
This  high  affinity  of  tumour  Hsp90  may  be  because  tumour  cells  are  highly 
dependent on Hsp90 for growth in the aggressive tumour environment (Blagg & 
Kerr, 2006). The use of Hsp90 specific inhibitors results in a decline in client 
protein activity in vivo and in the degradation of vital signaling proteins that are 
involved  in  cell  proliferation,  cell  cycle  regulation  and  apoptosis  (Maloney  & 
Workman, 2002). As a result, unfolded proteins become part of an unproductive 
heteroprotein  complex,  which  leads  to  their  degradation  by  the  ubiquitin 
proteasome pathway (Connell et al., 2001). Targeting a single molecule leads to 
the degradation of many other proteins, which is why Hsp90 has been suggested 
as a unique target for cancer therapeutics.   
Studies by Hostein et al (2001) on human colon cell lines showed that 17 
AAG inhibited the RAS RAF MEK ERK1/2 and PI 3K AKT/PKB pathway by targeting 
Hsp90 molecules. Subsequently, this was accompanied by cytostasis, cell cycle 
arrest  and  cell line  dependent  apoptosis.  Both  signalling  pathways  require 
activation by tyrosine kinase ErbB2, which was shown to be an important Hsp90 
client protein (Yarden & Sliwkowski, 2001; Citri et al., 2004). Studies by Smith 
et al (2002) showed that ErbB2 over expression caused a five fold increase in 
sensitivity to GA and 17 AAG. These observations suggest the potential use of 17 
AAG as an agent for chemotherapy. In phase 1 clinical trials, treatment of two 
patients  with  advanced  metastatic  malignant  melanoma  showed  that  B RAF 
mutants were very sensitive to 17 AAG mediated proteosomal degradation (da Chapter 1        35 
Rocha Dias et al., 2005) which may suggest a possible mechanism for the clinical 
activity of 17 AAG in melanoma. In addition, Pacey et al (2006) observed some 
clinical activity using 17 AAG in breast and prostate cancer. The activity of 17 
AAG was shown to be reduced in the presence of P glycoprotein (P gp)(Kelland 
et al., 1999) and it was metabolized by the cytochrome P450, CYP3A4 (Egorin et 
al., 1998). A second  generation of GA derivatives, 17 DMAG has also entered 
Phase  1  clinical  trials.  In  patients  with  chemotherapy refractory  acute 
myelogenous  leukaemia,  a  complete  response  to  treatment  in  3  out  of  17 
patients was observed (Lancet et al., 2010). These results indicate the potential 
of Hsp90 as a drug target in cancer chemotherapy.   
1.5 Hsp90 in nematodes 
Nematodes are very diverse organisms and are classified under the phylum 
Nematoda.  According  to  Blaxter  et  al  (1998)  nematodes  have  evolved  to  be 
parasitic on multiple occasions and have successfully adapted to non vertebrate, 
vertebrate  and  plant  hosts.  Despite  the  tremendous  medical  and  economic 
importance  of  nematodes,  the  great  majority  of  nematodes  are  free living. 
Initially,  nematodes  were  classified  based  on  morphological  characteristics 
derived primarily from light microscopy. Recently, attempts have been made to 
use  molecular  methods  to  classify  nematodes.  The  analysis  of  small  subunit 
ribosomal RNA genes (SSU rRNA) by Blaxter et al (1998) showed that nematodes 
can be divided into three major clades: Dorylaimia (clade I), Enoplia (clade II), 
and  Chromadorea  which  also  includes  the  Rhabditida.  The  Rhabditida  can  be 
further  divided into Sprurina (clade III), Tylenchina (clade IV) and Rhabditina 
(clade  V).  Clade  I  consists  of  Dorylaimida,  Mermithida,  Mononchida, 
Dioctophymatida  and  Trichinellida.  This  clade  includes  the  free living Chapter 1        36 
microbivores,  plant,  insect  and  animal parasitic  nematodes.  Clade  II  contains 
plant  parasitic  enoplids  and  triplonchids  but  no  animal  parasites.  Clade  III 
consists  of  parasitic  species  including  spirurids,  ascaridids,  oxyurids  and 
rhigonematids. B. pahangi resides in clade III together with Toxocara cati and 
Parascaris equorum. Clade IV comprises plant and animal parasites and some 
free living species.  Globodera  sp.  was  placed in  this clade  together with the 
vertebrate parasitic Strongyloidoidae. Clade V the Rhabditia, consists of free 
living  and  animal  parasitic  species.  C.  elegans  belongs  to  clade  V  with  some 
others  important  parasitic  species  such  as  Haemonchus  contortus  and 
Teladorsagia circumcincta. Figure 1.10 shows a classification of nematodes in 
different  clades  based  on  SSU  rRNA  (Blaxter  et  al.,  1998;  De  Ley  &  Blaxter, 
2002). 
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Figure 1.10: Nematode species from different clades of nematode (after Blaxter et al., 1998).  
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1.5.1 Nematodes life-cycles 
Nematodes show a great deal of diversity in their life cycles with many 
free lving species while others are parasitic in animals and plants. Genarally, 
nematodes have five developmental stages in their life cycle; L1, L2, L3, L4 and 
adult.  Free living  species  such  as  C.  elegans  exhibit  a  direct  life cycle 
developing  from  egg  to  adult  (see  Figure  1.11a).  However,  under  certain 
conditions such as an absence of food or over crowding, C. elegans can choose 
an  alternative  developmental  pathway leading  to  the  dauer  larva (Cassada  & 
Russell, 1975). In the dauer stage, worms do not feed but can survive under 
extreme  conditions  for  several  months.  When  conditions  become  more 
favourable, development is resumed. The nematodes exit the dauer larval stage 
and  develop  into  the  normal  L4  stage  before  becoming  adults.  For  parasitic 
species  such  as  the  Trichostrongyles,  e.g  H.  contortus,  part  of  the  life cycle 
takes place in the environment. Eggs are passed in the host faeces and L1, L2 
and L3 stages develop in the environment. The infective L3 is ingested and L4 
and adult stages develop in the definitive host (see Figure 1.11b).   
For obligate parasitic nematodes, such as filarial worms, the life cycle is 
more complex and requires an intermediate host. Mf to L3 development occurs 
in the mosquito, while L3 to adult stages takes place in the definitive host. The 
infection is initiated by the bite of a mosquito which harbours L3 stage parasites. 
The L3 are released and enter the body of the definitive host. In the definitive 
host,  the  L3  undergo  two  moults  before  become  an  adult  in  the  afferent 
lymphatics. After mating, females produce Mf that circulate in the bloodstream 
which are then available for a mosquito to ingest with a blood meal (see Figure 
1.12).        Chapter 1        39 
 
 
 
 
Figure 1.11: Life-cycles of free-living and parasitic nematodes. 
 
a) C. elegans life-cycle. As a free-living nematode, the C. elegans life-cycle takes place in the 
environment. Eggs hatch and develop from L1, L2, L3 and L4 before undergo a final moult to 
adult.  Under  certain  conditions  (such  as  crowded  or  limitated  food  source)  dauer  stages 
develop. Dauer stages are resistant and non-feeding. When the conditions revert to normal, 
dauer stages develop into L4 before becoming adult.  
b) Parasitic Trichostrongyle life-cycle e.g H. contortus, T. circumcincta.  Eggs are passed in the 
faeces and hatch. The L1, L2 and L3 develop in the environment. The infection occurs when the 
definitive  host  grazes  and  eat  grass  containing  infective  L3.  In  the  definitive  host,  the  L3 
develop  into  L4  and  to  adult.  (Image  courtesy  of  Virginia  State  University 
http://pubs.ext.vt.edu/410/410-027/410-027.html)   
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Figure 1.12: Filarial worm life-cycle.  
 
Filarial worms (such as B. pahangi or B. malayi) require a mosquito to complete the life-
cycle. During a blood meal, an infected mosquito introduces L3 filarial larvae onto the skin 
of the definitive host, where they penetrate into the bite wound. L3 develop into L4 and 
adults that commonly reside in the lymphatics. After mating, female worms produce Mf. The 
Mf migrate into lymph and then circulate in the bloodstream.  A mosquito ingests the Mf 
during a blood meal. The Mf develop into L2 and subsequently into L3. The L3 can infect 
another  human  when  the  mosquito  takes  a  blood  meal.  (Image  courtesy  of  Medscape 
http://emedicine.medscape.com/article/998011-overview) 
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1.5.2 What do we know about Hsp90 in nematodes? 
Much of the information on Hsp90 in nematodes comes from studies on C. 
elegans,  a  free  living  nematode  that  is  often  used  as  a  model  for  parasitic 
species. The C. elegans genome contains a single hsp90 gene (daf 21) located on 
chromosome V,  which is 74% and 76% identical to human  hsp90α  and  hsp90β 
respectively  (Birnby  et  al.,  2000).  daf 21  has  a  molecular  weight  of 
approximately 83 kDa as seen by Western blotting. By in situ hybridization, daf 
21 mRNA in L1 was shown to be expressed in the germline precursor cells and 
the head region of C. elegans (Inoue et al., 2003). In adult males, daf 21 was 
distributed  mainly  in  germline  cells  similar  to  hermaphrodites.  The  over 
expression  of  daf 21  in the germline suggests that it may be involved in  the 
maintenance and maturation of germline precursors.  A strong signal was  also 
observed in spermatocytes but no signal was observed in mature sperm (Inoue et 
al., 2003). In the same studies, Inoue and co workers showed that under stress 
conditions,  daf 21  mRNA  was  expressed  all  over  the  body  of  C.  elegans. 
Interestingly the localization of  daf 21 mRNA and DAF 21 protein are not the 
same in the L1 and adult stages. daf 21 mRNA was detected only in germline 
cells  at  both  the  L1  larva  and  adult  stages,  whilst  the  DAF 21  protein  was 
localized not only in germline cells but also in somatic cells at both stages (Inoue 
et al., 2003).            
 The transcription of hsp90 in C. elegans is increased 10 15 fold in dauer 
larvae compared to other life cycle stages (Dalley & Golomb, 1992). The dauer 
stage is an alternate third stage larva in C. elegans that enhances survival of the 
organism under harsh conditions. In the dauer stage, larvae do not eat because 
their oral orifice is blocked by an internal plug (Riddle et al., 1981). The reason Chapter 1        43 
why daf 21 mRNA is highly abundant in dauer stages compared with other life 
cycle  stages  remains  unknown.  It  may  provide  additional  chaperone  activity 
under stressful conditions. However, the expression of daf 21 mRNA decreased 
sharply within the first 75 minutes of recovery after worms had been stimulated 
to emerge from the dauer stage (Dalley & Golomb, 1992). It has been suggested 
that Daf 21/Hsp90 is involved in the formation of dauers in C. elegans acting in 
the same pathway as daf 11 (a transmembrane guanylyl cyclase) in regulating 
chemosensory transduction in several types of sensory neurons (Thomas et al., 
1993).  Furthermore,  the  dauer  is  a  long lived  stage  of  C.  elegans  and  other 
studies have also shown that daf 21 is highly expressed in long lived mutants of 
C. elegans (Morley & Morimoto, 2004). 
Two mutations have been characterised in C. elegans hsp90 namely, daf 
21(p673)  and  daf 21(nr2081)  (Birnby  et  al.,  2000).  daf 21(p673)  is  a  point 
mutation (E292 to K) that causes relatively limited phenotypes. This is not a null 
mutation  and  may  result  in  a  protein  that  specifically  fails  to  stabilize 
chemosensory  transduction  components  because  mutants  have  a  range  of 
sensory defects and reduced fertility (Birnby et al., 2000). daf 21(nr2801) is a 
true  null  mutation  and  has  an  860  bp  deletion  with  a  3 bp  insertion.  daf 
21(nr2081) arrests growth at the L2 to L3 stage (Birnby et al., 2000), indicating 
the  importance  of  Hsp90  in  C.  elegans.  RNAi  studies  on  daf 21  revealed  the 
necessity for Hsp90 in adult worms. Studies by Piano et al (2000) showed that 
injection  of  dsRNA  into  hermaphrodite  worms  results  in  an  embryonic  lethal 
phenotype in the progeny and a defect in egg production, which again suggests, 
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Hsp90  in  the  filarial  parasite  B.  pahangi,  is  82%  identical  to  C.  elegans 
Hsp90,  67%  identical  to  D.  melanogaster  Hsp90  and  69%  identical  to  human 
Hsp90 (Thompson et al., 2001). However, the expression of Hsp90 in B. pahangi 
is constitutive and no significant increase in the level of Hsp90 was observed in 
any life cycle stage of B. pahangi exposed to elevated temperatures (Devaney et 
al., 2005). These results suggest that in B. pahangi, Hsp90 is not a major heat 
inducible protein. B. pahangi Hsp90 contains all five features of Hsp90s that are 
common to others eukaryotic proteins. However, B. pahangi Hsp90 has a long 
charged region encompassing the amino acids 235–320 (Thompson et al., 2001).  
B. pahangi Hsp90 contains two putative ATP binding domains (amino acids 93–99 
and 135–142) and a large number of potential phosphorylation sites. Analysis by 
Southern blots showed that B. pahangi hsp90 is a single copy gene (Thompson et 
al., 2001), as in C. elegans.  
Skantar  and  Carta  (2004)  showed  that  the  plant  parasitic  nematodes, 
Heterodera  glycines  and  Meloidogyne  javanica,  contain  a  single  hsp90  gene 
similar to C. elegans (Birnby et al., 2000) and B. pahangi Hsp90 (Thompson et 
al.,  2001).  H.  glycines  Hsp90  was  shown  to  be  83%  indentical  to  B.  pahangi 
Hsp90, 82% to C. elegans and 73% to D. melanogaster. Despite the high level of 
conservation and homology between C. elegans Hsp90 and other eukaryotes, C. 
elegans Hsp90 is resistant to GA treatment and failed to bind to GA (David et al., 
2003; Devaney et al., 2005). The structure of Hsp90 is well conserved between 
B.  pahangi  and  C.  elegans,  the  only  major  feature  of  significance  being  the 
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1.5.3 C. elegans as a model for the study of parasitic nematodes 
C.  elegans  is  a  small  free living  nematode  usually  found  in  the  soil  in 
temperate climates all around the world. It has a direct life cycle and is very 
easy to maintain in the laboratory. It is only 1 mm long.   The first paper on the 
use of C. elegans for genetic studies was published in 1974 (Brenner, 1974) and 
since then, it has become one of the most interesting model organisms to study, 
especially  in  developmental  biology  (reviewed  by  Gilleard,  2004).  A  major 
problem faced by researchers working on parasitic nematode is the lack of in 
vitro culture systems and the requirement to propagate life cycles in vivo. As a 
result, the technology and genomic resources for parasitic nematode are still 
lagging behind those available for C. elegans.  
In  addition,  there  are  no  reverse  genetic  methods  available  to  study 
parasitic nematode gene function (Gilleard, 2004). One of the powerful methods 
to study gene function is RNA mediated interference (RNAi)(Fire et al., 1998). 
This mechanism of gene silencing was shown to be very reliable and effective in 
many  organisms  including  insects,  planarians,  protozoa  and  mammalian  cells 
(Britton & Murray, 2006). In C. elegans RNAi can be achieved by injection of 
double stranded RNA (dsRNA) into the adult worm body, by soaking in dsRNA or 
by feeding the worms with E. coli expressing dsRNA (Kamath et al., 2003). Using 
RNAi to knock down a gene can result in an observable phenotype. Based on the 
phenotypes observed it can give a starting point for studying the gene of interest 
in greater detail. The known phenotypes of RNAi in C. elegans can be assessed 
through the Wormbase website (http://www.wormbase.org/db/searches/basic). 
In  parasitic  nematodes,  there  are  several  reported  successful  applications  of 
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glycines and G. pallida (Urwin et al., 2002), Meloloidogyne incognita (Bakhetia 
et  al.,  2005),  B.  malayi  (Aboobake  &  Blaxter,  2003),  Onchocerca  volvulus 
(Lustigman et al., 2004), Trichostrongylus colubriformis (Issa et al., 2005) and 
H. contortus (Kotze & Bagnall, 2006; Samarasinghe et al., 2010). The success of 
RNAi in these parasitic nematodes suggests that the RNAi pathway does exist in 
some parasitic species and that some genes can be silenced by dsRNAi (Britton & 
Murray,  2006;  Samarasinghe  et  al.,  2010).  Furthermore,  the  level  of  target 
transcript or sites of gene expression influence susceptibility to RNAi by soaking 
(Samarasinghe  et al., 2010). However, the success of RNAi varies enormously 
with  parasite  species,  life  cycle  used  and  genes  targeted.  RNAi  studies  by 
Geldhof et al (2005) revealed that the success of RNAi approaches is variable in 
H.  contortus.  Under  certain  circumstances,  it  is  possible  to  suppress  gene 
expression but RNAi only works on a limited number of genes and the effect is 
often small and hard to reproduce.      
C.  elegans  was  the  first  multi cellular  organism  to  have  its  genome 
completely  sequenced  in  1998.  This  provided  a  very  important  resource  for 
bioinformatics and functional analysis of C. elegans genes. As more genomes for 
parasitic nematodes become available, it will be possible to identify important 
genes which can provides a good reference for understanding the molecular basis 
of the evolutionary adaptations of nematodes. In addition it will provide further 
understanding  of  the  many  adaptations  associated  with  parasitic  life cycles 
(Wasmuth et al., 2008).  The draft sequence of the B. malayi genome has been 
published (Ghedin et al., 2007) and sequencing the H. contortus genome is on 
going.  There  also  several  sequencing  projects  for  other  species  of  veterinary 
importance  which  can  be  accessed  through  the  website 
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C. elegans can provide a useful platform to study gene function particularly 
in  parasitic  nematodes  (Gilleard,  2004).  A  parasite  gene  of  interest  can  be 
expressed in C. elegans which then provides a tool to study its function. One of 
the methods is to introduce the gene of the interest into a C. elegans mutant 
strain to ask whether it can restore the wild type phenotype. The majority of 
the successful interspecies rescue experiments reported to date come from work 
using H. contortus (Britton & Murray, 2006). For example, H. contortus isotype 1 
β tubulin (tub 1) was the first parasitic gene to be functionally expressed in C. 
elegans (Kwa et al., 1995). In C. elegans, a mutation in the β tubulin gene, ben 
1  conferred  resistant  to  benzimidazole  compounds  (Driscoll  et  al.,  1989).  By 
expressing the H. contortus tub 1 susceptible gene in C. elegans ben 1 mutants, 
the resistance phenotype was reversed. In contrast expressing the H. contortus 
tub 1 resistant gene in the mutant had no effect on the susceptibility of the 
mutant  to  benzimidazole  (Kwa  et  al.,  1995).  This  experiment  proved  that 
interspecies mutant rescue can be used to study the function of a parasite gene.   
1.6 Hsp90 and its role in drug resistance  
1.6.1 The ability of Hsp90 to ‘buffer’ mutations has important 
implications 
Recently, a number of studies have suggested that Hsp90 may be involved 
in facilitating rapid evolutionary changes in organisms such as D. melanogaster 
(Rutherford & Lindquist, 1998; Sollars  et al., 2003), and Arabidopsis thaliana 
(Queitsch et al., 2002). The study of Rutherford & Lindquist (1998) showed that 
back crossing a D. melanogaster hsp90 mutant with a standard laboratory strain 
resulted in morphological abnormalities in the offspring e.g. deformed eyes or 
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when the wild type D. melanogaster strain was raised on food containing GA, 
similar abnormalities were produced as observed for the D. melanogaster hsp90 
mutants. It was proposed that these cryptic mutations are not observed when a 
sufficient  amount  of  Hsp90  is  normally  expressed.  In  the  plant,  A.  thaliana, 
Hsp90 was also suggested to act as a buffer for genetic variation (Queitsch et 
al.,  2002).  That  study  extended  the  early  concept  of  Hsp90  buffering  of 
morphological  traits  to  environmental  responses.  In  Arabidopsis  they  showed 
that  inhibition  of  Hsp90  function  by  treatment  with  GA  revealed  several 
phenotypes which were heritable even in the absence of GA. This effect may be 
conserved  in  other  organisms,  potentially influencing  the  pace  and  nature  of 
evolution.   
1.6.2 Hsp90 and its role in drug resistance in infectious agents 
Recent studies on Hsp90 have shown that it is required in Saccharomyces 
cerevisiae to survive the acute stress of drug exposure and also for some types of 
drug resistance.  The original study of Cowen & Lindquist (2005) demonstrated 
that Hsp90 was important for the acquisition of resistance to azole compounds in 
S. cerevisiae. The azole target Erg11 which is involved in the biosynthesis of 
ergosterol,  a  component  of  fungal  membranes  (Sanglard,  2002,  Odds  et  al., 
2003).  Compromising  Hsp90  functions  with  GA  or  radicicol  was  sufficient  to 
restore azole sensitivity to otherwise resistant S. cerevisae. The emergence of 
fluconazole resistance under rapid selection was shown to be highly dependent 
on  elevated  levels  of  Hsp90  and  this  resistance  was  abrogated  when  Hsp90 
expression was reduced (Cowen & Lindquist, 2005). In that system, inhibition of 
an Hsp90 client protein, calcineurin, mimicked Hsp90 inhibition suggesting that 
Hsp90  might  act  via  calcineurin.  Importantly,  the  role  of  Hsp90  in  drug Chapter 1        49 
resistance  in  S.  cerevisiae  was  also  conserved  in  a  number  of  medically 
important pathogenic fungi such as C. albicans and Aspergillus fumigatus (Cowen 
et  al.,  2009,  Singh  et  al.,  2009).  Calcineurin  is  a  serine/threonine  protein 
phosphatase  (Dobson  et  al.,  1999)  and  according  to  Singh  et  al  (2009),  in 
Candida albicans, Hsp90 inhibition blocks calcineurin activation, which leads to 
increased  sensitivity  to  the  novel  anti fungal  compound,  echinocandin.  These 
results suggest a role for Hsp90 in acquired drug resistance in fungi. 
In Leishmania donovani Hsp83, the orthologue of Hsp90, was shown to be 
expressed at higher levels in isolates from patients unresponsive to pentavalent 
antimonials,  compared  to  isolates  from  patients  responsive  to  these  drugs 
(Vergness et al., 2007). The mechanism by which pentavalent antimonials kill 
the parasite is not well understood, but they may interact with trypanothione, 
the main reduced cellular thiol of the parasite (Wyllie et al., 2004). L. donovani 
isolates  from  unresponsive  patients  were  not  only  resistant  to  pentavalent 
antimonials but also exhibited cross resistance to miltefosine and amphotericin 
B. Furthermore,  transfection of the  hp83  gene from  an  L.  donovani  resistant 
strain into an L. donovani sensitive strain resulted in an increased resistance to 
trivalent antimonials. The sensitive isolates overexpressing Hsp83 were shown to 
be more than two fold resistant to  trivalent antimonials compared to control 
parasites  and  also  showed  cross resistant  to  metefosine.  The  parasites  over 
expressing Hsp83, were protected from programmed cell death after treatment 
with trivalent antimonials, suggesting that Hsp83 might increase drug resistance 
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1.6.3 Hsp90 and drug resistance in tumour cells 
In tumour cells, Hsp90 is an important target for chemotherapy because it 
is required for the stability and function of many molecules that are important 
for tumour cell growth. In tumours, Hsp90 interacts with a variety of protein 
including steroid hormone receptors, Ser/Thr and Tyr kinases and proteins with 
various other functions (Maloney & Workman, 2002). Several studies in tumour 
cells suggest that Hsp90 is involved in drug resistance. For example, a breast 
cancer cell line was shown to be resistant to docetexal chemotherapy due to 
involvement of  the  PI 3K pathway which is modulated by Hsp90 (Xing  et  al., 
2008). Another interesting example of Hsp90 involvement in drug resistance in 
tumour cells comes from studies on malignant melanomas. According to Banerji 
(2009), malignant melanoma is relatively resistant to most conventional forms of 
cancer treatment such as chemotherapy and radiotherapy. Studies by Davies et 
al  (2002),  showed  that  an  Hsp90  client  protein,  BRAF,  is  highly  mutated  in 
malignant  melanoma.  Hsp90  inhibition  resulted  in  degradation  of  the  mutant 
BRAF compared  to  wild type  BRAF, which  suggests that Hsp90  might mediate 
resistance in malignant melanoma through BRAF. In addition, Hsp90 expression 
was  found  to  be  higher  in  metastasic  melanomas  (Faingold  et  al.,  2008; 
McCarthy et al., 2008). The higher expression level of Hsp90 in resistant tumour 
cells suggests that Hsp90 may be one mechanism by which tumour cells acquire 
drug resistance. 
A study by Costantino et al (2009) on TRAP1, an homologue of Hsp90 which 
resides in the mitochondria, in drug resistant HT 29 human colorectal carcinoma 
cells  showed  that  TRAP1  was  up regulated  after  treatment  with  three 
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compared  to  wild type  HT 29  cells.  In  addition,  they  also  showed  that  over 
expression  of  TRAP1  leads  to  5 fluoracil,  oxaliplatin  and  irinotecan  resistant 
phenotypes in HT 29 cells.  In contrast the inhibition of TRAP1 using sperherdin 
increased the sensitivity of resistant HT 29 to oxaliplatin and irinotecan but not 
to 5 fluoracil. These results suggest that TRAP1 may be involved in a multi drug 
resistant phenotype in vitro.  
A common mechanism of drug resistance in many tumour cell types is over 
expression of drug transporters such as P gp or detoxification systems. According 
to Bertram et al (1996), Hsp90β is associated with P gp in multi drug resistant 
colon carcinoma (LoVo) cells and in a murine cell line (S180). These cell lines 
were  shown  to  be  resistant  to  doxorubicin.  In  that  study,  they  showed  that 
Hsp90β was expressed constitutively in the resistant LoVo cell line but not in 
sensitive LoVo cells. In addition, in the doxorubicin resistant murine cell line, 
S180, Hsp90β was also expressed at higher levels compared to a sensitive cell 
line.  In  a  subsequent  study,  it  was  demonstrated  that  Hsp90β  and  P gp  co 
precipated  in  the  lysates  of  resistant  LoVo  cells,  which  suggests  a  direct 
interaction between P gp and Hsp90.
 Furthermore, reducing the Hsp90β levels by 
antisense oligonucleotides resulted in a reduced half life of P gp which increased 
the doxorubicin sensitivity of resistant LoVo cells by two fold (Betram et al., 
1996). These results suggest an intracellular co operation between Hsp90β and 
P gp and the involvement of Hsp90β in doxorubicin resistance. 
1.6.4 Could Hsp90 have a role in anthelmintic resistance in 
nematodes? 
In nematodes anthelmictic resistance is one of the major problems that 
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dependent on anthelmintic drugs from three different groups (benzimidazoles, 
imidazothiazoles and macrocylic lactones) for control of infection. Anthelmintic 
resistance  can  be  defined  as  a  decrease  in  anthelmintic  efficiency  against  a 
parasite  which  is  normally  susceptible  to  that  drug  (Sangster  &  Gill,  1999). 
Resistance  is  a  heritable  character,  therefore  many  of  these  nematodes  will 
have inherited their parent’s ability to survive exposure to drug (Prichard et al., 
1980).  The use of anthelmintic drugs to control gastrointestinal nematode put a 
massive selection pressure on nematode populations which led to emergence of 
anthelmintic resistance. According to Gilleard (2006), current understanding of 
the mechanism of benzimidazole resistance is more highly developed, but for 
imidazothiazole or macrocylic lactones, the underlying mechanisms are not well 
defined.  Studying  the  mechanisms  of  anthelmintic  resistance  in  parasitic 
nematodes is difficult because of the complexity of the life cycles and because 
it is not possible to genetically manipulate these organisms. Because of that, C. 
elegans has been used as a model to study the mechanisms of drug resistance in 
parasitic nematodes.  
Benzimidazoles exert their roles by binding to tubulin. Tubulin is a major 
component  of  microtubules  which  play  an  important  role  in  sustaining  the 
cellular homeostasis in eukaryotic cells. By binding to tubulin, benzimidazoles 
cause disruption of microtubule structure and function which lead to cell death. 
Benzimidazole  resistance  in  nematodes  appears  to  be  associated  with  an 
alteration in ß tubulin genes, which reduces the high affinity binding of drug to 
tubulin (Lacey, 1988). In C. elegans, sensitivity to benzimidazole is associated 
with a single gene,  ben 1, which encodes  β tubulin isotype 1 (Driscoll  et al., 
1989).  Deletion  or  mutation  of  ben 1  in  C.  elegans  does  not  impair  the 
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al., 1989). In the study of Kwa et al (1995), the wild type β tubulin isotype 1 
gene from H. contortus was expressed in benzimidazole resistant C. elegans and 
restored the sensitivity of C. elegans to benzimidazole compunds.  
 Anthelmintics  of  the  imidazothiazole  group  were  introduced  to  the 
market in 1968. The most widely used are levamisole, pyrantel and morantel. 
Levamisole is a nicotinic acetylcholine (nACh) receptor agonist (Aceves et al., 
1970;  Aubry  et  al.,  1970)  with  a  selective  action  on  nematode  receptors. 
Levamisole binds to nACh receptors and mimics this neurotransmitter resulting in 
paralysed worms (Sangster, 1999) and spastic paralysis and egg laying defects in 
C. elegans (Holden Dye & Walker, 2007). This muscle paralysis is thought to be 
caused by activation of the excitatory nACh receptors on the nematode body 
wall muscle (Martin et al., 1996).). In C. elegans, at least four subunits, unc 38, 
unc 29, unc 63 and lev 1 contribute to the levamisole receptor (Culetto et al., 
2004).  All  these  genes  were  suggested  to  be  associated  with  levamisole 
resistance  in  C.  elegans.  Development  of  levamisole  resistance  in  parasitic 
nematodes is also likely to be polygenic as reported in H. contortus (Sangster et 
al., 1991) and Oesophagostomum dentatum (Varady et al., 1997, Robertson et 
al., 1999). However the potential genes involved in levamisole resistance have 
not yet been identified in parasitic nematodes.    
The  macrocylic  lactones  that  have  been  used  commercially  to  combat 
nematode infections are ivermectin, moxidectin and abemectin. Ivermectin is a 
fermentation product of the micro organism Streptomyces avermilitis (Holden 
Dye & Walker, 2007). Ivermectin causes paralysis of worm somatic musculature 
(Kass et al., 1980; Kass et al., 1982) and inhibits feeding of the nematode by 
blocking pharyngeal pumping (Geary et al., 1993; Martin et al., 1996; Sangster & Chapter 1        54 
Gill, 1999), causing starvation and worm death. The mechanism of ivermectin 
resistance is thought to be associated with alterations in the GluCl receptor in C. 
elegans (Cully et al., 1994). As reviewed by Gilleard (2006), the mechanism of 
ivermectin resistance is complex and multigenic. For example, in C. elegans it 
was shown  that resistance  to ivermectin requires mutations in  at least three 
genes which are members of the GluCl family, namely in glc 1, avr 14 and avr 15 
(Dent et al., 2000, Holden Dye & Walker, 2007). Mutation of any two of these 
genes did not confer ivermectin resistance on C. elegans (Dent et al., 2000). 
Furthermore, recent studies in parasitic species suggest the involvement of P gp 
in ivermectin resistance in H. contortus (Xu et al., 1998). Expression of P gp 
mRNA was shown to be higher in ivermectin selected than unselected strains of 
H. contortus, which suggests that ivermectin resistance in H. contortus may be 
associated with a more efficient drug efflux system.  
In  tumour  cells  and  fungi,  the  emergence  of  drug  resistance  was 
suggested  to  be  associated  with  Hsp90  and  its  co chaperones.  However,  the 
mechanisms  underlying  the  development  of  drug  resistance  in  parasitic 
nematodes are not well understood. Because of that, research addressing the 
mechanisms of anthelmintic resistance must therefore be a main concern in this 
field.       
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1.7 Aims of thesis 
The specific aims are detailed below. 
·  Although the sequence of daf 21 (Hsp90) in C. elegans is highly conserved, 
it is unique amongst eukaryotes because it fails to bind to GA. In contrast, 
previous studies have shown that B. pahangi Hsp90 can bind GA. The first 
aim of the project is to determine whether the failure of C. elegans Hsp90 
to bind to GA is the norm or the exception amongst nematodes and to 
determine  whether  GA  binding  is  associated  with  particular  clades  of 
nematodes. 
·  B.  pahangi  is  known  to  be  susceptible  to  Hsp90  inhibition,  but  no 
information exists to explain why GA kills the worm. A second aim of the 
thesis is to characterise B. pahangi Hsp90 in more detail with a view to a 
better understanding of the function of Hsp90 in nematodes. 
·  Nematode resistance to anthelmintics threatens the viability of the small 
ruminant industry in many countries all over the world. In tumours and 
fungi, Hsp90 is known to be involved in drug resistance. So the third aim 
of  the  thesis  is  to  investigate  whether  Hsp90  plays  a  role  in  drug 
resistance in nematodes.         
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2  Materials and methods 
2.1 GA-binding assay 
2.1.1 Nematodes  
24 species of nematode from different clades were used for the analysis 
of  GA binding.  These  included  both  free–living  and  parasitic  species.  Some 
nematode  strains  were  received  from  the  Caenorhabditis  elegans  Genetics 
Centre (CGC, USA) including C. elegans Bristol N2, C. elegans JT6130, a daf 21 
mutant, C. briggsae, Oscheius tipuleae and Pristionchus pacificus, while others 
were  obtained  from  relevant  laboratories  (Appendix  1).  Parasitic  species 
analysed included Trichinella spiralis and Trichuris muris (both clade I). Clade III 
nematodes  included  the  filarial  species  (Brugia  pahangi,  Dirofilaria  immitis, 
Onchocerca ochengi, Acanthocheilonema viteae), Ascarid species (Toxocara cati, 
Ascaris  suum,  Parascaris  equorum),  Anisakids  (Anisakis  simplex, 
Pseudoterranova decipiens) and Anguillicola crassus. Clade IV species included 
Strongyloides ratti, Globodera rostochiensis and G. pallida and the free living 
species Panagrellus redivivus. Clade V species included Haemonchus contortus, 
Teladorsagia  circumcincta,  Nipponstrongylus  brasiliensis  and  Heligmosomoides 
polygyrus. Mixed life cycle stages were used for all free living nematodes, while 
for  parasitic  species,  usage  was  determined  by  availability  of  particular  life 
cycle  stages. In  most  cases  adult  males  and  females  were  analysed  with  the 
following exceptions: H. contortus, L3; T. spiralis, L1 muscle stage larvae; S. 
ratti adults were free living rather than parasitic females; Globodera spp. J2 
stages; O. ochengi only males were used; A. simplex and P. decipiens L3 were 
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2.1.2 Maintenance of nematodes 
2.1.2.1  Maintenance of free-living species  
C. elegans N2, C. elegans JT6130  (a daf 21 mutant which carries a point 
mutation in daf 21, E292 to K)(Birnby et al., 2000), C. briggsae, O. tipuleae and 
P. pacificus were cultured at 20
oC on NGM agar (Appendix 4.3) inoculated with 
Escherichia coli strain OP50 as a food source as described previously (Brenner, 
1974). Free living worms were  washed with M9 (Appendix 5.2)  several times, 
concentrated by centrifugation at 2000 rpm for 2 min and stored at  80
oC before 
use. 
P. redivivus was received from Prof. Aaron G. Maule (Queen’s University 
Belfast,  UK)  and  was  cultured  on  cooked  oats  in  Petri  dishes.  100  g  of  oats 
(Quaker Oats) were cooked in some water and poured into Petri dishes (6 x 9 
cm). Worms were then poured over the surface of the cold cooked oats and were 
maintained at room temperature. As the population of the worms bloom, the 
worms will crawl onto the lid from where they were colleted by washing off the 
lid with M9. Worms were pelleted by centrifugation at 2000 rpm at 4
oC and kept 
at  80
oC before use.  
2.1.2.2  Maintenance of parasitic species 
For  parasitic  species,  adult  stages  were  obtained  from  relevant 
laboratories from their respective hosts and were frozen as soon as possible at  
80
0C (see Appendix 1). L3 Larval stages  of  A. simplex  and  P. decipiens  were 
obtained from infected fish (kindly provided by Dr. S. Martin and Dr. I. Coombs 
respectively). T. spiralis L1 (kindly provided by Dr. C. Lawrence), muscle stages 
were obtained by digestion of infected mouse muscle using standard methods Chapter 2    59 
(Wakelin & Wilson, 1977; Knight et al., 2000).  H. contortus L3 were obtained by 
harvesting the eggs from infected sheep faeces and culturing to the L3 stage 
(received from Prof. D. Knox).       
The cysts of G. rostochiensis (obtained from Dr. J. Jones) and G. pallida 
(Dr. C. Fleming) containing infective stage juveniles (J2) were placed in large 
Petri dishes half filled with tap water and left for 5 days at room temperature. 
After 5 days, the water was replaced with tomato root diffusate (TRD) (kindly 
provided by Dr. J. Jones, Scottish Plant Breeding Institute, UK). The J2 begin to 
hatch a few days after TRD has been applied. The larval stages of Globodera 
spp.  were  colleted  and  cleaned  by  floating  them  on  a  sucrose gradient.  The 
larvae were suspended in 5 ml ddH2O in a 15 ml conical tube and 5 ml of sucrose 
solution (Appendix 5.3) was added. 500  l of ddH2O was overlaid on top of the 
surface of sucrose solution which was then centrifuged for 5 min at 2000 rpm. 
The nematodes will float at the interface between the sucrose and the water 
overlay. The nematodes were collected and rinsed several times in clean water 
and kept in  80
oC before use.  
2.1.3 Protein extraction for GA-binding experiments 
Extracts  of  worms  were  prepared  in  ice cold  TNES  buffer  (Appendix 
2.1.1), with protease inhibitors added prior to use (1 tablet per 10 ml TNES) 
(Complete  Mini  Protease  Inhibitor  Cocktail,  Roche  Diagnostics,  UK).  Liquid 
Nitrogen was poured into a mortar, the worm pellet was added and ground to a 
fine powder using the pestle. The worm extract was then re suspended in 1.0 ml 
TNES  containing  protease  inhibitors  and  the  mortar  washed  out  with  0.5  ml 
TNES. Following incubation on ice for 15 min, the extract was pelleted at 13200 
rpm at 4
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the worm material was very limiting, e.g. D. immitis and O. ochengi, the lysates 
were  prepared  using  small  glass  homogenisers.  100   l  of  ice cold  TNES  with 
protease inhibitors was added and the worms were ground. The supernatant was 
then prepared as described previously.  
2.1.4 Protein concentration estimation 
Protein concentrations were estimated using the Bio Rad protein assay in 
a  96  well  microtitre  format.  Usually  samples  were  diluted  1:50  and  then 
different amount added to the assay e.g. 5, 10, 15, 20  l.  Samples and bovine 
serum albumin (BSA) standards were incubated in the working reagent (Bio Rad, 
UK) for 8 min at room temperature, allowing a colorimetric reaction to occur. 
The  optical  density  (OD)  at  562  nm  was  measured  using  OpsysMR  (Dynex 
Technologies)  and  the  protein  concentration  of  the  sample  (in  duplicate) 
determined through comparison with a standard curve prepared using BSA. 
2.1.5 SDS polyacrylamide gel electrophoresis (SDS-PAGE) 
Soluble  extracts  of  worms  were  analysed  by  sodium  dodecyl  sulphate 
polyacrylamide  gel  electrophoresis  (SDS PAGE)  using  the  Mini Protean  Cell 
System (Bio Rad, UK). Protein separation was carried out in 10% polyacrylamide 
gels (Appendix 2.2.8). Approximately, equal amounts of worms extract (2 4  g) 
was mixed with SDS PAGE sample cocktail (Appendix 2.2.1), boiled for 3 min, 
centrifuged  at  13200  rpm  for  3  min  and  applied  to  the  gel.  Following 
electrophoresis at 200 volts for 60 min in running buffer (Appendix 2.2.4), gels 
were stained with Coomassie blue (Appendix 2.3.1) for 60 min and destained in 
the destaining solution (Appendix 2.3.3). In some cases, worms were directly 
solubilised with appropriate volume of SDS PAGE sample cocktail and boiled for Chapter 2    61 
3  min  followed  by  centrifugation  at  13200  rpm  for  3  min.  After  gel 
electrophoresis, gels were incubated with gentle agitation in Coomassie blue R 
250 (Sigma, UK)(Appendix  2.3.1) for  60 min at room  temperature. Gels were 
then destained in 10% acetic acid solution (Appendix 2.3.3). 
2.1.6 Western blotting 
Proteins  separated  by  SDS PAGE  were  transferred  onto  nitrocellulose
 
Hybond
TM c extra (NCP) membranes (Amersham, UK) using the Mini Trans Blot 
Electrophoretic Transfer Cell System (Bio Rad, UK) at a constant voltage of 100V 
for 60 min. The transfer set up consisted of pre wetting the NCP membrane in 
transfer buffer (Appendix 2.2.5). The transfer sandwich was created with a fibre 
pad pre soaked in transfer buffer. Then one pre soaked filter paper was laid on 
top,  followed  by  the  equilibrated  NCP  membrane.  The  SDS PAGE  gel,  having 
been  equilibrated  in  transfer  buffer  for  15  min,  was  then  laid  on  the  NCP 
membrane. Another pre soaked filter paper was laid on the gel and finally, a 
pre soaked fibre pad completing the transfer sandwich. The completed cassette 
was placed in the module. The same procedure was repeated for a second gel (if 
required).  Following  protein  transfer,  the  NCP  membrane  was  stained  with 
Ponceau S (Appendix 2.3.5) for 5 min with agitation to check that the transfer of 
protein  to  the  NCP  membrane  was  complete.  The  NCP  membrane  then  was 
incubated in blocking solution (Appendix 2.2.10) for 60 min at room temperature 
with gentle agitation.  
2.1.7 Antibody detection of transferred proteins 
Two antibodies were used in this study to detect Hsp90. The first antibody 
was raised in rabbits to a recombinant protein equivalent to the C terminal 238 Chapter 2    62 
amino acids of B. pahangi (Devaney et al., 2005). The second antibody used was 
a well characterised monoclonal antibody AC88, raised to Hsp90 from the water 
mould,  Achlya  ambisexualis,  which  recognises  Hsp90  from  many  different 
species.  AC88  was  kindly  provided  by  Dr.  David  Toft  (Mayo  Clinic  College  of 
Medicine, Rochester, USA). 
Following the blocking incubation, the NCP membrane was washed 3 x 5 
min with washing buffer (Appendix 2.2.11) at room temperature. The primary 
antibody (B. pahangi anti Hsp90 or AC88 monoclonal anti Hsp90 antibody) was 
diluted  at  appropriate  concentration  in  incubation  solution  (Appendix  2.2.10) 
and applied to the membrane overnight at 4
oC with gentle agitation. Following 
overnight incubation, the membrane was washed 3 x 5 min with washing buffer 
before incubation in either HRP conjugated anti rabbit IgG (1:10,000) or HRP 
conjugated anti mouse IgG (1:10,000) (both Sigma, UK) for a further 60 min at 
room temperature. The NCP membrane was then washed 3 x 5 min in washing 
buffer.  In  some  experiments,  blots  were  probed  with  an  antibody  to  actin 
(Sigma, UK), as a loading control, at a dilution of 1:1000 and followed by anti 
mouse IgG as a secondary antibody. 
The  Enhanced  Chemiluminescence  (ECL)  Plus  System  was  employed 
(Pierce,  UK)  to  detect  any  bound  antibody  by  autoradiography.  The 
autoradiograph was subjected to quantitation by scanning and analysing using 
FluorChem
TM IS 5500 software. The Integrated Density Value (IDV) was measured 
for  each  sample  and  subsequently  used  to  calculate  the  ratio  of  the  signal 
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2.1.8 Preparation of geldanamycin solid support 
GA  was  derivatised  as  described  by  Whitesell  et  al  (1994).  1.0  mg  GA 
(InvivoGen, UK) was dissolved in 180  l chloroform. 1,6 Hexamethylenediamine 
(Sigma,  UK)  was  weighed  out  and  dissolved  in  chloroform  to  give  a  final 
concentration of 28.7 mg/ml. 71  l of the 1,6 Hexanediamine in chloroform was 
added to the GA solution. The mixture was rocked for 4 h at room temperature 
in  the  dark  to  yield  17 hexamethylenediamine 17  demethoxygeldanamycin.  A 
yellow to purple colour change is evidence of this reaction. The mixture was 
extracted with 1.0 ml of 0.01 M NaOH by centrifugation at 2000 rpm for 2 min. 
These steps were repeated three times. The mixture was dried under nitrogen 
and the powder stored at  20
oC at this point.   
 
400  l of DMSO was added to 1.0 mg derivatised GA. Simultaneously, 400 
 l of Affi Gel 10 beads (Bio Rad, UK) were washed with 1.0 ml cold iso propanol. 
The beads  were centrifuged  at 2000 rpm  for 2 min  and  the supernatant was 
removed. These steps were repeated four times. Then, the beads were washed 
with  1.0  ml  of  DMSO  and  dried.  At  this  point,  the  bead  volume  looks  much 
smaller. 400  l of ~5 mM 17 hexamethylenediamine 17 demethoxygeldanamycin 
prepared as described previously was mixed with the beads and agitated for 4 h 
at room temperature in the dark. At this point the beads were expected to be 
purple. The supernatant was removed and the beads were washed with 1.0 ml 
DMSO  followed  by  three  washes  with  1.0  ml  TNES.  The  beads  were  rocked 
overnight in 1.0 ml 1.0 M ethanolamine, pH 8.3 to block non specific binding. 
Finally  the  beads  were  re suspended  at  50%  v/v  in  TNES.  The  beads  can  be 
stored at 4
oC at this point. The same procedures were applied for control beads, 
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2.1.9 GA pull-down assay 
50  l of GA beads were blocked in 1% BSA in TNES (Appendix 2.1.1) for 60 
min at room temperature. The beads were then washed 3 x 5 min with 1.0 ml 
TNES  on  a  rocker  and  were  then  centrifuged  at  2000  rpm  for  2  min.  The 
supernatant was removed and the beads were retained for the binding assay. 
300 500  g of worm protein in a volume 300  l was mixed with 50  l packed 
volume of GA or control beads for 2.5 h at 4
oC. The beads were then washed 5 x 
10 min with 1.0 ml of TNES buffer by centrifugation. Bound proteins were eluted 
in 40  l SDS PAGE sample cocktail by boiling for 3 min followed by centrifugation 
at 13200 rpm for 3 min. Proteins eluted from GA beads and control beads were 
loaded  on  a  10%  SDS PAGE  gel  and  were  analysed  by  Western  blotting  as 
described previously.  
2.1.10  The specificity of Hsp90 binding to GA beads 
For selected nematode species which showed positive results in pull down 
assays, the experiments were repeated in the presence of excess GA to block the 
binding sites in order to determine the specificity of the binding. Worm extracts 
were pre incubated with soluble GA at 2.0  M or 20.0  M for 60 min at room 
temperature then used in a pull down assay exactly as described above. 
2.2 Further characterisation of Brugia Hsp90 
2.2.1 Analysis of different life-cycle stages of B. pahangi 
Three  different  life cycle  stage  of  B.  pahangi  were  available  for  the 
analysis of Hsp90 expression levels. Adults and Mf were obtained from gerbils 
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(Devaney & Jecock, 1991). Gerbils were killed by CO2 inhalation. Worms were 
obtained by repeated peritoneal lavage with Hanks Balanced Salt Solution (HBSS, 
Gibco, UK) at 37
oC. Adults were washed in HBSS and were kept at  80
oC until 
they  were  required  for  the  preparation  of  parasite  extracts.  The  Mf  were 
collected by washing out the peritoneal cavity with HBSS medium at 37
oC. The 
combined washes were centrifuged 1000 rpm for 5 min. The Mf pellet was then 
purified to remove red blood cell contamination by adding 1.0 ml sterile ddH2O, 
and the Mf were collected by centrifugation at 1000 rpm for 5 min. To separate 
Mf from contaminating white  blood cells, Mf were centrifuged  on Histopaque 
(Sigma,  UK).  1.0  ml  of  Mf  suspension  was  carefully  layered  onto  5.0  ml  of 
Histopaque and centrifuged at 1200 rpm for 10 min. White blood cells float at 
the interface, while Mf were colleted from the pellet.  The number of Mf in a 20 
 l aliquot was counted and the number of Mf in the total volume calculated. The 
Mf were kept at  80
oC until use. 
2.2.2 B. pahangi Hsp90 expression level following exposure to 
heat shock or GA 
Heat  shock  proteins  respond  to  changes  in  the  environment  including 
elevated temperatures and chemical compounds. In order to investigate Hsp90 
expression levels after exposure to heat shock or to GA, adult B. pahangi were 
recovered from gerbils as described previously. 10 adult females were cultured 
in 10 ml RPMI 1640 culture medium (Appendix 4.5) Worms were heat shocked by 
incubating in a water bath at 41
oC for 60 min and were allowed to recover at 
37
oC for a further 2 h. The control group for the experiment was incubated in a 
water bath at 37
oC for 3 h. Worms were then directly solubilised by boiling in 
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centrifugation at 13200 rpm for 3 min. 5  l of supernatant were loaded onto 10% 
gel and analysed by SDS PAGE and Western blotting.     
In other experiments, 10 B. pahangi adult females were cultured in the 
presence of GA. 1 mg GA was dissolved in 171  l DMSO to give a stock of 10 mM 
GA  which  was  then  diluted  in  RPMI 1640  culture  medium  to  give  a  final 
concentration  of  1.0   M  GA.  Adult  worms  were  then  incubated  in  RPMI 1640 
containing GA at 37
oC in an atmosphere of 5% CO2 in air for 24 h. The control 
group for the analysis was incubated in RPMI 1640 culture medium containing 
DMSO alone for 24 h at 37
oC. Worms were directly solubilised in 100  l of SDS 
sample cocktail and were centrifuged at 13200 rpm for 3 min. Equal volumes (5 
 l)  were  analysed  by  SDS PAGE  and  Western  blotting  as  described  previously 
using actin as a control. 
2.2.3 Estimating the proportion of B. pahangi Hsp90 that binds to 
GA beads 
The  aim  of  this  experiment  was  to  investigate  the  percentage  of  the 
cytosolic Hsp90 that could bind to GA beads. Here, the supernatant from one GA 
pull down was applied to a second GA pull down, for a total of five times. 50  l 
of GA beads prepared as described in Section 2.1.8 were mixed with 300  g of B. 
pahangi extract in a volume of 300  l for 2.5 h at 4
oC. The supernatant from the 
pull down was retained for the next pull down. Simultaneously, the beads for 
the  first  pull down  were  processed  as  described  previously  in  Section  2.1.9. 
These steps were repeated five times. Equal volumes of supernatant (20  l) were 
loaded onto 10% SDS PAGE gels and bound protein was analysed by SDS PAGE and 
Western  blotting.  The  bands  on  the  autoradiograph  were  scanned  and  band 
densities were obtained using FlourChem
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2.2.4 Detection of Hsp90 in ES products of Mf and adult Brugia  
In B. malayi, Hsp90 was reported to be secreted as an ES product (Kumari 
et al., 1994). In order to investigate whether B. pahangi secretes Hsp90, two 
different  stages  of  B.  pahangi  were  analysed.  Mf  and  adult  B.  pahangi  were 
recovered from infected gerbils at approximately 120 days post infection. Adult 
worms were washed several times in HBSS. After a final wash, approximately 100 
B. pahangi female and male adult worms were cultured in 40 ml of RPMI 1640 
culture medium (Appendix 4.5) at 37
oC in an atmosphere of 5% CO2 in air for 48 
h. Medium was changed every 24 h. Spent medium, containing ES products, was 
passed through a 0.45  m sterile syringe filter (Iwaki, Japan) to remove Mf and 
ES was stored at  20
oC until analysis. A total of 80 ml spent culture medium was 
concentrated  to  approximately  150   l  in  a  10,000  Mr  cut  off  Viva  Spin  15R 
Hydrasart (Sartorius Biolab Products, UK) by centrifugation at 3000 g for 45 min. 
The Mf were collected as described previously in Section 2.2.1. Approximately 
1.05 x10
5 Mf were incubated in RPMI 1640 medium as described previously at 37 
oC  in  an  atmosphere  of  5%  CO2  in  air  for  48  h.  The  medium  containing  ES 
products  was  centrifuged  at  1000  rpm  for  5  min  to  remove  Mf  and  the 
supernatant  was  processed  as  described  above  for  adults.  To  detect  the 
presence of Hsp90 in B. pahangi ES products, 10  l of concentrated ES products 
were added to 10  l of SDS PAGE sample cocktail. The mixture was boiled for 3 
min and centrifuged for further 3 min at 13200 rpm. Samples were then analysed 
by SDS PAGE and Western blotting.  
Gels were initially analysed by Coomassie blue staining but no bands were 
observed, so a silver staining protocol was used. Following electrophoresis, the 
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for 20 min with gentle agitation. The gel was then rinsed in 400 ml of ddH2O for 
3 x 10 min. ddH2O was discarded and the gel was stained with staining solution 
(Appendix  2.3.4.2)  for  approximately  20  min  or  until  the  desired  staining 
intensity was reached. Finally, the gel was placed  in stop  solution (Appendix 
2.3.4.3)  containing  5%  acetic  acid.  The  gel  was  then  rinsed  in  ddH2O  for  a 
further 5 min.         
2.2.5 Identification of B. pahangi Hsp90-associated proteins 
Hsp90 is the central component of a complex chaperone system. In most 
organisms, Hsp90 associates with a large set of co chaperones to mediate the 
activation and maturation of client proteins. Inhibition of Hsp90 function will 
lead  to  the  disassociation  of  these  co chaperones  and  the  destabilisation  of 
client proteins. GA was shown to be toxic to B. pahangi, but it is not known how 
inhibition of Hsp90 function kills the worm. In an attempt to address this point, 
two  different  approaches  were  carried  out.  In  the  first  approach,  proteomic 
analysis of B. pahangi adult worms cultured in vitro in the presence or absence 
of GA was carried out. In the second approach, attempts were made to purify 
Hsp90 associated  proteins  using  a  modified  pull down  approach  (Neef  et  al., 
2010). This modified pull down relies upon the binding of biotin labelled GA to 
Hsp90 protein complexes. The complexes are then isolated using Neutravidin 
agarose beads as described below.    
2.2.5.1  GA-biotin 
B. pahangi protein extracts were prepared in biotin binding buffer with 
protease inhibitors added prior to use as described by Neef et al (2010).  1.0 mg 
of worm extract was incubated with 100  l of GA biotin (InvivoGen, UK) for 15 h Chapter 2    69 
at 4
oC. Hsp90 associated proteins were captured by incubating the mixture with 
Neutravidin agarose beads for 90 min at 4
oC. The beads were pelleted and the 
supernatant was discarded and beads were then washed 3 x 1.0 ml in biotin 
binding buffer and bound proteins were eluted in SDS PAGE sample cocktail by 
boiling for 5 min. Bound proteins were analysed by Coomassie blue staining.  
2.2.5.2  Protein lysate preparation for proteomic analysis 
B.  pahangi  adult  worms  were  recovered  and  processed  as  described 
previously in Section 2.2.1. 60 adult worms were cultured in RPMI 1640 culture 
medium as described previously, containing 1.0  M GA at 37
oC for 24 h. The 
control  group  was  cultured  under  identical  conditions  in  the  presence  of  an 
equivalent volume of DMSO. Both samples were kept at  80
oC until required for 
preparation of the parasite extracts.  
Worm  extracts  were  prepared  using  a  mortar  and  pestle  in  2D 
electrophoresis lysis buffer (Appendix 3.1) with protease inhibitors added prior 
to use (Roche Diagnostics, UK) exactly as described in 2.1.3. The supernatant 
was retained for protein precipitation. 4x sample volume of 80% cold acetone 
was added and incubated on ice for 30 min, following which the extract was 
pelleted at 13200 rpm at 4
oC for 15 min and the supernatant was discarded. The 
protein pellet was dried for approximately 5 min at room temperature and then 
re suspended in 50  l lysis buffer and the protein concentration estimated using 
the protein assay as described in Section 2.1.4. Lysis buffer was added to a give 
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2.2.5.3  Isoelectric Focusing (IF) 
50  g in 10  l volume of GA treated B. pahangi lysate was labelled with 
1.0  l Cy3 and 50  g in 10  l volume of untreated group was labelled with Cy5 by 
incubating the mixture for 30 mins on ice in the dark. Cy3 and Cy5 dye were 
provided by GE Healthcare Bio Sciences, UK. 1.0  l of 10 mM lysine was added to 
each tube and incubated for 10 mins in the dark. The labelled protein lysates 
were then mixed together and added to 430  l rehydration buffer (Appendix 3.3) 
containing Bromophenol blue and DDT. The sample was incubated for 30 min at 
room temperature in the dark followed by centrifugation at 13200 rpm for 3 
min. 450  l of sample was loaded into an Immobilised pH Gradient (IPG) strip 
holder using a Gilson pipette. The samples were distributed along the bed of the 
strip holder. 
A 24 cm IPG strip, ph 4 7 (GE Healthcare Bio Sciences, UK) was removed 
from the protective package using forceps. The IPG strip was laid into the IPG 
holder with the  sticky surface facing down to make  contact with the  sample 
solution.  The  barcode  was  placed  toward  the  pointed  end  of  the  IPG  strip 
holder. The strip was then overlaid with 1.0 ml mineral oil, sufficient to cover 
the entire strip to avoid evaporation. The IPG strip was placed on the electrode 
bed of an IPGphor Isoelectric Focusing System (GE Healthcare Bio Sciences, UK) 
with  the  pointed  end  of  the  holder  oriented  towards  the  anode.  IF  was 
performed at 20
oC for approximately 25 h at a limited current of 50  Amp/IPG 
strip and accumulated volts from 70000 80000 Vhs. After IF, the IPG strip was 
removed for analysis or alternatively could be stored at  20
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2.2.5.4  Second dimension SDS-PAGE  
 
Prior to SDS PAGE, the IPG strip was equilibrated in equilibration buffer. 
The IPG strip was removed from the strip holder and transferred to a cylindrical 
tube containing the first equilibration buffer (Appendix 3.4) supplemented with 
100 mg DTT/10 ml. The IPG strip was incubated for 15 min on a rocker at room 
temperature. The solution was then poured off and the IPG strip was incubated 
with  a  second  equilibration  buffer  (Appendix  3.5)  containing  250  mg 
iodoacetamide/10 ml on a rocker for 15 min at room temperature.  
The  second  dimension  12%  gel  was  prepared  using  standard  recipes 
(Appendix 3.6). The equilibrated strip was laid onto the top of the SDS PAGE gel 
so that there was complete contact between gel and strip, and 1.0 ml of 0.5% 
agarose in SDS PAGE running buffer with Bromophenol blue was added to overlay 
the  strip.  Electrophoresis  was  performed  using  an  Ettan  DALTtwelve 
electrophoresis unit (Amersham Bio Sciences, UK) in running buffer at constant 
voltage of approximately 6V for 25 h at 25
oC or until the dye front reached the 
base of the gel. Following electrophoresis, gels were scanned using Typoon 9400 
scanner and the images were analysed using the Differential In Gel Analysis (DIA) 
software module of the DeCyder batch processor (Amersham Bio Sciences, UK).  
In  a  further  experiment,  GA treated  and  control  worms  were  analysed 
separately by 2D gel electrophoresis. Approximately 50  g of each worm lysate 
in 50  l volume was added to 400  l rehydration buffer (Appendix 3.3) containing 
Bromophenol  blue  and  DTT.  The  sample  was  incubated  for  30  min  at  room 
temperature in the dark followed by centrifugation at 13200 rpm for 3 min. 450 
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distributed along the bed of the strip holder, and were processed as described 
above for IF and second dimension SDS PAGE. Following electrophoresis, the gels 
were  stained  with  Coomassie  blue  G 250  (Appendix  2.3.2)  then  washed  with 
ddH2O  to  remove  the  blue  residue  off  the  staining  tray.  The  gels  were  then 
incubated with 10% acetic acid solution (Appendix 2.3.3) with gentle agitation 
until the desired staining intensity was reached. 
The Ettan Spot handling workstation (Amersham Bio Sciences) was used to 
spot  the  differences  between  the  GA treated  and  control  group.  Spots  of 
interest were excised and placed in 1.5 ml eppendorf tubes. The samples were 
then subjected to in gel trypsin digest. 
2.2.5.5  In-gel trypsin digest 
The  gel  pieces  were  washed  for  60  min  in  500   l  100  mM  ammonium 
bicarbonate followed by a further wash in 50% acetonitrile/100 mM ammonium 
bicarbonate for 60 min at room temperature. The supernatant was discarded and 
gel  pieces  were  washed  in  500   l  50%  acetonitrile/100  mM  ammonium 
bicarbonate with shaking for 60 min, followed by 50  l of acetonitrile for 10 min. 
After  10  min,  the  solvent  was  removed  and  the  gel  pieces  were  dried  in  a 
vacuum centrifuge. 20  l of 0.2  g/ l sequencing grade modified Porcine Trypsin 
(Promega, UK) in 25 mM ammonium bicarbonate was added to rehydrate each 
gel piece. 25 mM ammonium bicarbonate was added to cover the gel pieces (~20 
 l) and then left overnight at 37
oC for digestion. The following day, the tube was 
centrifuged  to  pellet  the  gel  pieces.  Supernatant  in  the  tube  was  then 
transferred to the 96 well plate. 20  l of 5% formic acid was added to the tube 
and  incubated  for  20  min  followed  by  incubation  in  20   l  acetonitrile  for  a 
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was then transferred into the same well as the first extract. The combination 
extracts were dried completely in a Speedvac. The dried digested samples were 
then  subjected  to  analysis  by  mass  spectrometry  where  all  peptides  samples 
were  separated  on  a  liquid  chromatography electrospray  (LC)  system  before 
analysing by ionization/multi stage mass spectrometry (ESI MS).     
2.2.6 Post-translational modification of Hsp90  
Post translational  modifications  of  Hsp90  are  known  to  be  essential  in 
regulating  Hsp90  chaperoning  functions  (Rose  et  al.,  1987;  Scroggins  et  al., 
2007).  In  order  to  investigate  whether  post translational  modification  could 
influence  the  ability  of  Hsp90  to  bind  to  GA,  recombinant  human  Hsp90α 
(rHsp90α)  and  Hsp90  isolated  from  the  breast  cancer  cell  line  (SkBr3)  were 
compared. Ideally, purified B. pahangi Hsp90 would have been used but was not 
available. The rHsp90α (StressMarq, Biosciences Inc., UK) used in the study was 
expressed in E. coli, and therefore had no post translational modifications. SkBr3 
cells  were  obtained  from  Dr.  Tina  Rich  (Faculty  of  Veterinary  Medicine, 
University  of  Glasgow,  UK).  SkBr3  cells  were  extracted  in  extraction  buffer 
(Appendix 2.1.2) by adding 1.0 ml of buffer containing protease inhibitors. The 
mixture was shaken gently to lyse the cells following which the supernatant was 
collected by centrifugation at 13200 rpm for 3 min at 4
oC. The supernatant was 
assayed  for  protein  concentration  as  described  previously  in  Section  2.1.4. 
Approximately, equal amounts of SkBr3 extract (2 4  g) was mixed with SDS 
PAGE sample cocktail, boiled for 3 min, centrifuged at 13200 rpm for 3 min and 
loaded onto the 10% gel and analysed by SDS PAGE and Western blotting. For the 
pull down assay, 5  g of rHsp90α and 500  g of SkBr3 lysates were used, exactly 
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Hsp90α and SkBr3 to GA beads was specific, both samples were subjected to 
competition  assay  with  free  soluble  GA.  Protein  extracts  were  pre incubated 
with soluble GA at 1.0  M or 2.0  M for 60 min at room temperature followed by 
pull down. Bound proteins were analysed as described previously. 
2.2.7 Competition assays with B. pahangi Hsp90 
2.2.7.1  Competition assay with GA, ATP and novobiocin 
In order to investigate whether the binding of B. pahangi Hsp90 to GA 
beads could be competed with other compounds that bind to Hsp90, a variety of 
experiments  were  carried  out.  Compounds  used  included  Adenosine  Tri 
Phosphate (ATP) which is known to compete for GA binding, and Novobiocin, a 
drug which binds at the 3’ end of Hsp90, but which can alter the ability of the 5’ 
end of Hsp90 to bind to GA/ATP (Grenert et al., 1997, Garnier et al., 2002). For 
the competition assay with GA beads, 500  g of worm extract was pre incubated 
with  competitors  at  different  concentrations  (Table  2.1)  for  60  min  at  room 
temperature  with  gentle  agitation.  The  control  tube  contained  only  worm 
extract  and  control  beads.  50   l  of  packed  volume  of  GA  or  control  beads, 
prepared as described previously, was then added to the mixture and incubated 
for 2.5 h at 4
oC. The beads were then washed 5 x 10 min with 1.0 ml of TNES 
buffer  by  centrifugation.  Bound  proteins  were  eluted  in  SDS PAGE  sample 
cocktail  by  boiling  for  3  min  and  were  centrifuged  at  13200  rpm  for  3  min. 
Proteins eluted from GA beads and control beads were run on a 10% SDS PAGE 
gel  and  were  analysed  by  Western  blotting  with  antibody  as  described 
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2.2.7.2  B. pahangi Hsp90 binding to ATP beads 
ATP binds to Hsp90 at the N terminal domain in the same binding site as 
for GA (Grenert et al., 1997, Garnier et al., 2002, David et al., 2003). These 
experiments  were  carried  out  in  order  to  investigate  whether  free  GA  could 
compete the binding of Hsp90 to ATP beads. For the competition assays with ATP 
beads, 500  g of worm extract was pre incubated with free GA over a range of 
concentration from 250 nM to 2000 nM for 60 min at room temperature with 
gentle  agitation.  100   l  volume  of  ATP  beads  (Sigma,  UK)  was  added  to  the 
mixture and incubated for 1.5 h at 4
oC. The beads were then washed 5 x 10 min 
with 1.0 ml of ATP binding buffer (Appendix 2.1.4). Bound proteins were eluted 
in SDS PAGE sample cocktail by boiling for 3 min and were centrifuged at 13200 
rpm for 3 min. Proteins eluted from GA beads and control beads were run on a 
10%  SDS PAGE  gel  and  were  analysed  by  Western  blotting  with  antibody  as 
described previously.     
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Table 2.1: Concentration of compounds used in competition assays with GA-beads 
 
Competitor  Concentration 
Soluble GA  0.0  
25 nM 
50 nM 
100 nM 
200 nM 
1000 nM 
ATP  5.0 mM 
10.0 mM 
15.0 mM 
20.0 mM 
Novobiocin  2.5 mM 
5.0 mM 
10.0 mM 
20.0 mM 
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2.2.8 Comparison of B. pahangi and C. elegans Hsp90 
2.2.8.1  Hsp90 expression levels in B. pahangi and C. elegans 
Hsp90 is a well conserved protein in most organisms. C. elegans Hsp90 
was shown to be resistant to GA treatment and failed to bind to GA beads in 
pull down  assays  (David  et  al.,  2003;  Devaney  et  al.,  2005).  In  order  to 
investigate the differences in Hsp90 sequence of B. pahangi and C. elegans, both 
sequences were compared using a Clustal W alignment.    
In  addition,  Hsp90  expression  levels  between  B.  pahangi  and  C.  elegans 
were  compared  in  adult  stages.  B.  pahangi  adult  worms  were  collected  as 
described  in  Section  2.2.1,  while  C.  elegans  adult  worms  were  collected  by 
washing NGM plates with M9. Protein extracts of adult B. pahangi and C. elegans 
were  prepared  as  described  in  Section  2.1.3  and  assayed  for  protein 
concentration.  Equal  amounts  of  protein (2 4   g) were loaded  onto  10% SDS 
PAGE gel and analysed by SDS PAGE and Western blotting using actin as a loading 
control.  The  autoradiograph  was  scanned  and  analysed  using  FluorChem
TM  IS 
5500 software. Hsp90 expression levels in B. pahangi and C. elegans were scored 
based on the ratio of Hsp90 to actin.       
2.2.8.2  B. pahangi and C. elegans Hsp90 binding to ATP beads  
ATP was shown to bind to the N terminal domain of Hsp90, which is the 
same binding site for GA. ATP binding affinity can differ from one organism to 
another. It order to investigate the affinity of Hsp90 binding to ATP beads, B. 
pahangi and C. elegans extract were compared. Approximately 300  g of worm 
lysates were incubated with 100  l ATP beads (Sigma, UK) for 60 min at room 
temperature with gentle agitation. The beads were then washed 5 x 10 min in Chapter 2    78 
ATP binding buffer. The bound proteins were eluted by boiling for 3 min in 30  l 
of SDS PAGE sample cocktail followed by centrifugation at 13200 rpm for 3 min. 
Samples  were  analysed  by  SDS PAGE  and  Western  blotting.  Any  band  on  the 
autoradiograph was scanned and analysed as described previously.  
2.3 Hsp90 and drug resistance 
In order to determine whether Hsp90 may play a role in drug resistance in 
nematodes,  a  number  of  experiments  were  carried  out.  Hsp90  levels  were 
examined in anthelmintic resistant and susceptible Teleodorsagia circumcincta. 
In  addition,  Hsp90  expression  in  various  strains  of  C.  elegans  was  assessed. 
Finally, attempts were made to reduce Hsp90 levels in ivermectin resistant C. 
elegans  to  investigate  the  effect  of  Hsp90  reduction  on  susceptibility  to 
ivermectin. 
2.3.1 Hsp90 expression levels in drug resistant and susceptible 
worms 
In a previous study on tumour cells, Hsp90 was shown to be expressed at 
higher level in drug resistant cell lines compared to wild type cell lines (Bertram 
et al., 1996, Banerji, 2009; Constantino et al., 2009). However, in nematodes no 
such information is available. In order to determine the Hsp90 expression levels 
in  resistant  and  susceptible  nematodes,  three  groups  of  resistant  nematodes 
were  analysed.  A  T.  circumcincta  resistant  isolate  (Tci5)  and  a  susceptible 
isolate (Tci2) were obtained from Prof. David Knox (Moredun Research Institute, 
UK). Tci5 worms are known to be resistant to anthelmintics from all three broad 
spectrum  families  (benzimidazole,  ivermectin  and  levamisole)(Bartley  et  al., 
2005).  In  contrast  the  Tci2  isolate  is  susceptible  to  all  broad  spectrum Chapter 2    79 
anthelmintic  families.  Both  of  the  strains  were  originally  field  isolates.  T. 
circumcincta  resistant  and  susceptible  worms  were  extracted  and  assayed  as 
described previously in Section 2.1.3. Approximately equal amounts of protein 
(2 4   g)  were  analysed  by  SDS PAGE  and  Western  blotting,  using  actin  as  a 
loading control as described previously.  
C.  elegans  CB3474  and  C.  elegans  DA1316  were  obtained  from  the  C. 
elegans Genetics Centre (CGC, USA) for analysis. The C. elegans CB3474 strain 
shows resistance to benzimidazoles conferred by a mutation in the ben 1 gene 
(β tubulin  isotype 1)  (Driscoll  et  al.,  1989).  C.  elegans  DA1316  contains 
mutations  in  avr 14,  avr 15  and  glc 1  and  exhibits  high  level  resistance  to 
ivermectin (Dent et al., 2000). Worms were maintained on standard NGM plates 
as described in Section 2.1.2.1. For C. elegans CB3474 and C. elegans DA1316 
mixed  stages  were  analysed.  Worms  were  directly  solubilised  in  SDS PAGE 
sample  cocktail  by  boiling  for  3  min  and  extracts  were  collected  by 
centrifugation at 13200 rpm for 3 min. 5  l samples were loaded onto 10% gels 
and analysed SDS PAGE and Western blotting.   
Two  additional  lines  of  ivermectin resistant  C.  elegans  were  also 
available, IVM 6 and IVM 10. In contrast to C. elegans DA1316 and CB3474 which 
are the product of mutagenesis screen, IVM 6 and IVM 10 worm were selected by 
growth on increasing levels of ivermectin over a period of time. Therefore, these 
worms  may  be  more  similar  to  field  isolates  of  drug  resistant  parasitic 
nematodes. IVM 6 worms are resistant to ivermectin at 6 ng/ml and IVM 10, to 
10 ng/ml (James & Davey, 2009). These strains were obtained from the Institute 
for  Biotechnology  of  Infectious  Diseases,  University  of  Technology  Sydney, 
Australia. IVM 6 and IVM 10 worms were cultured on ivermectin plates containing Chapter 2    80 
drug at 6 ng/ml or 10 ng/ml respectively (Appendix 4.7). For C. elegans IVM 6 
and IVM 10 worms, adult stages were used for the analysis of Hsp90 levels. 30 
worms were solubilised in 30  l SDS PAGE sample cocktail by boiling for 3 min 
and extracts were collected by centrifugation at 13200 rpm for 3 min. 5  l of 
samples were loaded onto 10% gels and analysed SDS PAGE and Western blotting.   
2.3.2 C. elegans methods 
2.3.2.1  Synchronisation of C. elegans cultures 
For ivermectin sensitivity assays and RNAi feeding experiments, L4 stage 
worms were used. In order to get worms at the same  stage of development, 
gravid  adult  worms  were  lysed  in  bleach  solution  containing  15%  sodium 
hypochlorite solution  (Appendix 5.1). Bleaching also cleans the  worms  of any 
bacterial contamination from the plates. Worms were cultured on standard NGM 
plates with E. coli OP50 as a food source and were allowed to grow for 3 to 4 
days at 20
oC so that the plates contained many gravid adults. Gravid adults were 
collected by washing in M9 buffer in 15 ml conical centrifuge tubes and worms 
were  pelleted  at  2000  rpm  at  4
oC  for  2  min.  The  supernatant  was  removed 
without disturbing the worm pellet and 0.5 ml bleach solution was then added to 
the tube. The mixture was shaken gently for 3 5 min to help to lyse the gravid 
adults. Eggs were then pelleted by centrifugation at 2000 rpm for 2 min and the 
supernatant  was  discarded.  Following  four  washes  in  M9  buffer,  eggs  were 
incubated in M9 and allowed to hatch overnight at 20
oC in an incubator.  L1 
hatched  in  M9  arrest  development.  The  synchronised  L1  stage  worms  were 
spotted  onto  standard  NGM  plates  seeded  with  OP50  and  were  allowed  to 
develop to early L4 stage at 20
oC before use in ivermectin sensitivity assays or in 
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2.3.2.2  Ivermectin sensitivity assays 
Two assays were used for this analysis; a drug cytotoxicity assay and a 
motility assay. In the drug cytotoxicity assay, the growth of C. elegans from egg 
to gravid adult was scored, while in the motility assays, the motility of worms 
after exposure to ivermectin at different concentrations for 24 h and 48 h was 
scored. The drug cytotoxicity assay was applied as described previously by Hart 
(2006). C. elegans N2 and IVM 10 resistant worms were bleached as described 
previously in Section 2.3.2.1. Eggs were then re suspended in M9 and 10  l of the 
suspension was spotted onto plates containing containing 1 ng/ml, 5 ng/ml, 10 
ng/ml ivermectin or DSMO as a control in triplicate and were incubated at 20
oC. 
The worms were allowed to grow for 3 4 days and growth was scored (egg to 
adult).  The  motility  assay  was  applied  as  described  previously  (Arena  et  al., 
1995). Five L4 stage worms of C. elegans N2 or IVM 10 resistant worms were 
incubated  in  24  well  plates.  Six  replicates  were  made  for  each  dilution  of 
ivermectin. IVM 10 resistant worms were incubated in M9 culture containing 1 
ng/ml, 5 ng/ml or 10 ng/ml ivermectin and DMSO as a control in 24 well plates. 
OP50 was added as a food source. Plates were incubated for 24 h and 48 h at 
20
oC and worm motility was scored based on the percentage of worms that were 
still thrashing in the different wells. The activity of the worms was scored (see 
Table 2.2) and the score was converted to a numerical value. 
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Table 2.2: Scoring system for motility assay 
 
  Activity*  Score 
Thrashing  
Slow 
Paralysed 
Dead 
3 
2 
1 
0 
   
* All scores based on the movement or activity of the worm after 24 h and 48 h in liquid 
culture  system  containing  ivermectin  at  different  concentration  (ng/ml).  Each  worm  was 
observed for 10 sec. 
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2.3.2.3  Reducing Hsp90 levels by RNA mediated interference (RNAi) 
There are a variety of RNAi approaches that can be applied to C. elegans 
including injection of dsRNA into the hermaphrodite gonad, feeding the worms 
on lawns of bacteria expressing dsRNA, soaking worms in dsRNA or expressing 
dsRNA from a transgene (Kamath et al., 2001, 2003). The experiments presented 
in this thesis involved the feeding of bacteria expressing dsRNA to C. elegans. 
hsp90(RNAi)  constructs  used  in  this  thesis  was  prepared  previously  by  Dr. 
Victoria Gillan (University of Glasgow, UK). Two different constructs was used; a 
300 bp and a 75 bp construct, as described in Gillan et al (2009). Figure 2.2a 
shows a schematic time frame of a single experiment using RNAi by feeding.   
2.3.2.4  Preparation of plates for hsp90(RNAi), bacteria preparation and 
induction 
For the RNAi feeding experiment, worms were cultured on RNAi plates 
containing IPTG and ampicillin. IPTG and ampicillin were added to standard NGM 
agar (Appendix 4.3) to give a final concentration of 1.0 mg/ml and 25  g/ml, 
respectively.  Plates  were  prepared  4 7  days  before  use  and  kept  at  room 
temperature  to  allow  the  plates  to  dry.  RNAi  plates  must  be  dried  before 
seeding  with  bacteria  because  wet  plates  will  affect  the  efficiency  of  RNAi 
(Kamath et al., 2001).  
HT115 (DE3) cells containing the RNAi construct of interest, or containing 
an empty vector were used in these studies. Bacteria from glycerol stocks were 
spotted onto L Broth agar plates (Appendix 4.2) containing 50  g/ml ampicillin 
and 15  g/ml tetracycline. Plates were incubated overnight at 37
oC. Next day, 
one large colony of bacteria was picked and inoculated into L Broth (Appendix 
4.1) containing 50  g/ml ampicillin and grown overnight with shaking at 37
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an  orbital  incubator.  The  bacteria  were  then  seeded  onto  RNAi  plates  as 
described  above  and  incubated  overnight  at  room  temperature  to  allow  the 
bacteria to grow and to begin induction by IPTG. The same procedures were 
applied  to  the  control  group,  which  consisted  of  bacteria  expressing  empty 
vector as a food source.       
2.3.2.5  Optimising the conditions for hsp90(RNAi)  
In  order  to  determine  the  optimal  conditions  for  hsp90(RNAi)  and  to 
estimate the reduction of Hsp90 levels in RNAi worms, L4 stages of C. elegans N2 
were incubated at different temperature or were fed for different time periods. 
Synchronised L4 were incubated at 16
oC, 20
oC or 25
oC for 24 h feeding time. To 
determine the reduction of Hsp90 expression levels after 24 h on RNAi or control 
plates, 30 worms were solubilised in 30  l of SDS sample cocktail by boiling for 3 
min and collected by centrifugation at 13200 rpm for 3 min. 5  l of worm extract 
were  loaded  on  a  10%  SDS PAGE  gel  and  the  Hsp90  expression  levels  were 
analysed  by  SDS PAGE  and  Western  blotting.  In  other  experiments,  L4  were 
incubated  at  20
oC  for  6  h,  12  h  or  24  h  on  RNAi  or  control  plates.  Hsp90 
expression levels were analysed by SDS PAGE and Western blotting. Any bands on 
the  autoradiograph  were  scanned  and  analysed  using  FluorChem
TM  IS 5500 
software as described previously in Section 2.1.7. For all experiments, actin was 
used as a loading control. These experiments were carried out using both the 
300 bp and 75 bp hsp90(RNAi) constructs. 
2.3.2.6  Scoring the efficiency of hsp90(RNAi) by counting progeny 
To investigate the efficiency of hsp90(RNAi), adult worms were fed on the 
300 bp or 75 bp hsp90(RNAi) construct for a 24 h period and then the number of Chapter 2    85 
progeny  were  counted.  After  24  h  on  hsp90(RNAi)  plates,  3  adults  were 
transferred onto each of three fresh NGM plates and were allowed to lay eggs for 
24 h at 20
oC. Adults were then removed from the plates. The number of eggs 
laid by adults was counted and plates were incubated for further 24 h at 20
oC. 
Embryonic  lethality,  early  larval  phenotypes  and  post embryonic  phenotypes 
were scored using a dissecting microscope. 
2.3.2.7  Ivermectin sensitivity assays following hsp90(RNAi) 
   C.  elegans  N2  and  IVM 10  resistant  worms  were  fed  on  the  75  bp 
hsp90(RNAi) construct or the control empty vector for 24 h at 20
oC. After 24 h on 
RNAi  plates,  worms  were  subjected  to  the  drug  cytotoxicity  assay  on  plates 
containing ivermectin at 1, 5 or 10 ng/ml or DSMSO alone as a control. For the 
motility assay, five worms were transferred into 24 well plates in six replicates. 
The  medium  contained  1,  5,  or  10  ng/ml  of  ivermectin  or  DMSO  alone  as  a 
control. OP50 was added as food source and the plates were incubated at 20
oC 
for 24 h or 48 h.  Figure 2.2b and 2.2c shows a schematic time frame of a single 
experiment using RNAi by feeding.  
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Figure 2.1: Schematic time-frame of RNAi feeding experiment.  
 
a) Feeding time-line. 
b) Schematic of the time-frame of experiment using RNAi followed by ivermectin 
cytotoxicity assay. 
c) Schematic of the time-frame of experiment using RNAi followed by ivermectin motility 
assay. 
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(a) 
 
(b) 
 
(c) 
Adapted from Kamath et al (2003) 
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2.4 Statistical analysis   
The Student t test and Mann Whitney  U test was  used to determine  the 
statistical  of  significance  differences  between  groups.  Differences  between 
groups were considered significant at p<0.05.        
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3  Hsp90 and the biology of nematodes 
3.1  Introduction 
Hsp90 is a unique molecular chaperone which is involved in chaperoning 
important  proteins  such  as  kinases,  telomerase,  helicases  and  transcription 
factors. Because it is involved in multiple cellular processes, knock out of hsp90 
is lethal to most organisms, so the functions of Hsp90 have been studied using 
inhibitors. One of the best characterised Hsp90 inhibitors is geldanamycin (GA) 
which is synthesised by Stremptomyces hygroscopicus. By binding to Hsp90, GA 
prevents the binding of ATP, resulting in the destabilisation of client proteins (as 
reviewed in Chapter 1). The sequence of Hsp90 is highly conserved and in most 
eukaryotes Hsp90 is inhibited in the presence of GA, the exception to date being 
Caenorhabditis elegans. C. elegans Hsp90 failed to bind GA while retaining the 
ability to bind ATP (David et al., 2003). In that study no discernable effects on 
larval viability, dauer development, adult fertility and life span were observed 
despite continuous passage of worms for three generations on plates saturated 
with  GA  at  178   M.  Furthermore,  C.  elegans  showed  no  ill effect  when 
maintained on a lawn of S. hygroscopicus secreting GA. In contrast, studies on 
the filarial nematode Brugia pahangi, revealed the importance of Hsp90 in these 
worms  (Devaney  et  al.,  2005).  After  being  exposed  to  GA  at  1.0   M  (the 
concentration  known  to  inhibit  mammalian  Hsp90  activity),  there  was  a 
significant decrease in microfilariae release from adult worms. Similar results 
were obtained at 500 nM GA but not at 100 nM GA. The female worms appeared 
flaccid and become progressively more lethargic until, by day 7 8, 100% were 
dead, while the male worms were more sensitive to GA with 100% dying by day 
5 6. This finding suggests that GA has a direct macrofilaricidal effect on Brugia. Chapter 3    91 
Moreover, in solid phase pull down assays, Hsp90 of B. pahangi bound to GA as 
analysed by Western blotting using an antiserum to B. pahangi Hsp90. Thus, the 
effect of GA on filarial worms contrasts with its lack of activity on C. elegans.  
The failure of C. elegans Hsp90 to bind GA was suggested to be an example of 
adaptive evolution, as C. elegans shares the same ecological niche of the soil 
with the Streptomyces species that elaborates GA (David et al., 2003). Given the 
different results with the GA binding assay using extracts of B. pahangi and C. 
elegans, some questions arise. Why does Hsp90 of C. elegans  not bind to GA 
while Hsp90 of B. pahangi does?  Is the ability of Hsp90 to bind to GA associated 
with a particular nematode life cycle or with a specific clade of nematodes? Is 
GA  resistance  or  susceptibility  the  norm  amongst  nematodes?  What  are  the 
differences between the structure of non binding and binding of Hsp90s?  
Many nematodes are important parasites of humans, animals and plants 
and are responsible for significant economic losses worldwide. Nematodes can 
be grouped into five separate clades based on the phylogenetic analysis of small 
subunit ribosomal RNAs (as reviewed in Introduction). Nematode life cycles are 
very diverse between species. Some species have a free living larval stage within 
the  environment,  e.g.  the  Trichostrongyles,  while  some  species,  e.g.  filarial 
worms,  are  obligate  parasites  transmitted  by  the  bite  of  an  infected 
intermediate  host.  Furthermore  other  species  are  permanently  parasitic  and 
transmitted by ingestion of infected tissues, such as Trichinella spiralis, a clade 
I species.  
  At  the  start  of  this  study  only  two  species  of  nematode  had  been 
examined for GA  binding,  B. pahangi, a clade III parasitic nematode  and  the 
free living clade V species C. elegans. The aim of the studies described in this Chapter 3    92 
chapter  was  to  examine  a  range  of  other  nematode  species  for  GA  binding 
capacity and to determine whether the ability of Hsp90 to bind GA is associated 
with a particular clade of nematodes or particular nematode life cycles.   
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3.2  Results 
3.2.1 Do other clade V species bind GA? 
Initial  studies  involved  analysing  extracts  of  a  variety  of  nematodes  to 
detect the expression of Hsp90 using the B. pahangi anti Hsp90 antibody or the 
AC88 monoclonal antibody by immuno blotting. B. pahangi lysate was used as a 
positive  control  in  all  experiments  because  it  reacted  with  both  of  the 
antibodies. Any species which showed no reactivity with the B. pahangi anti 
Hsp90 antibody was tested with the AC88 monoclonal antibody. Nine species of 
clade  V  nematode  were  used  for  the  analysis,  of  which  five  were  free living 
species and four were parasitic. Free living species were wild type C. elegans 
N2, C. elegans JT6130, a daf 21 mutant (which carries a point mutation in daf 
21(E292  to  K),  Caenorhabditis  briggsae,  Pristionchus  pacificus  and  Oscheius 
tipulae. For these worms, mixed life cycle stages were analysed. All free living 
species reacted positively with the B. pahangi anti Hsp90 antibody (see Figure 
3.1).  The  strongest  signal  was  obtained  with  B.  pahangi  extracts,  with  O. 
ochengi  and  P.  pacificus  extracts  showing  a  relatively  weak  signal.  The 
autoradiograph shown in Figure 3.1b was developed for 10 sec. The signal for O. 
tipulae and P. pacificus improved with increased time of exposure (results not 
shown).   
 The parasitic species from Clade V analysed were Haemonchus contortus, 
Nipponstrongylus  brasiliensis,  Teladorsagia  circumcincta  and Heligmosomoides 
polygyrus. In all cases, adult males and females were used.  All these parasitic 
species tested reacted with the B. pahangi anti Hsp90 antibody (see Figure 3.2) 
except for H. contortus adults. The anti Hsp90 monoclonal antibody (AC88) also 
failed to detect Hsp90 in H. contortus adult worms (results not shown). A new Chapter 3    94 
extract of H. contortus adult worms was prepared by directly solubilising in SDS 
PAGE sample cocktail by boiling for 3 minutes. The soluble supernatant was run 
on a 10% gel (see Figure 3.3a) and was analyzed by western blot (Figure 3.3b). 
From the blot it was clear that Hsp90 from H. contortus adult worms that were 
directly solubilised in SDS PAGE sample cocktail reacted well with the B. pahangi 
anti Hsp90 antibody, but no signal was obtained from the TNES soluble extract 
of  H.  contortus  adults.  In  an  attempt  to  overcome  this  problem,  different 
protease  inhibitors  from  SIGMA  (containing  AEBSF,  Aprotinin,  Bestatin 
hydrochloride,  E 64,  Leupeptin  hemisulfate  salt  and  pepstatin  A)  and  the 
Complete Mini Protease Inhibitor from ROCHE (formulation not available) were 
compared using the standard extraction methods as described before. Then the 
extracts were run on a 10% gel and analyzed by Western blot. Even using the 
new protease inhibitor cocktail there was still no signal from H. contortus adult 
TNES soluble  lysates  using  the  B.  pahangi  anti Hsp90  antibody.  This  result 
suggested that the TNES soluble extract of H. contortus adults may be degraded 
during  the  preparation  of  the  extract,  despite  the  presence  of  protease 
inhibitors. Examination of the Coomassie blue stained gel shown in Figure 3.3a 
(Lane 3) suggested that this explanation may be correct. Adult worms extracted 
directly into SDS sample cocktail show a range of bands of different molecular 
weight (Lane 2), while the TNES soluble extract of adult worms shows few bands 
and an abundance of material at the bottom of the gel (Lane 3). As H. contortus 
adults are known  to  be rich in proteases  (Knox et  al., 1993), attempts  were 
made to identify Hsp90 in TNES soluble  extracts of  H. contortus L3. A TNES 
soluble extract of H. contortus L3 reacted with B. pahangi anti Hsp90 antibody 
(Figure 3.3b) and was used for subsequent pull down assays. Chapter 3    95 
Previous results had shown that C. elegans Hsp90 failed to bind GA. Pull 
down assays were carried out on a range of free living species belonging to clade 
V in order to investigate the GA binding ability of Hsp90 from other free living 
nematodes. As shown in Figure 3.4, no binding was observed to GA beads for any 
free living species tested. Analysis of clade V parasitic species produced similar 
results, with no binding observed (Figure 3.5). B. pahangi lysate was used as a 
positive control in all experiments (see Lane 1, Figure 3.4 and Figure 3.5). In all 
cases,  blots  were  exposed  for  extended  periods  of  time,  but  no  positive 
reactions were observed compared to the B. pahangi positive control. Each pull 
down was repeated at least twice with similar results. These data demonstrated 
that  like  C.  elegans,  Hsp90  from  the  other  clade  V  free living  and  parasitic 
nematodes  tested  do  not  bind  GA.  In  all  experiments,  worm  lysate  were 
incubated with control beads in pull downs and were analysed as for GA beads. 
Non specific binding of Hsp90 to control beads was not observed.  
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                  (a)  
 
  (b)  
 
Figure 3.1: All clade V free-living nematodes were observed to react with the antibody to B. 
pahangi anti-Hsp90.  
 
a) Coomassie blue stained gel of different worm extracts. Approximately equal amounts of 
proteins were loaded on a 10% SDS-PAGE gel as assessed by Coomassie blue staining for 
B. pahangi (Lane 1), C. elegans (Lane 2), C. elegans (JT6130) (Lane 3), C. briggsae (Lane 4), 
O. tipulae (Lane 5) and P. pacificus (Lane 6). Mr represents the molecular weight markers.  
b) Free-living clade V nematodes reacted with the B. pahangi anti-Hsp90 antibody. A strong 
signal was observed with B. pahangi extract (Lane 1); weaker signals were observed for O. 
tipulea and P. pacificus (Lane 5 and Lane 6). Approximately, equal amounts of each extract 
were analysed on a 10% gel, which was blotted and probed with 1:5000 dilution of the B. 
pahangi anti-Hsp90 antibody. Bound antibody was detected using a 1:10,000 dilution of anti-
rabbit IgG conjugated to HRP. The blot was developed using the Pierce Super Signal West 
Pico chemiluminescence kit. The autoradiograph shown was developed for 10 sec. 
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(a)  
 
(b)  
 
Figure 3.2: Clade V parasitic nematodes show cross reactivity with B. pahangi anti-Hsp90 
antibody. 
 
a) Coomassie blue stained gel of clade V parasites. Equal amounts of proteins were loaded 
on a 10% SDS-PAGE gel. B. pahangi (Lane 1), T. circumcincta (Lane 2), N. brasiliensis (Lane 
3), H. polygyrus (Lane 4) and H. contortus L3 (Lane 5). Mr represents the molecular weight 
markers. 
b) Clade V parasitic nematodes react with the B. pahangi anti-Hsp90 antibody. B. pahangi 
(Lane 1), T. circumcincta (Lane 2), N. brasiliensis (Lane 3), H. polygyrus (Lane 4) and H. 
contortus L3 (Lane 5). Proteins were transferred to NCP using standard methods, blocked 
o/n  in  5%  dried  milk  in  PBS/0.5%  Tween  20  and  then  the  blot  was  probed  with  1:5000 
dilution  of  the  B.  pahangi  anti-Hsp90  antibody.  Bound  antibody  was  detected  using  a 
1:10,000 dilution of anti-rabbit IgG conjugated to HRP. The blot was developed using the 
Pierce Super Signal West Pico chemiluminescence kit. 
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(a)  
 
(b)  
 
Figure 3.3: Analysis of H. contortus worm extracts with B. pahangi anti-Hsp90 antibody. 
 
a) Coomassie blue staining of H. contortus extracts. 10% SDS-PAGE gel with B. pahangi 
lysate as a control (Lane 1). An extract of adult H. contortus solubilised directly in SDS-
PAGE sample cocktail (Lane 2), TNES-soluble extract of H. contortus adults (Lane 3) and 
TNES-soluble extract of H. contortus L3 (Lane 4).    
b) TNES-soluble extracts of H. contortus adults are not recognised by B. pahangi anti-Hsp90 
antibody. B. pahangi extract (Lane 1), adult H. contortus solubilised in SDS-PAGE sample 
cocktail (Lane 2), TNES-soluble extracts of adult H. contortus (Lane 3), TNES-soluble extract 
of  H.  contortus  L3  (Lane  4).  Proteins were  transferred  to  NCP  using  standard  methods, 
blocked o/n in 5%  dried milk  in  PBS/0.5%  Tween 20  and then the blot was  probed with 
1:5000 dilution of the B. pahangi anti-Hsp90 antibody. Bound antibody was detected using a 
1:10,000 dilution of anti-rabbit IgG conjugated to HRP. The blot was developed using the 
Pierce Super Signal West Pico chemiluminescence kit. 
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(a)  
 
(b)  
 
Figure 3.4: Pull-down assays demonstrate that Hsp90 from free-living clade V nematodes 
does not bind GA.  
 
a) Pull-down assays with GA beads. B. pahangi (Lane 1), C. elegans N2 (Lane 2), C. elegans 
(JT6130), C. briggsae (Lane 4), O. tipulae (Lane 5)  and P. pacificus (Lane 6).  
b)  Pull-down  assay  with  control  beads.  B.  pahangi  (Lane  1),  C.  elegans  N2  (Lane  2),  C. 
elegans JT6130 (Lane 3), C. briggsae (Lane 4), O. tipulae (Lane 5) and P. pacificus (Lane 6).  
GA pull-down assays were carried out with 500 µg of worm lysate incubated with 50 µl of GA 
beads for 2.5 h at 4
o C. The beads were washed extensively in TNES and bound proteins 
were  eluted  by  boiling  in  SDS-PAGE  sample  cocktail.  Bound  proteins were  analysed  by 
SDS-PAGE  and  immuno-blotting.  The  blots  were  probed  with  1:5000  dilution  of  the  B. 
pahangi anti-Hsp90 antibody. Bound antibody was detected using a 1:10,000 dilution of anti-
rabbit IgG conjugated to HRP. The blot was developed using the Pierce Super Signal West 
Pico chemiluminescence kit. 
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                           (a) 
 
(b)  
 
Figure 3.5: Hsp90 from clade V parasitic nematodes does not bind to GA. 
 
a)  Pull-down  assay  with  GA  beads.  B.  pahangi  (Lane  1),  T.  circumcincta  (Lane  2),  N. 
brasiliensis (Lane 3), H. polygyrus (Lane 4) and H. contortus L3 (Lane 5).  
b) Pull-down assays with control beads. B. pahangi (Lane 1), T. circumcincta (Lane 2), N. 
brasiliensis (Lane 3), H. polygyrus (Lane 4) and H. contortus L3 (Lane 5). 
Results  shown  here  from  three  different  pull-down  assays.  GA  pull-down  assays  were 
carried out with 500 µg of worm lysate with GA beads. Lysate of worms were incubated with 
50 µl of GA beads for 2.5 h at 4
o C. The beads were washed extensively in TNES and bound 
proteins  were  eluted  by  boiling  in  SDS-PAGE  sample  cocktail.  Bound  proteins  were 
analysed by SDS-PAGE and immuno-blotting. The blot was probed with 1:5000 dilution of 
the B. pahangi anti-Hsp90 antibody. Bound antibody was detected using a 1:10,000 dilution 
of  anti-rabbit  IgG  conjugated  to  HRP.  The  blots  were  developed  using  the  Pierce  Super 
Signal West Pico chemiluminescence kit.  
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3.2.2 Do other clade III species bind GA? 
Hsp90 from  B. pahangi, a clade III nematode, was previously shown to 
bind GA in pull down assays and was also sensitive to GA treatment (Devaney et 
al., 2005). In order to investigate whether the ability to bind GA is shared with 
other  clade  III  species,  several  other  nematodes  were  available  for  analysis 
including  three  filarial  worms,  Acanthocheilonema  viteae,  Dirofilaria  immitis 
and Ochocerca ochengi, the Ascarid species, T. cati, Ascaris suum, Parascaris 
equorum and the Anisakids, Anisakis simplex and Pseudoterranova decipiens. In 
addition a Dracunculid, species Anguilicola crassus was also tested. All filarial 
worms  reacted  with  B.  pahangi  anti Hsp90  antibody  (Figure  3.6b)  as  did  the 
ascarid and anisakid species (Figure 3.7b) but no reaction was observed with A. 
crassus (Figure 3.6c). For A. crassus, the immuno blot was repeated using the 
AC88 monoclonal anti Hsp90 antibody. However no reaction was observed (see 
Figure 3.6c).  
GA pull downs assays of clade III parasites showed an interesting variation 
in results. All filarial nematodes tested were shown to bind to GA (Figure 3.7a), 
while Hsp90 from the three Ascarid species analysed also bound to GA (Figure 
3.7c). However, Hsp90 from the Anisakids (A. simplex and P. decipiens) did not 
bind to GA. The autoradiograph was left overnight for further exposure, but still 
no signal was observed. All experiments were repeated at least twice. As no 
signal was obtained with the antibody using A. crassus extracts, attempts were 
made to visualise a band in the GA pull downs with A. crassus by Coomassie blue 
staining of a gel, but no band was observed (results not shown).  
For selected species which showed positive results in pull down assays, 
the  experiments  were  repeated  in  the  presence  of  excess  GA  to  block  free Chapter 3    102 
binding sites (see Figure 3.8). Two concentrations of GA were used, 2  M and 20 
 M. The binding of A. suum Hsp90 to GA beads was blocked by pre incubation 
with GA at 2  M or 20  M (Panel a, Figure 3.8). Similar results were observed for 
P.  equorum  (Panel  b,  Figure  3.8),  D.  immitis  (Panel  c,  Figure  3.8),  and  O. 
ochengi  (Panel  d,  Figure  3.8).  These  results  indicate  the  specificity  of  the 
interaction. In separate experiments, male and female worms were available for 
two species A. suum and T. cati, so it was possible to compare GA binding of 
both sexes. The results demonstrate that Hsp90 from males and females of both 
nematodes bound to GA (Figure 3.9a and 3.9b).   
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Figure 3.6: Hsp90 from clade III nematode reacted with B. pahangi anti-Hsp90 antibody. 
 
a) Coomassie blue stained gel. Gel shows equivalent amounts of proteins from selected 
clade  III  nematodes  loaded  on  10%  gel  and  analysed  by  Coomassie  blue  staining.  B. 
pahangi (Lane 1), A. viteae (Lane 2), D. immitis (Lane 3), O. ochengi (Lane 4), A. simplex 
(Lane 5).  
b) Hsp90 from clade III nematodes is recognised by the B. pahangi anti-Hsp90 antibody. 
The  blots  were  probed  with  1:5000  dilution  of  the  B.  pahangi  anti-Hsp90  antibody.  B. 
pahangi (Lane 1), A. viteae (Lane 2), D. immitis (Lane 3), O. ochengi (Lane 4), T. cati (Lane 
5), A. suum (Lane 6), P. equorum (Lane 7), A. simplex (Lane 8) and P. decipiens (Lane 9). 
Bound antibody was detected using a 1:10,000 dilution of anti-rabbit IgG conjugated to 
HRP. The blot was developed using the Pierce Super Signal West Pico chemiluminescence 
kit. 
c) A TNES-soluble extract of A. crassus (Lane 2 and Lane 4) failed to react with the B. 
pahangi anti-Hsp90 or the AC88 anti-Hsp90 antibody. In these experiments a C. elegans 
lysate was used as a positive control (Lane 1 and Lane 3). The blots were probed with 
1:5000 dilution of the B. pahangi anti-Hsp90 antibody (Lane 1 and Lane 2). Bound antibody 
was detected using a 1:10,000 dilution of anti-rabbit IgG conjugated to HRP.  Lane 3 and 
Lane 4 were probed with 1:500 dilution of AC88 anti-Hsp90 monoclonal antibody. Bound 
antibody  was  detected  using  a  1:10,000  dilution  of  anti-mouse  IgG.  Both  blots  were 
developed using the Pierce Super Signal West Pico chemiluminescence kit. 
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B. pahangi anti Hsp90 antibody  AC88 anti Hsp90 antibody   
 
 
(c) 
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Figure 3.7: GA pull-down assays using clade III nematodes 
 
a) Immuno-blot of GA pull-down assays using extracts of filarial worms. B. pahangi (Lane 1), A. 
viteae (Lane 2), D. immitis (Lane 3) and O. ochengi (Lane 4).  
b) Immuno-blot of pull-down assays with control beads. Gel loaded as in Panel a.  
c)  Immuno-blot  of  GA  pull-down  assays  using  extracts  of  ascarid  and  anisakid  worms.  B. 
pahangi (Lane 1), A. suum (Lane 2), P. equorum (Lane 3) and T. cati (Lane 4), P. decipiens (Lane 
5) and A. simplex (Lane 6).  
d) Immuno-blot of control beads for the pull-down assays. Gel loaded exactly as in Panel c.  
For pull-down assays, 500 µg of proteins extract were incubated with 50 µl of GA beads for 2.5h 
at  4
oC  on  rocker.  The  blots  were  probed  with  1:5000  dilution  of  the  B.  pahangi  anti-Hsp90 
antibody. Bound antibody was detected using a 1:10,000 dilution of anti-rabbit IgG conjugated 
to HRP. The blot was developed using the Pierce Super Signal West Pico chemiluminescence 
kit.  
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(b)  
 
 
 
                                     (c) 
 
(d)  
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Figure 3.8: The binding of Hsp90 to GA is specific 
 
For selected species which showed a positive result in pull-down assay, the experiments 
were repeated in the presence of excess GA at 2.0 µM or 20.0 µM to block free binding sites. 
A. suum (Panel a), P. equorum (Panel b), D. immitis (Panel c) and O. ochengi (Panel d).  
For the competition assays, 500 µg of worm lysate were first incubated in a total volume 300 
µl with GA at 2.0 µM or 20.0 µM for 1 h at room temperature. Then 50 µl of GA beads were 
added and incubated for further 2.5 h at 4
o C. The beads were washed extensively in TNES 
and bound proteins were eluted by boiling in SDS-PAGE sample cocktail. Bound proteins 
were  analysed  by  SDS-PAGE  and  immuno-blotting.  The  blots  were  probed  with  1:5000 
dilution  of  the  B.  pahangi  anti-Hsp90  antibody.  Bound  antibody  was  detected  using  a 
1:10,000 dilution of anti-rabbit IgG conjugated to HRP. The blot was developed using the 
Pierce Super Signal West Pico chemiluminescence kit.  
 
 
 
 
(a) A. suum  (b) P. equorum 
(c) D. immitis  (d) O. ochengi Chapter 3    108 
 
 
(a)  (b) 
Figure 3.9: The binding of Hsp90 to GA is independent of the sex of the worm.  
 
a) Immuno-blot of GA pull-down assay using A. suum male and female worms. B. pahangi 
(Lane 1), A. suum female (Lane 2) and A. suum male (Lane 3).     
b) Immuno-blot of GA pull-down assay using T. cati male and female. B. pahangi (Lane 1), T. 
cati female (Lane 2) and T. cati male (Lane 3).     
500 µg of worm lysate of male or female worms were incubated with 50 µl of GA beads for 
2.5 h at 4
o C.  The beads were washed extensively in TNES and bound proteins were eluted 
by boiling in SDS-PAGE sample cocktail. Bound proteins were analysed by SDS-PAGE and 
immuno-blotting. The blots were probed with 1:5000 dilution of the B. pahangi anti-Hsp90 
antibody.  Bound  antibody  was  detected  using  a  1:10,000  dilution  of  anti-rabbit  IgG 
conjugated  to  HRP.  The  blot  was  developed  using  the  Pierce  Super  Signal  West  Pico 
chemiluminescence kit.  
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3.2.3 Do nematodes from other clades bind to GA? 
Two  species  of  clade  I  nematode  were  available  for  the  analysis,  T. 
spiralis  and  Trichuris  muris.  Equal  amounts  of  TNES soluble  protein  extracts 
were loaded onto a  10% SDS polyacrylamide gel and were analysed to detect 
Hsp90 on the blots. However, neither species reacted with the B. pahangi anti 
Hsp90 antibody or with AC88 antibody at a range of antibody concentrations or 
exposure times (Figures 3.10a and 3.10b). Consequently, it was not possible to 
analyse GA pull downs by immuno blotting. GA and control pull downs using both 
T.  spiralis  and  T.  muris  were  analysed  by  Coomassie  blue  staining.  For  T. 
spiralis, a band of 83 kDa was observed on the gel that was not present using the 
control beads (Figure 3.10c). However, for T. muris no band was observed when 
GA pull downs were analysed by Coomassie blue staining (Figure 3.10c). The T. 
spiralis band was excised from the gel and was sent to the Sir Henry Welcome 
Functional  Genomics  Unit,  University  of  Glasgow  for  proteomic  analysis. 
Following trypsin digestion and mass spectrometry, MASCOT searches revealed 
that the T. spiralis band was likely to be Hsp90. Multiple peptide hits showed a 
high degree of similarity (p<0.05) with Hsp90s from many other species. These 
experiments were repeated in the presence of excess GA to block free binding 
sites (see Figure 3.10e). Two concentrations of GA were used, 2  M and 20  M. 
At  2   M  GA,  the  binding  of  T.  spiralis  Hsp90  to  GA  beads  was  completely 
blocked. This demonstrated the specificity of the interaction of T. spiralis Hsp90 
with GA.   
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Figure 3.10: T. spiralis Hsp90 binds to GA beads in pull-down assay. 
 
a) Immuno-blot showing that Hsp90 from clade I nematodes is not recognised by the B. 
pahangi anti-Hsp90 antibody. B. pahangi (Lane 1), T. spiralis (Lane 2) and T. muris (Lane 
3).  The  blot probed with 1:5000 dilution  of  the  B. pahangi  anti-Hsp90  antibody.  Bound 
antibody was detected using a 1:10,000 dilution of anti-rabbit IgG conjugated to HRP. The 
blot was developed using the Pierce Super Signal West Pico chemiluminescence kit.  
b) Immuno-blot of clade I nematodes failed to reacted with AC88 monoclonal anti-Hsp90 
antibody. C. elegans (Lane 1), T. spiralis (Lane 2) and T. muris (Lane 3). The blot probed 
with  1:500  dilution  of  the  AC88  monoclonal  anti-Hsp90  antibody.  Bound  antibody  was 
detected using a 1:10,000 dilution of anti-mouse IgG. The blot was developed using the 
Pierce  Super  Signal  West  Pico  chemiluminescence  kit.  In  this  experiment,  C.  elegans 
lysate was used as a control.  
 c) Coomassie blue stained gel of GA pull-down assay for clade I nematodes. B. pahangi 
(Lane 1), T. spiralis (Lane 2) and T. muris (Lane 3). Note the band at ~ 83 kDa in Lane 1 and 
Lane 2.  
d) Coomassie blue stained gel of control beads. Gel loaded as in Panel c. For pull-down 
assays, 500 µg of proteins extract were incubated with 50 µl of GA beads for 2.5 h at 4
oC 
on rocker. The beads were washed extensively in TNES and bound proteins were eluted by 
boiling in SDS-PAGE sample cocktail. Bound proteins were analysed by SDS-PAGE and 
gel was stained using 0.1% Coomassie blue by agitation for 1h at room temperature.  
e) Panel e shows a Coomassie blue stained gel of a T. spiralis pull-down pre-incubated 
without GA (Lane 1) and with GA at 2.0 µM (Lane 2) or 20.0 µM (Lane 3) and control beads 
(Lane 4). 500 µg of worm lysate was incubated in a total volume of 300 µl containing GA at 
2.0 µM or 20.0 µM for 1 h at room temperature. Then 50 µl of GA beads were added and 
incubated for further 2.5 h at 4
oC. The beads were washed extensively in TNES and bound 
proteins  were  eluted  by  boiling  in  SDS-PAGE  sample  cocktail.  Bound  proteins  were 
analysed by SDS-PAGE. Gel was stained with 0.1% Coomassie blue. 
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             (c)  (d) 
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The  clade  IV  nematode  species  tested  were  the  plant  parasitic 
nematodes, Globodera pallida and Globodera rostochiensis, a free living species 
Panagrellus redivivus and the animal parasite Strongyloides ratti. The S. ratti 
adults  used  in  the  analysis  were  free living  rather  than  parasitic.  Both  plant 
parasitic nematodes reacted with the antibody, as did P. redivivus (see Figure 
3.11a). S. ratti reacted weakly with the B. pahangi anti Hsp90 antibody although 
the signal obtained improved with increasing exposure times. Next, pull down 
assays  were  carried  out  to  investigate  the  ability  of  Hsp90  from  clade  IV 
nematodes to bind GA. From this experiment it could been seen that Hsp90 from 
the two plant parasitic nematodes failed to bind GA as did Hsp90 from the free 
living clade IV species,  P. redivivus (see Figure 3.11b). Similarly, Hsp90 from S. 
ratti did not bind to GA in pull down assays (Figure 3.11d). Because the Hsp90 
signal in S. ratti was relatively weak using the B. pahangi anti Hsp90 antibody, 
the pull downs were exposed for prolonged period of time (overnight) but no 
signal was obtained. These experiments were repeated at least two occasions 
with similar results Table 3.1 shows the summary of GA pull down assays with a 
range of nematodes from different clades.    
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Figure 3.11: Analysis of clade IV nematodes  
 
(a) Immuno-blot of Hsp90 from clade IV nematodes probed with the B. pahangi anti-Hsp90 
antibody. G. pallida (Lane 2), G. rostochiensis (Lane 3), S. ratti (Lane 4) and P. redivivus 
(Lane 5). B. pahangi lysate was used as a positive control (Lane 1).   
b) Immuno-blot of GA pull-down assays. G. pallida (Lane 2), G. rostochiensis (Lane 3) and 
P. redivivus (Lane 4). For these experiments, D. immitis lysate was used as a positive 
control (Lane 1).  
c) Immuno-blot of pull-down assays for control beads. D. immitis (Lane 1), G. pallida (Lane 
2), G. rostochiensis (Lane 3) P. redivivus (Lane 4).   
d) Immuno-blot of GA pull-down assay with S. ratti lysate. S. ratti (Lane 2). B. pahangi 
lysate was used as a positive control (Lane 1).  
e) Immuno-blot of pull-down assays for control beads. B. pahangi (Lane 1), S. ratti (Lane 
2). 
Panel a shows a lay-up of GA pull-downs for three separate experiments. Proteins were 
transferred to NCP using standard methods, blocked o/n in 5% dried milk in PBS/0.5% 
Tween  20  and  then  the  blot  probed  with  1:5000  dilution  of  the  B.  pahangi  anti-Hsp90 
antibody.  Bound  antibody  was  detected  using  a  1:10,000  dilution  of  anti-rabbit  IgG 
conjugated  to  HRP.  The  blot  was  developed  using  the  Pierce  Super  Signal  West  Pico 
chemiluminescence kit.  
For pull-down assays (Panel b,c, d and e), 500 µg of proteins extract were incubated with 
50 µl of GA beads for 2.5 h at 4
oC on rocker. The beads were washed extensively in TNES 
and bound proteins were eluted by boiling in SDS-PAGE sample cocktail. Bound proteins 
were  analysed  by  SDS-PAGE  and  immuno-blotting.  The  blots  were  probed with  1:5000 
dilution  of  the  B.  pahangi  anti-Hsp90  antibody.  Bound  antibody  was  detected  using  a 
1:10,000 dilution of anti-rabbit IgG conjugated to HRP. The blot was developed using the 
Pierce Super Signal West Pico chemiluminescence kit.  
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Table 3.1: Summary of GA pull-down assays 
 
Species  Clade  Life cycle 
stage 
Life style  GA 
binding 
T. spiralis 
 
T. muris 
 
 
 
A. crassus 
A. simplex 
P. decipiens 
 
A. suum 
P. equorum 
T. cati 
 
B. pahangi 
A. viteae 
D. immitis 
O. ochengi 
 
 
S. ratti 
 
 
P. redivivus 
G. rostochiensis 
G. pallida 
 
 
C. elegans 
C. elegans daf 21 mutant 
C. briggsae 
O. tipulae 
P. pacificus 
 
H. contortus  
T. circumcincta 
H. polygyrus 
N. brasiliensis 
I 
 
I 
 
 
 
III 
III 
III 
 
III 
III 
III 
 
III 
III 
III 
III 
 
 
IV 
 
 
IV 
IV 
IV 
 
 
V 
V 
V 
V 
V 
 
V 
V 
V 
V 
L1 
 
adult 
 
 
 
adult 
L3 
L3 
 
adult 
adult 
adult 
 
adult 
adult 
adult 
adult 
 
 
adult, FL 
 
 
mixed stages 
J2 
J2 
 
 
mixed stages 
mixed stages 
mixed stages 
mixed stages 
mixed stages 
 
L3 
adult 
adult 
adult 
Obligate parasite 
 
Parasitic, egg in 
the environment 
 
 
Parasitic, Fl larvae 
Parasitic, Fl larvae 
Parasitic, Fl larvae 
 
Parasitic 
Parasitic 
Parasitic 
 
Obligate parasite 
Obligate parasite 
Obligate parasite 
Obligate parasite 
 
 
Parasitic or FL 
adult, FL larvae 
 
Free living 
Plant parasitic 
Plant parasitic 
 
 
Free living 
Free living 
Free living 
Free living 
Free living 
 
Parasitic, FL larvae 
Parasitic, FL larvae 
Parasitic, FL larvae 
Parasitic, FL larvae 
+ 
 
? 
 
 
 
? 
  
  
 
+ 
+ 
+ 
 
+ 
+ 
+ 
+ 
 
 
  
 
 
  
  
  
 
 
  
  
  
  
  
 
  
  
  
  
         
FL = free-living - = Negative binding  + = Positive binding ? = uncertain GA binding status Chapter 3    116 
3.3  Discussion 
As  reviewed  in  Chapter  1,  Hsp90  plays  a  fundamental  role  in  cells  by 
regulating specific client proteins often involved in signalling pathways. These 
proteins depend on Hsp90 for maturation and stabilisation. Any disruption in this 
process will lead to degradation of the proteins and to cell death. An important 
characteristic of Hsp90 is its ability to bind to GA, a specific Hsp90 inhibitor (as 
reviewed  in  Chapter  1).  According  to  Whitesell  et  al  (1994),  most  eukaryote 
Hsp90s are susceptible to GA and will bind to GA in pull down assays. However, 
the ability of Hsp90 to bind to GA is not shared by C. elegans (David et al., 2003) 
while Hsp90 from the parasitic nematode B. pahangi does bind GA (Devaney et 
al., 2005).The results with C. elegans were hypothesised to be an example of 
adaptive  evolution  as  C.  elegans  and  Streptomyces  spp.  shared  the  same 
ecological niche of the soil (David et al., 2003). In this chapter this hypothesis 
was tested by analysing the GA binding properties of a range of nematode.    
Table  3.1  summarises  the  GA  binding  assays  for  the  nematodes  tested. 
From  these  results  some  interesting  conclusions can  be  drawn.  All  free living 
nematodes tested or those parasitic species which have free living larval stages 
in the environment failed to bind GA. Five free living species from clade V (C. 
elegans, C. elegans daf 21 mutant, C. briggsae, O. tipulae and P. pacificus) and 
one  species  from  clade  IV  (P.  redivivus)  were  tested.  The  parasitic  species 
tested that have free living larval stages in the environment belong to clade V 
(H. contortus, N. brasilliensis, H. polygyrus and T. circumcincta) and clade IV (S. 
ratti).  This  group  of  nematodes  are  generally  gut dwelling  parasites  in  the 
mammalian host and are transmitted between hosts when eggs, passed out in 
the  faeces  of  the  infected  animal,  hatch  to  release  free living  larval  stages. Chapter 3    117 
These generally develop to the L3 stage in the environment before infecting a 
new host by ingestion. The clade IV species, S. ratti has a unique life cycle, 
which  has  both  a  parasitic  and  a  free living  phase.  S.  ratti  can undergo  two 
types of development outside of the host: homogonic and heterogonic (Viney, 
1996). In homogonic development, the eggs pass out in the faeces, hatch and 
moult  through  two  larval  stages  into  infective  L3.  While  in  heterogonic 
development, the eggs hatch and moult through four larval stages into dioecious 
free living adults (Viney et al., 1993). In the analysis described here, only free 
living adult worms were available.  
Likewise, none of the clade IV plant parasitic nematodes (G. pallida and G. 
rostochiensis) tested could bind to GA. Globodera spp. are parasites of plant 
roots commonly known as potato cyst nematodes, which live in soil. The second 
stage  juvenile  worms  (J2)  are  the  infective  stage  in  the  soil  where  they 
penetrate  the  roots  of  the  susceptible  plant  and  feed  on  it  and  develop  to 
adults. The cyst containing eggs remains dormant within the body of the dead 
female  until  the  proper  stimulus  to  hatch  is  received.  Eggs  of  potato  cyst 
nematodes can remain dormant and viable within the cyst for 30 years (Winslow 
&  Willis,  1972).  In  this  stage  (J2),  the  nematodes  are  more  resistant  to 
anthelmintic drugs. 
 For the clade III nematodes, the results were more variable. Some of the 
species analysed exhibited the ability to bind to GA while some did not. Hsp90 
from  all  filarial  worms  tested  in  this  study  bound  to  GA.  Filarial  worms  are 
obligate parasites and their life cycle does not involves any free living stages in 
the environment, with arthropods acting as a intermediate hosts for transmission 
between  definitive  hosts.  In  keeping  with  this  result,  analysis  of  Hsp90  from Chapter 3    118 
another obligate parasite from clade I, T. spiralis, also showed binding to GA. 
The life cycle of T. spiralis involves two phases. The first phase is enteral, the 
worms remain in the intestine, growing from larvae to adults and reproducing. 
For  the  second  phase  known  as  the  parenteral  phase,  newly  hatched  larvae 
migrate to the host's muscle cells and become encysted. Infection occurs when 
meat contaminated with encysted L1 larvae is eaten. 
Analysis  of  Hsp90  from  the  Ascarid  species  (T.  cati,  A.  suum  and  P. 
equorum) shows the ability to bind to GA. For these species, the eggs are passed 
out in the faeces of the infected animal into the environment, but the larvae are 
protected  within  an  egg.  For  example,  infection  with  Toxocara  occurs  after 
ingestion  of  eggs,  which  hatch  in  the  stomach  of  the  definitive  host. 
Alternatively infection can also occur by ingestion of a paratenic host, such as a 
mouse. All Ascarid parasites have an egg with a thick shell, giving protection 
against potentially harsh environmental conditions. 
The clade III Anasakid parasites, A. simplex and P. decipiens, did not bind 
to GA. These parasites have a complex life cycle in the marine environment. 
Unembryonated eggs are excreted by mammals such as whales, seals or dolphins 
and eggs embryonate to form L2 in sea water. When eggs hatch, the larvae are 
eaten by crustaceans e.g. Eusphausids for Anisakis and cyclopod copepods for 
Pseudoterranova (Bristow & Berland, 1992). Similar to the Anasakid, A. crassus 
has a free swimming larval stage as part of its life cycle in the environment. A. 
crassus is a parasite of eels where the L2 stage is excreted in the water before 
being consumed by paratenic or intermediate host e.g. copepods. It develops 
into the infective stage in the intermediate host before being ingested by the Chapter 3    119 
eel. In the eel, the infective stage moves from the intestine to the swim bladder 
and develops into an adult.  
For some species it was not possible to ascertain with certainty whether 
Hsp90 bound to GA or not. These species were A. crassus and T. muris. For both 
species and for T. spiralis from clade I no reactivity was observed with any anti 
Hsp90  antibody  tested, so  the  pull downs could  not  be  analysed  by  immuno 
blotting. For T. spiralis, staining a gel of a pull down with Coommasie blue was 
sufficient  to  detect  a  band  running  at  approximately  the  correct  molecular 
weight (83 kDa) but not for A. crassus and T. muris. The T. spiralis band was 
excised from the gel and subjected to mass spectrometry, revealing that the T. 
spiralis band was likely to be Hsp90. Although it was not possible to identify 
Hsp90 binding to GA in pull down assays using A. crassus and T. muris, it is not 
possible to definitively conclude that Hsp90 from these species does not bind to 
GA. As extracts of A. crassus and T. muris failed to react with either antibody, 
the GA binding status of these species remains unresolved. Further experiment 
would have to be carried out using a more sensitive detection method e.g. silver 
staining or perhaps using different life cycle stages.  
The results in this chapter so far suggested that the ability of nematode 
Hsp90 to bind to GA is correlated with particular nematode life histories. Free 
living species and species with a free living larval stage did not bind to GA. In 
contrast, species which are permanently parasitic (filarial worms and T. spiralis) 
or species which have free living stages in the environment enclosed within a 
protective egg shell possess a GA binding Hsp90. However, there are limitations 
to these results as described above. Overall, these data could be interpreted in 
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argue  that  C.  elegans  Hsp9O  is  resistant  to  GA  because  it  shares  the  same 
ecological niche as the Streptomyces spp. which produces GA. However, whether 
C.  elegans  and  Streptomyces  spp.  do  actually  share  the  same  spatial  and 
temporal niches within the soil is unknown. Although C. elegans can be found in 
the soil, the predominant in the wild is the dauer larvae, which is usually found 
in organic rich environment such as compost. Dauer stages are resistant and non 
feeding  and  the  natural  food  source  of  C.  elegans  in  the  wild  is  unknown 
(Kiontke & Sudhause, 2006).  
A fascinating example of the interaction between a micro organism that 
synthesises an Hsp90 inhibitor and its host plant come from the work of McLellan 
et  al  (2007).  They  studied  a  fungus  (Paraphaeospharia  quadriseptata)  that 
synthesises the Hsp90 inhibitor, Monocillin I (MON) and showed that MON could 
inhibit plant (Arabidopsis thaliana) Hsp90. Inhibition of Hsps such as Hsp70 or 
Hsp90,  is  known  to  induce  a  stress  response  in  many  organisms  and  plants 
exposed to MON were no exception. Indeed, MON was shown to induce Hsp101, a 
protein  required  for  thermotolerence.  Finally  it  was  demonstrated  that  co 
association of the MON producing fungus and A. thaliana enhanced the tolerance 
of the plant to heat stress, suggesting an intricate association between plant and 
micro organism.  
In  order  to  further  investigate  the  adaptive  evolution  theory,  a 
collaboration with Dr. Richard Emes (University of Nottingham), analysed hsp90 
sequences  from  a  range  of  nematodes  to  determine  if  there  were  particular 
amino  acid  substitutions  associated  with  GA  binding  or  not.  This  analysis 
demonstrated three separate lineages for hsp90 sequences (Branch A, B and C) 
which correlated with the ability to bind GA (Figure 3.12). Branch A represents Chapter 3    121 
the group of GA binding clade III species, Branch B represents the group of non 
GA binding clade V species and Branch C represents the group of plant parasitic 
nematode  hsp90  sequences.  While  a  number  of  residues  showed  significant 
evidence  of  adaptive  evolution,  the  results  did  not  demonstrate  a  direct 
relationship between amino acid substitutions in Hsp90 and GA binding ability 
(Him  et  al.,  2009).  These  data  suggest  that  the  evolution  of  hsp90  may  be 
correlated to key functions other than the ability to bind GA.  
While  it  was  not  possible  to  identify  specific  amino  acid  sequences 
associated with GA binding or not, studies in other organisms have demonstrated 
that  point  mutations  in  hsp90  can  alter  sensitivity  to  Hsp90  inhibitors.  For 
example, in yeast an increased sensitivity to GA and radicicol was observed in 
hsp90 mutants (Piper et al., 2003a). That study revealed an increased sensitivity 
to GA of A587T and T101I with T22I, G313S and E381K showing lesser effect. In 
addition, in chicken Hsp90, mutation of S113A abolished GA binding and K112A 
reduced the GA binding compared to wild type Hsp90 (Lee et al., 2004). A study 
on human Hsp90 also showed the effect of mutations in hsp90 on GA binding 
(Onuoha et al., 2007).  Mutation of residues L106A and S107A, in the N terminal 
of human Hsp90, was shown to be important for the isomeration of GA. As a 
result of these mutations, the binding of Hsp90 to GA was reduced. S107 is an 
important element in the catalysis of trans to cis GA (Lee et al., 2004). S107 
acts as a docking site for the binding of trans GA and catalyses the conversion to 
the  cis isoform. So any mutation at this site, may affect the association and 
dissociation rates of GA binding, which may explain the differences in GA binding 
between mutant and wild type Hsp90.  
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Figure 3.12: Unrooted phylogenetic tree showing relationship of hsp90 sequences from 
fifteen different nematode species. 
 
Three  different  branches  showed  significant  evidence  of  adaptive  evolution.  Branch  A 
represents the group of GA binders (red), B (green) and C (blue) represents the group of 
non-GA binders. B, non-binding hsp90 sequences from clade V species and C the plant 
parasitic nematode hsp90 sequences.    
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As GA and related Hsp90 inhibitors, such as radicicol, are produced by 
micro organisms,  study  of  the  micro organism  Hsp90  might  be  revealing  as 
presumably  inhibition  of  Hsp90  would  be  deletenous.  In  the  yeast  Humicola 
fuscoatra,  a  species  that  produce  radicicol,  a  single  conserved  amino  acid 
substitution  (L33I)  in  Hsp90  is  enough  to  influence  the  binding  of  radicicol 
without altering the ability to bind ATP or GA (Prodromou et al., 2009). In that 
study they showed that substitution of leucine to isoleucine alters the size of the 
hydrophobic drug binding pocket. As a result of this, there is increased binding 
of H2O molecules and hydration of the drug. These findings demonstrate that 
small alterations in amino acid residues can have major affects on drug binding 
efficacy.   
There  are  also  additional  theories  on  GA  binding  to  Hsp90  that  may 
explain  the  differences  in  the  ability  of  nematode  Hsp90  to  bind  to  GA.  A 
possible explanation of the differences between B. pahangi and C. elegans Hsp90 
in  GA  binding  is  the  cellular  context  of  Hsp90;  that  is  the  degree  of  post 
translational  modifications  or  the  presence  of  specific  co chaperones  in  the 
Hsp90 complex. This is best exemplified by studies in tumour cells where Hsp90 
appears  to  exist  in  high  affinity  complexes  with  a  number  of  co chaperones 
(Kamal et al., 2003). In this configuration Hsp90 was shown to be more sensitive 
to 17 AAG than Hsp90 from normal cells, which exists in a free uncomplexed 
state. Hsp90 complexes in tumour cells contain the co chaperones p23 and Hop, 
and have a higher affinity for GA than Hsp90 from normal cells. p23 is thought to 
modulate  Hsp90  activity  in  the  last  stages  of  the  chaperoning  pathway.  Hop 
belongs to the large group of Hsp co chaperones. It is one of the best studied co 
chaperones of the Hsp70/Hsp90 complex and it is essential to link Hsp70 and 
Hsp90  together.  By  forming  a  super chaperone  complex  containing  many Chapter 3    124 
essential co chaperones, Hsp90 becomes more active and this helps it carry out 
its function. In addition, by adding p23, Hop, Hsp70 and Hsp40 to purified Hsp90 
the  affinity  of  Hsp90,  for  17 AAG  was  significantly  increased  (Kamal  et  al., 
2003). These results were substantiated by the studies of Vilenchik et al (2004), 
who reported a 10  to 50 fold difference in binding of PU24FCI, a novel Hsp90 
inhibitor, to Hsp90 from tumour cells compared to normal cells.   
 Piper  et  al  (2003a)  showed  that  expressing  the  human  Hsp90β  in  S. 
cerevisiae  increased  the  sensitivity  of  the  yeast  to  GA  and  radicicol  whereas 
expression  of  C.  elegans  Hsp90  made  the  yeast  more  resistant  to  GA  and 
radicicol. In yeast, complementation  by  human Hsp90β and  C. elegans  Hsp90 
requires the presence of the co chaperones, Sti 1 and p23. Recently Sti 1 has 
been  recognised  as  an  Hsp90 interacting  protein  in  C.  elegans  (Song  et  al., 
2009). This indicates that in the cell, Hsp90 functions in a complex rather than 
in isolation. In addition, studies from this lab (Gillan et al., 2009), showed that 
there are fundamental differences between C. elegans and B. pahangi Hsp90. 
Injection of B. pahangi hsp90 into C. elegans failed to rescue a daf 21 mutant, 
while  injection  of  the  wild type  C.  elegans  daf 21  rescued  the  mutant. 
Interestingly,  injection  of  an  H.  contortus  hsp90  construct  provided  a  partial 
rescue. In these studies, wild type C. elegans expressing a translational fusion of 
B. pahangi hsp90 gave a positive signal with GA beads in contrast to wild type C. 
elegans hsp90, showing that even though the Brugia protein was translated in C. 
elegans, it was not functional. This suggests that in different nematodes Hsp90 
may require different co chaperones for activity or perhaps reflect difference in 
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While  the  differences  in  Hsp90  binding  to  GA  in  different  species  of 
nematode  could  be  explained  by  the  presence  of  different  co chaperones  or 
perhaps different client proteins, it might be also relate to differences in post 
translational modification of Hsp90. Hsp90 is known to be modified significantly, 
by phosphorylation, acetylation and glycosylation (Scroggins et al., 2007; Chiosis 
et  al.,  2004).  These  post translational  modifications  are  known  to  alter  its 
activity.  However  to  date,  very  little  known  of  Hsp90  modifications  in 
nematodes.  
In conclusion, the results in this chapter demonstrated that C. elegans 
Hsp90 is not unique and that the non GA binding phenotype is shared by other 
nematodes from different clades. The ability to bind to GA is associated with the 
life  history  of  the  species.  Free living  nematodes  and  those  parasitic  species 
which have a free living larval stage in the environment do not bind to GA. In 
contrast,  obligate  parasite  or  those  parasitic  species  which  have  free living 
stages enclosed within a protective egg, do bind to GA. However, while these 
observations  may  be  consistent  with  the  adaptive  evolution  theory  of  hsp90 
sequences as proposed by (David  et al., 2003), no evidence was produced of 
specific  amino  acids  that  were  associated  with  the  binding  or  non binding 
phenotype.         
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4  Further characterisation of B. pahangi Hsp90 
4.1  Introduction 
Lymphatic filariasis is a disabling and disfiguring parasitic disease caused by 
the adult and developing stages of filarial nematode parasites residing in the 
lymphatic system of a mammalian host. Nearly 120 million people are infected 
and,  until  the  advent  of  the  global  elimination  programme,  the  number  was 
increasing in affected countries. The disease is caused by the parasitic filarial 
worms  Wuchereria  bancrofti,  Brugia  malayi  or  Brugia  timori  that  are 
transmitted by the bite of the mosquitoes acting as their intermediate hosts. 
Approximately  one  billion  people  are  faced  with  the  risks  of  infection  and 
preventing and combating lymphatic filariasis is a long term goal of World Health 
Organisation (WHO) (http://www.who.int/mediacentre/ factsheets/fs102/en/). 
However, there are no current drugs which have activity against adult worms. 
The drugs currently used in control, such as diethylcarbamazine and ivermectin, 
largely  target  the  microfilariae  (Mf).  The  mechanism  by  which 
diethylcarbamazine kills Mf is still poorly understood but it has been suggested 
that it acts as an inhibitor of arachidonic acid metabolism in Mf (Liu & Weller, 
1990) making the Mf more susceptible to host immune attack. As the inhibition 
of Hsp90 in Brugia pahangi by geldanamycin (GA) kills both adult worms and Mf 
(Devaney et al., 2005) it is relevant to ask whether Hsp90 or its client proteins 
would be suitable targets for drug development.  
In the filarial nematode B. pahangi, hsp90 is a single copy gene which is 
69%  identical  to  human  hsp90  (Thompson  et  al.,  2001).  B.  pahangi  Hsp90 
contains all the features of Hsp90 that are common to other eukaryotic proteins; 
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region that links the N terminal domain to the M domain. In B. malayi, Hsp90 
was  shown  to  be  excreted  by  adult  worms  cultured  in  vitro  (Kumari  et  al., 
1994). The quantification of excretory/secretory (ES) products released by living 
worms may be useful for detection of antibody, because these products appear 
to be more species specific than crude somatic extracts (de Savigny et al., 1979; 
Kaushal et al., 1984). In nematodes, most of the information on Hsp90 comes 
from studies on C. elegans. The C. elegans genome contains a single hsp90 gene 
(daf 21) located on chromosome V, which is 74% and 76% identical to human 
Hsp90α and Hsp90β, respectively (Birnby et al., 2000). In addition, Hsp90 also 
has been characterised in Trichinella spiralis (Martinez et al., 2001; Martinez et 
al., 2002) and cloned from Haemonchus contortus (Gillan et al., 2009).  
 As described in Chapter 3, GA inhibits Hsp90 function in most eukaryotes 
with  the  exception  of  C.  elegans  and  some  other  nematodes.  However,  the 
mechanism  which  confers  resistance  to  GA  on  C.  elegans  Hsp90  is  not 
understood.    In  most  organisms,  GA  interferes  with  the  folding,  maturation, 
localisation or degradation of certain Hsp90 client proteins and co chaperones. 
Hsp90  requires  a  series  of  co chaperones  to  form  a  complex  required  for  its 
function. For example, the Hsp90 dependant activation of kinases requires cell 
cycle  division  protein  37  (Cdc37)  (Vaughan  et  al.,  2008).  In  that  study,  they 
showed that phosphorylation and dephosporylation of Cdc37 is necessary for the 
kinase  client  protein  to  bind  to  Hsp90.  Most  Hsp90  co chaperones  or  client 
proteins  have  been  characterised  from  human  or  yeast.  However,  a  recent 
bioinformatic analysis revealed that the C. elegans genome contained most of 
the  well  characterised  co chaperones  with  the  exception  of  cyclophilin 40 
(Johnson & Brown, 2009). Cyclophilin 40 is a member  the  peptidyl prolyl cis Chapter 4    129 
trans isomerase family and was shown to interact with steroid receptors such as 
the glucocorticoid receptor and androgen receptor (Riggs et al., 2004).  
The role of post translational modifications in regulating Hsp90 functions 
remains  unclear.  As  reviewed  previously,  post translational  modifications  are 
required for some Hsp90 chaperone functions (Scroggins & Neckers, 2007),. For 
example,  dephosphorylation  and  re phosphorylation  of  Hsp90  regulated  the 
activity of heme regulated inhibitor kinase, an Hsp90 client protein, (Szyszka et 
al., 1989) suggesting that Hsp90 phosphorylation is required for its function. In 
human Hsp90α, acetylation at lysine K294 was shown to reduce Hsp90 activity 
and chaperone function (Scroggins et al., 2007). K294 resides in the M terminal 
domain  of  human  Hsp90α  and  acetylation  of  K294  significantly  impacts  the 
interaction of Hsp90 with a diverse set of client proteins. These results suggest 
that  acetylation  of  Hsp90  plays  an  important  role  in  regulating  chaperone 
function. 
The  aim  of  this  chapter  was  to  further  characterise  B.  pahangi  Hsp90. 
Experiments  were  carried  out  to  examine  the  expression  profile  of  Hsp90  in 
different  life cycle  stages,  to  further  characterise  the  binding  of  B.  pahangi 
Hsp90 to GA, to identify B. pahangi Hsp90 associated proteins and to investigate 
the effect of Hsp90 post translational modifications on GA binding.  
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4.2  Results 
4.2.1 Hsp90 is expressed in all life-cycles of B. pahangi 
Three different stages of B. pahangi were available for analysis. Initial 
experiments focused on the expression of Hsp90 in adult, L3 and Mf by Western 
blotting  using  the  B.  pahangi  anti Hsp90  antibody.  Anti actin  was  used  as  a 
loading  control  for  all  the  experiments.  All  worm  lysates  were  prepared  by 
grinding in liquid nitrogen as described in Materials and Methods (Section 2.1.3). 
The protein concentration for each lysate was assayed using the Bio Rad Protein 
Assay.  Equal  amount  of  proteins  were  analysed  by  SDS PAGE  and  Western 
blotting.  Hsp90  is  expressed  in  all  three  life  cycle  stages  (Figure  4.1b)  and 
reacted well with the B. pahangi anti Hsp90 antibody. The autoradiograph was 
then scanned to quantify the band densities using FlourChem
TM IS 5500 software. 
Figure 4.1c shows the mean ratio of Hsp90 to actin ± SD in each life cycle stage 
in three separate experiments. The highest relative level of Hsp90 expression 
was seen in the Mf, followed by the adult worm with the lowest level in L3. 
However  there  was  no  statistically  significant  difference  between  the  three 
groups (p>0.05).  
Next the extracts of the three life cycle stages were used in GA pull down 
assays to compare the ability of Hsp90 to bind to GA beads. Surprisingly, only 
Hsp90 from adult worms bound to the beads (Figure 4.2).  Initially, the failure of 
L3 and Mf extract to bind to GA beads was thought to be due to degradation of 
the beads. A new batch of GA beads was subsequently derivatised and prepared. 
Despite the new batch of GA beads, both L3 and Mf stages failed to bind to GA. 
These experiments were repeated again using fresh worm lysates but the same 
results were obtained.  Chapter 4    131 
 
 
 
Figure 4.1: Hsp90 is expressed in different stages of B. pahangi  
 
a) Coomassie Blue stained gel of equal amount of B. pahangi lysate from different life-cycle 
stages. Adult (Lane 1), L3 (Lane 2) and Mf (Lane 3).  
b) Immuno-blot of the three life-cycle stages. Hsp90 is expressed in different life-cycle stages 
and reacted with B. pahangi anti-Hsp90 antibody.  Adult (Lane 1), L3 (Lane 2) and Mf (Lane 3). 
Proteins were transferred to NCP using standard methods, then blocked o/n in 5% dried milk 
in PBS/0.5% Tween 20 and then the blot was probed with 1:5000 dilution of the B. pahangi 
anti-Hsp90 antibody. Bound antibody was detected using a 1:10,000 dilution of anti-rabbit IgG 
conjugated to HRP. For actin, the blot was probed with 1:1000 dilution of anti-actin and bound 
antibody was detected using a 1:10,000 dilution of anti-mouse IgG.  The blot was developed 
using the Pierce Super Signal West Pico chemiluminescence kit. 
c) The graph shows Hsp90 expression levels in three different life-cycle stages of B. pahangi 
relative  to  actin  as  quantified  by  FlourChem
TM  IS-5500  software.  The  results  represent  the 
mean ±  standard deviation of Hsp90/actin ratio from three different experiments. 
Adult 2.10 ± 1.04, L3 0.967 ± 0.33, Mf 2.59 ± 1.32 
Adult vs L3,  p = 0.1641 
Adult vs Mf, p = 0.1353 
L3 vs Mf, p = 0.1548 
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Figure 4.2: Hsp90 from B. pahangi L3 and Mf did not bind to GA in pull-down assays.  
 
Western blotting analysis of B. pahangi Hsp90 pull-down assay. Adult (Lane 1), L3 (Lane 2) 
and Mf (Lane 3). For pull-down assays, 300 µg of protein extracts were incubated with 50 µl 
of GA beads for 2.5h at 4
oC on a rocker. The beads were washed extensively in TNES and 
bound proteins were eluted by boiling in SDS-PAGE sample cocktail. Bound proteins were 
analysed by SDS-PAGE and immuno-blotting as described previously. 
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4.2.2 B. pahangi Hsp90 is constitutively expressed and not 
strongly inducible by heat shock or geldanamycin 
As a heat shock protein, Hsp90 responds to stress conditions such as heat 
and chemicals. In many cellular systems exposure to Hsp90 inhibitors induces a 
heat  shock  response.    Here  I  investigated  whether  Hsp90  levels  were  up 
regulated after exposure to heat shock or to GA. B. pahangi adult worms were 
used  in  this  analysis.  For  heat  shock  treatments,  10  adult  worms  were  heat 
shocked at 41
oC for 60 min and allowed to recover for 2 h at 37
oC. In addition, 
one group containing 10 adult worms were incubated at 37
oC for 3 h as a control. 
All worms were solubilised in SDS PAGE sample cocktail and levels of Hsp90 were 
then analysed by SDS PAGE and Western blotting. 
 In other experiments, 10 adult worms were incubated in 1.0  M GA for 24 
h as described in Materials and Methods (Section 2.2.2), then removed from the 
drug  and  directly  solubilised  in  SDS PAGE  sample  cocktail.  Controls  included 
worms incubated with carrier DMSO or in medium alone. Figure 4.3 shows the 
autoradiograph  of  B.  pahangi  Hsp90  expression  levels  after  heat  shock  or 
exposure to GA with actin used as a loading control. The autoradiograph shows 
that  no  significant  increase  in  the  level  of  Hsp90  was  observed  in  adult  B. 
pahangi exposed to elevated temperatures (Lane 5) or treated with GA (Lane 3) 
compared to control groups (Lane 1, 2 and 4). The bands on the autoradiograph 
were  scanned  and  band  densities  were  obtained  using  FlourChem
TM  IS 5500 
software. Statistical significance between groups was calculated based on the 
density values as quantified by the software. There was no significant difference 
in  the  expression  level  of  Hsp90  in  any  treatment  group  compared  to  the 
relevant control group (p>0.05).  Chapter 4    135 
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Figure 4.3: Hsp90 expression levels of B. pahangi are not significantly induced by heat 
shock or GA treatment.  
 
a) Coomassie blue stained gel of worm extracts. Adult B. pahangi from each group were 
analysed on a 10% SDS-PAGE gel. Equal amounts of protein were analysed (as assessed by 
Coomasie  blue  staining)  of  control  group  without  GA  (Lane  1),  carrier  DMSO  (Lane  2), 
treated with GA at 1.0 µM for 24h (Lane 3), control group at 37
oC (Lane 4) and heat shocked 
at 41
oC (Lane 5).   
b) B.  pahangi Hsp90  expression is  not affected  by  heat  shock or  GA  treatment. Control 
group without GA (Lane 1), carrier DMSO (Lane 2), treated with GA at 1.0 µM for 24h (Lane 
3), control  group at  37
oC  (Lane  4)  and  heat  shocked  at  41
oC  (Lane 5).    All worms were 
solubilised directly into SDS-PAGE sample cocktail and analysed on 10% SDS-PAGE gels 
followed by Western blotting. Proteins were transferred to NCP using standard methods, 
blocked o/n in 5% dried milk in PBS/0.5% Tween 20 and then the blot probed with 1:5000 
dilution  of  the  B.  pahangi  anti-Hsp90  antibody.  Bound  antibody  was  detected  using  a 
1:10,000  dilution  of  anti-rabbit  IgG  conjugated  to  HRP.  For  loading  control,  anti-actin 
antibody was used at 1:1000 dilution and bound protein was detected using anti-mouse IgG 
at  1:10,000  dilution.  The  blot  was  developed  using  the  Pierce  Super  Signal  West  Pico 
chemiluminescence  kit  and  Hsp90  levels  were  assessed  relative  to  actin,  as  described 
previously (data not shown).                 
GA vs Control, p = 0.6576 
DMSO vs Control, p = 0.1618 
37
oC vs 41
oC, p = 0.2123 
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4.2.3 How much B. pahangi Hsp90 binds to GA beads? 
Hsp90 is an abundant protein in cells and it can constitute up to 1 2% of 
the total cellular protein under normal conditions (Welch & Feramisco, 1982). In 
these experiments, the proportion of B. pahangi Hsp90 that bound to GA was 
investigated by carrying out a series of pull down assays. The worm lysate was 
incubated with GA beads and the non bound supernatant was retained for the 
next  pull down.  This  was  repeated  five  times  and  the  bound  proteins  were 
analysed by SDS PAGE and Western blotting. Figure 4.4a shows a representative 
autoradiograph of a series of pull down assays. It can be seen that most of the 
Hsp90 available to bind to GA beads was present in the first pull down (Figure 
4.4a, Lane 2) with progressively diminishing amounts in subsequent pull downs. 
In the fifth pull down, no band was observed (Lane 6). The autoradiograph was 
scanned to quantify the band densities using FlourChem
TM IS 5500 software. The 
percentage of Hsp90 binding in each pull down was calculated relative to the 
amount of Hsp90 in the starting extract (Figure 4.4a, Lane 1).   
Figure 4.4b shows a graph of the mean percentage of B. pahangi Hsp90 
bound to GA beads after a series of five pull down assays calculated from three 
different experiments. For the first pull down, approximately 2.88% of the input 
Hsp90  bound to GA (2.88  ±  0.6025). For  the second  pull down  approximately 
2.10% Hsp90 bound to GA (2.10 ± 0.6401). For the third and fourth pull downs, 
approximately 0.93% and 0.39% respectively bound to GA (0.93 ± 0.1305 and 0.39 
± 0.0901), while in the fifth pull down no signal was observed. Based on these 
results, approximately 6.31% of the total cellular Hsp90 bound to GA beads in 
solid pull down assays.   Chapter 4    137 
 
 
 
Figure 4.4: Estimating the proportion of B. pahangi Hsp90 bound to GA beads 
 
a) Autoradiograph showing the binding of B. pahangi Hsp90 to GA beads in a series of pull-
down assays. A strong signal is obtained with B. pahangi input (Lane 1) and in the first pull-
down (Lane 2). Progressively less Hsp90 is present in the second pull-down (Lane 3), the third 
pull-down (Lane 4), fourth pull-down (Lane 5) with the fifth pull-down (Lane 6) being negative. 
B. pahangi input was analysed at 1:150 dilution.   
300 µg of protein extract was incubated with 50 µl of GA beads for 2.5h at 4
oC on a rocker. 
Beads were washed extensively in TNES and bound proteins were eluted by boiling in SDS-
PAGE sample cocktail. The supernatant for each pull-down was retained and kept for another 
round of pull-down. These steps were repeated five times. Then, bound proteins for each pull-
down were analysed by SDS-PAGE and immuno-blotting. Proteins were transferred to NCP 
using standard methods, blocked o/n in 5% dried milk in PBS/0.5% Tween 20 and then the blot 
probed  with  1:5000  dilution  of  the  B.  pahangi  anti-Hsp90  antibody.  Bound  antibody  was 
detected  using  a  1:10,000  dilution  of  anti-rabbit  IgG  conjugated  to  HRP.  The  blot  was 
developed using the Pierce Super Signal West Pico chemiluminescence kit.  
b) Graph shows the proportion of Hsp90 binding to GA beads in pull-down assays. Results 
presented the mean ± standard deviation of Hsp90 bound to GA beads from three different 
experiments.  
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4.2.4 Hsp90 is secreted by adult B. pahangi 
Previous experiments analysing the ES products of adult B. malayi showed 
that Hsp90 is secreted (Kumari et al., 1994). In this section, the ES products of 
Mf and adult B. pahangi were analysed. Mf and adult worms were incubated in 
RPMI 1640  medium  and  ES  products  were  collected  and  concentrated  as 
described in Materials and Methods (Section 2.2.4). Figure 4.5 shows the analysis 
of ES products from both life cycle stages. The gel shown in Figure 4.5a was 
stained with Coomassie blue but this staining method did not detect any bands in 
the ES products for either stage. The ES products were then analysed using the 
more sensitive silver staining, as shown in Figure 4.5b. In Lane 1 (adult stage) 
there were a few bands visible in the ES products but no staining was seen with 
Mf (Lane 2). In order to validate this observation, concentrated ES from both 
stages was analysed by SDS PAGE and Western blotting using the B. pahangi anti 
Hsp90  antibody.  The  autoradiograph  in  Figure  4.5c  shows  the  analysis  of  ES 
products detected using B. pahangi anti Hsp90 antibody. Hsp90 was shown to be 
secreted in ES products of adults (Lane 1) but not Mf (Lane 2).  
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Figure 4.5: Analysis of ES products of adult and Mf stages of B. pahangi 
 
a) Coomassie blue stained gel of ES products from Mf and adult B. pahangi. Mr represents 
the molecular weight marker, adult (Lane 1) and Mf (Lane 2).  
b)  Silver  stained  gel  of  ES  products  from  Mf  and  adult  B.  pahangi.  Mr  represents  the 
molecular weight marker, adult (Lane 1) and Mf (Lane 2).  
c) Autoradiograph of ES products as detected using B. pahangi anti-Hsp90 antibody. Adult 
stage  (Lane  1)  and  Mf  (Lane  2).  ES  products  of  both  stages  were  concentrated  and 
solubilised in SDS-PAGE sample cocktail by boiling for 3 min followed by centrifugation at 
13200  rpm  for  3  min  and  analysed  by  SDS-PAGE  and  Western  blotting.  Proteins  were 
transferred to NCP using standard methods, blocked o/n in 5% dried milk in PBS/0.5% 
Tween  20  and  then  the  blot  probed  with  1:5000  dilution  of  the  B.  pahangi  anti-Hsp90 
antibody.  Bound  antibody  was  detected  using  a  1:10,000  dilution  of  anti-rabbit  IgG 
conjugated  to  HRP.  The  blot  was  developed  using  the  Pierce  Super  Signal  West  Pico 
chemiluminescence kit.  
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4.2.5 Identification of B. pahangi Hsp90-associated proteins 
As reviewed by Jackson et al (2004) and Wegele et al (2004), Hsp90 plays 
a role as a central component of the assembly and disassembly machine and as 
such, associates with several groups of proteins. In this section, attempts were 
made to identify B. pahangi associated proteins by proteomic analysis or using a 
modified GA biotin binding assay (Neef et al., 2010).   
4.2.5.1  Modified GA-biotin binding assay 
This assay relies upon the binding of biotin labelled GA to Hsp90 protein 
complexes. The complexes are then isolated using Neutravidin agarose beads.  
B. pahangi lysate was incubated in the present of GA biotin, while the control 
sample was incubated without GA biotin. The bound proteins were captured by 
incubating with Neutravidin agarose beads and analysed as described previously 
in Materials and Methods (Section 2.2.5.1). 
Figure  4.6a  shows  a  representative  Coomassie  blue  gel  of  B.  pahangi 
lysate incubated with GA biotin or not, followed by Neutravidin capture. It can 
clearly be seen from the gels, that in the presence of GA biotin, a number of 
proteins were present in the eluate of the Neutravidin agarose beads (Lane 1). 
However, careful examination of Lane 2 (without GA biotin) shows that most of 
the bands were also present, albeit at a lower level, suggesting that binding is 
mostly  non specific.  Attempts  were  made  to  overcome  this  problem  by  pre 
incubating  B.  pahangi  lysate  with  Neutravidin agarose  beads  in  order  to 
eliminate any proteins that might bind non specifically to the beads. Following 
the  pre incubation  with  Neutravidin agarose  beads,  the  supernatant  was 
incubated  with  GA–biotin  and  processed  as  described  previously.  Figure  4.6b Chapter 4    143 
shows the pull down assay after pre incubation with Neutravidin agarose beads. 
Lane  1  shows  the  B.  pahangi  proteins  bound  non specifically  to  Neutravidin 
agarose beads. The supernatant from this incubation was then mixed with GA 
biotin and processed as described previously. Lane 2 shows that a number of 
proteins were present in the eluate of the Neutravidin agarose beads. However, 
many of the bands were also observed in the control lane (Lane 3). Based on 
these results, this approach was not used further.        
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                (a)  (b) 
 
Figure 4.6: GA-biotin binding assay  
 
a) Coomassie blue  stained gel showing the proteins bound to GA-biotin as analysed by 
SDS-PAGE.    Bound  protein  captured  by  Neutravidin-agarose  beads  incubated  with  GA-
biotin (Lane 1) or without GA-biotin (Lane 2). 1.0 mg B. pahangi lysate was incubated with 
100 µl of GA-biotin for 15 h at 4
oC. The bound proteins were captured by incubating the 
mixture with Neutravidin-agarose beads. Bound protein were eluted in 100 µl SDS-PAGE 
sample cocktail and 20 µl of sample was loaded onto a 10% gel for the analysis.  Control 
(Lane 2) was incubated without GA-biotin and analysed exactly as for Lane 1.  
b) Coomassie blue stained gel showing the proteins bound to GA-biotin. B. pahangi lysate 
was pre-incubated with Neutravidin-agarose beads (Lane 1), the remaining supernatant was 
then incubated with GA-biotin followed by Neutravidin-agarose beads (Lane 2) or without 
GA-biotin (Lane 3) followed by Neutravidin-agarose beads.       
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4.2.5.2  Proteomic analysis of B. pahangi Hsp90-associated proteins 
Hsp90 exists within the cell in complexes with co chaperones and client 
proteins.  After exposure to GA, Hsp90 undergoes a conformational change with 
the result that client proteins are released from the complexes and subject to 
degradation. Thus, it may be possible to identify some Hsp90 associated proteins 
by their disappearance following GA treatment. B. pahangi adult worms were 
incubated in RPMI 1640 medium containing 1.0  M GA or DSMSO alone for 24 h 
and worm lysates were prepared as described in Materials and Methods (Section 
2.2.5.1). Equal amounts of protein (50  g) were labelled with Cy3 for GA treated 
group or Cy5 for the control group and the samples mixed and subjected to IF 
and SDS PAGE as described in Materials and Methods (Section 2.2.5.3). After SDS 
PAGE,  the  gel  was  scanned  using  a  Typhoon  9400  scanner.  The  separate  gel 
images of the treated group (with GA) and the control group (non treated) were 
compared  using  the  Differential  In Gel  Analysis  (DIA)  software  module  of  the 
DeCyder batch processor (Amersham Bio Sciences, UK). Figure 4.6a shows the 
2D gel image of the treated group with GA at 1.0  M and Figure 4.7b shows the 
2D gel  image  of  control  group.  Using  the  DeCyder  batch  processor, 
approximately 2113 spots were detected, of which 96.2% showed similarity in 
the protein abundance for each sample. Approximately 3.1% of proteins were 
shown to be up regulated in the treated group compared to the control group, 
while approximately 0.7% of the proteins were down regulated in the treated 
group compared to the control group. Figure 4.7c shows the spots detected using 
DIA  software.  The  spots  in  yellow  represent  those  proteins  that  differed  in 
abundance as analysed using the software. See Table 4.1 for a summary of the 
analysis.  Chapter 4    146 
 
 
 
Figure 4.7: Proteomic analysis of B. pahangi adult extract following GA treatment or control 
worms.  
 
a) Scanned image of a 2D-gel of B. pahangi adult worms treated with GA using the Typhoon 
9400  Scanner.  60  adult  worms  were  cultured  in  RPMI-1640  medium  containing  a  final 
concentration of GA  at 1.0 µM at 37
oC in an  atmosphere of 5%  CO2 in air for  24 h.  Equal 
amounts of protein (50 µg) were labelled with Cy3 for GA-treated and subjected to IF and SDS-
PAGE as described in Materials and Methods (Section 2.2.5.3).   
b) Scanned image of a 2D-gel of the control group using the Typhoon 9400 Scanner. 60 adult 
worms were cultured in RPMI-1640 medium containing an equivalent volume of DMSO at 37
oC 
in an atmosphere of 5% CO2 in air for 24 h. Equal amounts of protein (50 µg) were labelled with 
Cy5 for control and subjected to IF and SDS-PAGE as described in Materials and Methods 
(Section 2.2.5.3).  
c) Protein spots detected by the DIA software. The red circles represent the spots of equal 
abundance in both samples, while the yellow circles represent the spot that were differentially 
expressed in the two samples, as detected by the DIA software.  Chapter 4    147 
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Table 4.1: Summary of spot statistics as analysed by DIA Software 
 
  Number of spots  Percentage (%) 
Increased  61  3.1 
Similar  1911  96.2 
Decreased  14  0.7 
Total  2113  100 Chapter 4    149 
Unfortunately it was not possible to identify the up regulated and down 
regulated protein spots because the spot picking equipment required was out of 
order. In an attempt to analyse the differences, the experiment was repeated 
using  a  new  fresh  worm  lysate,  prepared  exactly  as  described  previously. 
However,  in  this  experiment,  the  experimental  and  the  control  group  were 
analysed separately. The IPG strip samples of the treated group and the control 
group were transferred onto different gels. The gels were stained by Coomassie 
blue, destained and then scanned using the Typhoon Trio Variable Imager. Any 
differences  were  spotted  manually  using  the  Ettan  Spot  handling  workstation 
(Amersham Bio Sciences, UK).  
Figure 4.8a and 4.8b show the image of the GA treated group and the 
non treated group as stained by Coomassie blue. Protein spots that are present 
on  the  control  gel  but  absent  in  the  GA treated  group  are  considered  to  be   
down regulated  proteins,  while  protein  spots  that  are  absent  in  the  control 
group  but  present  in  GA treated  group  are  considered  to  be  up regulated 
proteins. There were only a few spots in the control group that were absent in 
the GA treated group (black circles). In addition, there were two clear protein 
spots that are present in the GA treated group compared to the control group 
(Figure 4.8c, blue circles). Overall, 12 spots were identified of which seven were 
differently expressed (see Figure 4.8c). Spots of interest were carefully excised 
and subjected to in gel trypsin digest following which the dried digested samples 
were  subjected  to  analysis  by  mass  spectrometry.  All  peptide  samples  were 
separated on liquid chromatography electrospray (LC) system before analysing 
by ionization/multi stage mass  spectrometry (ESI MS) (see Appendix  6). Table 
4.2  shows  the  results  of  the  protein  identification  of  2D gel  spots  in  a Chapter 4    150 
comparative  screen  between  GA treated  and  control  worms.  These  proteins 
belong to several groups most of which have structural or chaperone function.      
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Figure 4.8: 2D-gel image of B. pahangi protein lysate as analysed by 2D SDS-PAGE. 
  
a) Image of 2D-gel scanned using Typhoon Scanner represents the GA-treated group. 60 adult 
worms were cultured in RPMI-1640 medium containing a final concentration of GA at 1.0 µM at 
37
oC  in  an  atmosphere  of  5%  CO2  in  air  for  24  h.  Equal  amounts  of  protein  (50  µg)  were 
prepared  as  described  previously  and  subjected  to  IF  and  SDS-PAGE  as  described  in 
Materials and Methods (Section 2.2.5.3). Gel was stained with Coomassie blue.    
b) Image of 2D-gel scanned using Typhoon Trio Variable Imager representing the untreated 
control group. 60 adult worms were cultured in RPMI-1640 medium containing an equivalent 
volume of DMSO at 37
oC in an atmosphere of 5% CO2 in air for 24 h.  Equal amounts of protein 
(50  µg)  were  prepared  as  described  previously  and  subjected  to  IF  and  SDS-PAGE  as 
described in Materials and Methods (Section 2.2.5.3). Gel was stained with Coomassie blue.     
c) 2D-image of gel as analysed by Coomassie blue staining showing the spot of interest for 
the analysis. 12 spots were excised. The black circles represent the spots that decreased in 
abundance  in  the  GA  group.  The  red  circles  represent  the  spots  which  were  similar  in 
abundance in both groups and the blue circles represent the spots which were increased in 
abundance after exposure to 1.0 µM GA.  
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Table 4.2: Identification of 2D-gel spots differentially expressed in a comparative screen 
between B. pahangi GA-treated group vs control group.  
 
Sample ID*  Protein hit  Hit score  Function 
1a  Tropomyosin  1233  Structural 
1b  Myosin regulatory light chain 1  469  Structural 
1c  Actin depolymerising factor 1  700  Structural 
1d  Actin depolymerising factor 1  757  Structural 
1e  DJ 1 family protein  817  Unknown 
2a  Small heat shock protein  194  Chaperone 
2b  Alkali myosin light chain  601  Structural 
2c  Thioredoxin  219  Antioxidant 
2d  Small heat shock protein  814  Chaperone 
2e  Tropomyosin  1174  Structural 
3a  Myosin regulatory light chain 1  613  Structural 
3b  Tropomyosin  701  Structural 
       
* 1 – down-regulated in GA vs control group, 2 – similar in both groups, 3 – up-regulated in 
GA vs control group. 
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4.2.6 Recombinant human Hsp90α binds to GA beads 
Post translational  modifications  such  as  phosphorylation,  acetylation, 
nitrosylation and ubiquitinylation have been shown to regulate the chaperone 
function  of  Hsp90.  In  order  to  investigate  the  possible  effect  of  post 
translational modifications on Hsp90 binding to GA, the binding of recombinant 
human Hsp90α (rHsp90α) was compared with native human Hsp90. Human Hsp90 
was used in these experiments because recombinant B. pahangi Hsp90 was not 
available for analysis. Native Hsp90 was isolated from SkBr3 cells. The rHsp90α 
(StressMarq, UK) was expressed in E. coli and therefore does not bear any post 
translational  modification.  8   g  of  SkBr3  was  analysed  by  SDS PAGE.  For 
comparison  2   g  of  rHsp90  was  analysed  (Figure  4.9a).  An  abundant  band  at 
approximately 90 kDa was detected for rHsp90α (Lane 1) but only a faint band 
for  the  SkBr3  lysate  was  detected  (Lane  2).  Both  samples  were  then  tested 
against B. pahangi anti Hsp90 antibody at 1:5000 dilution or AC88 monoclonal 
anti Hsp90 antibody at 1:1000 dilution. Figure 4.9b shows that the B. pahangi 
anti Hsp90 antibody failed to react with rHsp90α (Lane 1) or SkBr3 lysate (Lane 
2).  However,  the  AC88  monoclonal  antibody  is  able  to  detect  Hsp90  in  both 
samples (data not shown). Analysis of pull down assays showed that Hsp90 from 
both sources bound to GA beads (Figure 4.9c), which suggests that the presence 
or absence of post translational modifications did not affect the ability of human 
Hsp90 to bind to GA. Blocking assays were then used to show the specificity of 
the binding by pre incubation in soluble GA at 1.0  M or 2.0  M GA. Figure 4.9d 
and Figure 4.9e show that the binding of rHsp90α and SkBr3 Hsp90 is blocked by 
soluble GA, with 1.0  M GA being sufficient to completely block Hsp90 binding to 
GA beads for both extracts.  Chapter 4    155 
 
 
 
Figure 4.9: Analysis of recombinant human Hsp90α and SkBr3 extract 
 
a) Coomassie blue stained gel of rHsp90α and SkBr3 extract. 2 µg of rHsp90α (Lane 1) and 8 
µg of SkBr3 lsyate (Lane 2) were analysed. Mr represents the molecular weight marker.   
b) Autoradiograph of rHsp90α and SkBr3 extract probed with B. pahangi anti-Hsp90 antibody. 
2 µg of rHsp90α (Lane 1) and 8 µg of SkBr3 lsyate (Lane 2) were analysed by SDS-PAGE and 
Western blotting. Proteins were transferred to NCP using standard methods, blocked o/n in 
5% dried milk in PBS/0.5% Tween 20 and then the blot probed with 1:5000 dilution of the B. 
pahangi anti-Hsp90 antibody. Bound antibody was detected using a 1:10,000 dilution of anti-
rabbit IgG conjugated to HRP. The blot was developed using the Pierce Super Signal West 
Pico chemiluminescence kit.                      
c) Pull-down analysis of rHsp90α and SkBr3 extract with GA beads or control beads. rHsp90α 
with GA beads (Lane 1), rHsp90α with control beads (Lane 2), SkBr3 laysate with GA beads 
(Lane 3) and SkBr3 lysate with control beads (Lane 4). 5 µg of rHsp90α or 500 µg of SkBr3 
extract were incubated with 50 µl of GA beads for 2.5h at 4
oC on rocker. Beads were washed 
extensively in TNES and bound proteins were eluted by boiling in SDS-PAGE sample cocktail. 
Then,  bound  proteins  were  analysed  by  SDS-PAGE  and  immuno-blotting.  Proteins  were 
transferred to NCP using standard methods, blocked o/n in 5% dried milk in PBS/0.5% Tween 
20 and then the blot probed with 1:1000 dilution of the AC88 anti-Hsp90 monoclonal antibody. 
Bound  antibody  was  detected  using  a  1:10,000  dilution  of  anti-mouse  IgG.  The  blot  was 
developed using the Pierce Super Signal West Pico chemiluminescence kit.  
d)  Blocking assays of rHsp90α with soluble GA at 1.0 µM or 2.0 µM GA. rHsp90α without 
soluble GA (Lane 1), 1.0 µM GA (Lane 2), 2.0 µM GA (Lane 3), DMSO (Lane 4) and control beads 
(Lane 5). 5 µg of rHsp90α was pre-incubated with soluble GA at different concentration for 1 h 
at room temperature and subjected to pull-down assay. Bound protein was analysed by SDS-
PAGE and Western blotting.  
e) Blocking assays of SkBr3 extract with soluble GA at 1.0 µM or 2.0 µM GA. SkBr3 extract 
without soluble GA (Lane 1), 1.0 µM GA (Lane 2), 2.0 µM GA (Lane 3), DMSO (Lane 4) and 
control beads (Lane 5). 500 µg of SkBr3 extract was pre-incubated with soluble GA for 1 h at 
room temperature and processed exactly as rHsp90α. 
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4.2.7 Competition assays with B. pahangi Hsp90 
4.2.7.1  Competition assay with soluble GA 
To further characterise the binding of B. pahangi Hsp90 to GA, I examined 
the ability of soluble GA to block binding to solid phase GA. The soluble extract 
of B. pahangi worms was pre incubated with varying concentrations of GA from 
25 nM to 1000 nM for 60 min at room temperature. Pull downs were then carried 
out  as  described  previously,  analysed  by  immuno blotting  and  quantified  by 
scanning of the subsequent autoradiograph. The autoradiograph in Figure 4.10a 
demonstrates  that  soluble  GA  blocks  the  binding of  B.  pahangi  Hsp90  to GA 
derivatised beads. At 1000 nM free GA (Lane 6), the binding of B. pahangi Hsp90 
to GA beads is completely blocked. Overnight exposure of the blot failed to show 
any band (result not shown). The autoradiograph was then scanned and band 
densities were  obtained  using FlourChem
TM IS 5500  software.  Based  on  these 
values, a graph was plotted and analysed. Figure 4.10b shows the competition 
assay of B. pahangi Hsp90 binding to GA pre incubated with free GA. The IC50 
value, which represents the concentration of free GA that block the binding of 
50% of Hsp90 to GA beads, is 100 200 nM GA.  
 
 
 
 
 
 Chapter 4    158 
 
 
 
Figure 4.10: Competition for Hsp90 binding to GA beads with soluble GA. 
 
a) The autoradiograph shows an experiment in which B. pahangi extracts were pre-incubated 
with increasing concentrations of soluble GA. The GA pull-down assays were performed as 
described previously either using GA beads (Lane 1), pre-incubated with soluble GA at 25 nM 
(Lane 2), 50 nM (Lane 3), 100 nM (Lane 4), 200 nM (Lane 5), 1000 nM Lane 6), DMSO alone 
(Lane 7) or control beads (Lane 8). Bound proteins were analysed by SDS-PAGE and Western 
blotting. Proteins were transferred to NCP using standard methods, blocked o/n in 5% dried 
milk in PBS/0.5% Tween 20 and then the blot probed with 1:5000 dilution of the B. pahangi 
anti-Hsp90 antibody. Bound antibody was detected using a 1:10,000 dilution of anti-rabbit IgG 
conjugated  to  HRP.  The  blot  was  developed  using  the  Pierce  Super  Signal  West  Pico 
chemiluminescence kit. The figure shown is representative of three separate experiments.  
b) Graph shows the binding of B. pahangi Hsp90 to GA beads is competed by soluble GA. At 
1000 nM, GA completely blocks the binding of Hsp90 to GA beads. The estimated IC50 value is 
between 100 nM to 200 nM GA. Results presented are the mean ± standard deviation of three 
different experiments. Binding to GA beads in the absence of GA was set at 100%. 
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4.2.7.2  The ability of Hsp90 to bind to GA beads is altered by novobiocin  
GA and novobiocin do not share the same binding site in Hsp90. However, 
studies with mammalian Hsp90 have shown that novobiocin can affect the ability 
of  Hsp90  to  bind  to  GA.  GA  binds  to  the  N terminal  domain  of  Hsp90  while 
novobiocin binds to the C terminal domain. In this experiment, I tested whether 
novobiocin can affect the binding of B. pahangi Hsp90 to GA. B. pahangi lysates 
were pre incubated with different concentration of novobiocin (from 2.5 20 mM) 
prior to addition of GA beads (as described in Materials and Methods)(Section 
2.2.7.1). The results of a representative experiment are shown in Figure 4.11a. 
It  can  be  seen  that  the  amount  of  Hsp90  bound  to  GA  decreased  as  the 
concentration of soluble novobiocin increased (Lane 1 to Lane 5).  At 20 mM 
soluble novobiocin (Lane 5), binding was completely inhibited and no signal was 
obtained even though the blot was exposed overnight (result not shown). Bands 
on  the  autoradiograph  were  scanned  and  band  densities  were  obtained  using 
FlourChem
TM IS 5500 software. Figure 4.11b shows that 10 mM soluble novobiocin 
was sufficient to inhibit approximately 90% of the binding with an IC50 value of 
approximately  5  mM  novobiocin.  The  IC50  value  here  represents  the 
concentration of soluble novobiocin able to inhibit 50% of Hsp90 binding to GA 
beads. The ability of free soluble novobiocin to compete with GA beads to bind 
Hsp90  suggested  there  is  some  kind  of  interaction  between  the  N terminal 
domain and the C terminal domain which affects the binding of Hsp90 to GA.        
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Figure 4.11: Binding of B. pahangi Hsp90 to GA beads is altered by excess novobiocin. 
 
a) The autoradiograph shows that soluble novobiocin alters the ability of Hsp90 to bind to GA 
beads. B. pahangi extract incubated with GA beads without soluble novobiocin (Lane 1), with 
2.5 mM (Lane 2), 5.0 mM  (Lane 3), 10.0 mM (Lane 4), 20.0 mM (Lane 5) novobiocin or with 
control beads (Lane 6). Lysates were prepared in liquid Nitrogen with a pestle and mortar. 500 
µg of lysate in a total volume of 300 µl was pre-incubated with soluble novobiocin (2.5 mM, 5.0 
mM, 10.0 mM and 20.0 mM) for 1h at room temperature and then incubated with GA beads or 
beads  alone.  Bound  proteins  were  analysed  by  SDS-PAGE  and  Western  blotting.  Proteins 
were transferred to NCP using standard methods, blocked o/n in 5% dried milk in PBS/0.5% 
Tween 20 and then the blot probed with 1:5000 dilution of the B. pahangi anti-Hsp90 antibody. 
Bound antibody was detected using a 1:10,000 dilution of anti-rabbit IgG conjugated to HRP. 
The  blot  was  developed  using  the  Pierce  Super  Signal  West  Pico  chemiluminescence  kit. 
Exposure 30 sec. 
  b) Graph shows that the binding of B. pahangi Hsp90 is competed by soluble novobiocin. 20 
mM  novobiocin  completely  blocks  the  binding  of  Hsp90  to  GA  beads.  IC50  value  is 
approximately  5.0  mM.  Results  presented  are  the  mean  ±  standard  deviation  from  three 
different experiments. Binding to GA beads in the absence of novobiocin was set at 100%. 
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4.2.7.3  ATP affects the binding of B. pahangi Hsp90 to GA beads 
In mammalian and yeast Hsp90, GA and ATP were shown to bind to the 
same  site  in  the  N terminal  domain  of  Hsp90.  The  binding  of  ATP  to  Hsp90 
followed by ATP hydrolysis is essential for the activity of Hsp90 as reviewed in 
Chapter 1. In this section the ability of ATP to affect the binding of Hsp90 to GA 
beads was tested by pre incubation of B. pahangi lysates with ATP at various 
concentrations (5.0  mM,  10.0 mM,  15.0  mM  and  20.0  mM).  Pre incubation  of 
worm lysate with ATP affected the ability of Hsp90 to bind to GA beads. Figure 
4.12a shows an autoradiograph of a typical experiment while Figure 4.12b shows 
that approximately 15.0 mM ATP was sufficient to block 50% of Hsp90 binding to 
GA beads. However, the highest concentration used in the experiments (20.0 mM 
ATP) was not able to completely block the binding of Hsp90 to GA beads. The 
IC50 value here represents the concentration of soluble ATP that inhibits 50% of 
Hsp90 binding to GA beads. 
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Figure 4.12: ATP alters the ability of B. pahangi Hsp90 to bind to GA beads 
 
a) The autoradiograph shows an experiment in which B. pahangi lysate was pre-incubated 
with  increasing  concentrations  of  soluble  ATP.  The  solid  GA  pull-down  assays  were 
performed as described previously either using GA beads (Lane 1), pre-incubated with soluble 
ATP at 5.0 mM (Lane 2), 10.0 mM (Lane 3), 15.0 mM (Lane 4), 20.0 mM (Lane 5) or control beads 
(Lane 6). Bound proteins were analysed by SDS-PAGE and Western blotting. Proteins were 
transferred to NCP using standard methods, blocked o/n in 5% dried milk in PBS/0.5% Tween 
20 and then the blot probed with 1:5000 dilution of the B. pahangi anti-Hsp90 antibody. Bound 
antibody was detected using a 1:10,000 dilution of anti-rabbit IgG conjugated to HRP. The blot 
was developed using the Pierce Super Signal West Pico chemiluminescence kit.  The figure 
shown is representative of three separate experiments. 
b) Graph shows the binding of B. pahangi Hsp90 to GA beads is altered by soluble ATP. The 
estimated IC50 value is 15.0 mM. Results presented are the mean ± standard deviation from 
three different experiments. Binding to GA beads in the absence of ATP was set at 100%. 
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4.2.7.4  The binding of B. pahangi Hsp90 to ATP beads is competed by free 
GA 
In  further  experiments,  I  investigated  whether  pre incubation  of  B. 
pahangi lysates with soluble GA could inhibit the binding of B. pahangi Hsp90 to 
bind ATP using γ phosphate immobilised ATP. B. pahangi lysates were incubated 
with soluble GA at different concentrations prior to incubation with ATP beads. 
Then the bound proteins were analysed by SDS PAGE and Western blotting (as 
described previously). Figure 4.13a shows that B. pahangi Hsp90 bound to ATP 
beads and that binding was competed by free GA. The lowest concentration of 
GA used was 0.25  M and the highest was 2.0  M. However, 2.0  M GA was not 
sufficient to completely block the binding of Hsp90. Then, the autoradiograph 
was  scanned  and  band  densities  were  obtained  using  FlourChem
TM  IS 5500 
software. Figure 4.13b shows that approximately 1.0  M GA was sufficient to 
block about 50% of the Hsp90 binding to ATP beads. The IC50 represents the value 
of free GA that inhibits 50% of the Hsp90 binding to ATP beads. 
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Figure 4.13: Binding of B. pahangi Hsp90 to ATP beads is competed by soluble GA. 
 
a)  Autoradiograph  showing  the  results  of  a  typical  ATP-binding  assay.  B.  pahangi  lysates 
were prepared in liquid Nitrogen with a pestle and mortar. 500 µg of lysate in a total volume of 
500 µl was pre-incubated with soluble GA at 0.25 µM (Lane 2), 0.5 µM (Lane 3), 1.0 µM (Lane 4), 
2.0  µM  (Lane  5)  or  with  control  beads  (Lane  6)  for  60  min  at  room  temperature  and  then 
incubated with ATP beads or with beads alone. Bound proteins were analysed by SDS-PAGE 
and Western blotting. Proteins were transferred to NCP using standard methods, blocked o/n 
in 5% dried milk in PBS/0.5% Tween 20 and then the blot probed with 1:5000 dilution of the B. 
pahangi anti-Hsp90 Ab. Bound Ab was detected using a 1:10,000 dilution of anti-rabbit IgG 
conjugated  to  HRP.  The  blot  was  developed  using  the  Pierce  Super  Signal  West  Pico 
chemiluminescence kit.                      
b) Graph showing that the binding of B. pahangi Hsp90 to ATP is competed by soluble GA. 1.0 
µM GA is sufficient to block 50% of Hsp90 binding to ATP beads. Data presented are the mean 
± standard deviation from three separate experiments. Binding to ATP beads in the absence of 
GA was set at 100%. 
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4.2.8 Analysis of Hsp90 in B. pahangi and C. elegans 
In Chapter 3, the ability of B. pahangi Hsp90 to bind GA was shown to be 
shared by some clade III parasitic species and by Trichinella spiralis (clade I) but 
not with parasitic species from other clades or with free living nematodes. In 
most eukaryotes, the sequence of Hsp90 proteins is highly conserved. The most 
obvious explanation for the surprising lack of GA binding by Hsp90 from some 
worms would be an alteration in the N terminal domain of the chaperone. In 
order to investigate the differences between B. pahangi and C. elegans Hsp90 
sequence, an alignment of the predicted amino acid sequence of B. pahangi and 
C.  elegans  was  compared  (Figure  4.14).  This  confirmed  the  high  degree  of 
conservation within the whole sequence (Figure 4.14). C. elegans Hsp90 is 84% 
identical  (91%  similar)  to  B.  pahangi  Hsp90.  The  N terminal  domain  shows  a 
minimal number of substitutions (see Figure 4.14). The sequence of C. elegans 
Hsp90 is shorter than B. pahangi Hsp90, because the charged region contains 
fewer amino acids.      
Despite the high degree of similarity between C. elegans Hsp90 and B. 
pahangi  Hsp90,  C.  elegans  Hsp90  failed  to  bind  GA  in  solid  phase  pull down 
assays (see Chapter 3). In order to further investigate these contrasting results, 
Hsp90  expression  levels  were  compared  in  both  species.  Worm  lysates  were 
prepared as  described  previously.  For  this analysis,  only adult  stages  of  both 
nematodes were used. The protein concentration of each lysate was estimated 
using the Bio Rad protein assay and equal amounts of protein were loaded onto 
10% SDS PAGE gels and blotted (see Figure 4.15a).  
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B. pahangi     1 MSEEMNGETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIR 
C. elegans     1 --MSENAETFAFQAEIAQLMSLIINTFYSNKEIYLRELISNASDALDKIR 
                                                               
B. pahangi    51 YQALTEPAELETGKELYIKITPNKADKTLTIMDTGIGMTKADLVNNLGTI 
C. elegans    49 YQALTEPSELDTGKELFIKITPNKEEKTLTIMDTGIGMTKADLVNNLGTI 
                  
B. pahangi   101 AKSGTKAFMEALQAGADISMIGQFGVGFYSAFLVADKVVVASKHNDDDCY 
C. elegans    99 AKSGTKAFMEALQAGADISMIGQFGVGFYSAFLVADKVVVTSKNNDDDSY 
                  
B. pahangi   151 QWESSAGGSFIIRQVNDPELTRGTKITLYIKEDQTDYLEERRIKEIVKKH 
C. elegans   149 QWESSAGGSFVVRPFNDPEVTRGTKIVMHIKEDQIDFLEERKIKEIVKKH 
                  
B. pahangi   201 SQFIGYPIKLTVEKERDKEVSDDEAEEEKKDEDKEKKEGEIEDVGEDEEE 
C. elegans   199 SQFIGYPIKLVVEKEREKEVEDEEAVEAK---DEEKKEGEVENVADDADK 
                  
B. pahangi   251 DKKDKDKKKKKIKEKYHEDEELNKTKPIWTRNPDDISNEEYAEFYKSLSN 
C. elegans   246 ------KKTKKIKEKYFEDEELNKTKPIWTRNPDDISNEEYAEFYKSLSN 
                  
B. pahangi   301 DWEDHLAVKHFSVEGQLEFRALLFVPQRAPFDLFENKKTKNAIKLYVRRV 
C. elegans   290 DWEDHLAVKHFSVEGQLEFRALLFVPQRAPFDLFENKKSKNSIKLYVRRV 
                  
B. pahangi   351 FIMENCDELMPEYLNFIKGVVDSEDLPLNISREMLQQSKILKVIRKNLVK 
C. elegans   340 FIMENCEELMPEYLNFIKGVVDSEDLPLNISREMLQQSKILKVIRKNLVK 
                  
B. pahangi   401 KCLELFDEIAEDKDNFKKFYEQFSKNIKLGIHEDSTNRKKLSEFLRFYTS 
C. elegans   390 KCMELIDEVAEDKDNFKKFYEQFGKNLKLGIHEDSTNRKKLSDFLRYSTS 
                  
B. pahangi   451 ASSEEMTSLKDYVSRMKENQKQIYFITGESREAVASSAFVERVKRRGFEV 
C. elegans   440 AG-DEPTSLKEYVSRMKENQTQIYYITGESKDVVAASAFVERVKSRGFEV 
                  
B. pahangi   501 IYMTDPIDEYCVQQLKEYDGKKLVSVTKEGLELPESEEEKKKFEEDKVKF 
C. elegans   489 LYMCDPIDEYCVQQLKEYDGKKLVSVTKEGLELPETEEEKKKFEEDKVAY 
                  
B. pahangi   551 ENLCKVMKDILEKKVEKVAVSNRLVSSPCCIVTSEYGWSANMERIMKAQA 
C. elegans   539 ENLCKVIKDILEKKVEKVGVSNRLVSSPCCIVTSEYGWSANMERIMKAQA 
                  
B. pahangi   601 LRDSSTMGYMAAKKHLEINPDHSVIKALRERVEADKNDKTVKDLVVLLFE 
C. elegans   589 LRDSSTMGYMAAKKHLEINPDHAIMKTLRDRVEVDKNDKTVKDLVVLLFE 
                  
B. pahangi   651 TALLSSGFSLEDPQLHASRIYRMIKLGLDITEDEEEEAIASVSGEKDECV 
C. elegans   639 TALLASGFSLEEPQSHASRIYRMIKLGLDIGDDEIEDSAVPSS---CTAE 
                  
B. pahangi   701 PNLVGAEEDASRMEEVD 
C. elegans   686 AKIEGAEEDASRMEEVD 
 
 
Figure 4.14: Hsp90 is conserved in B. pahangi and C. elegans. 
 
Figure  shows  an  alignment  of  the  predicted  amino  acid  sequences  of  B.  pahangi  (Bp, 
accession number  AJ005784) and C.  elegans (Ce, accession number Z75530) Hsp90s by 
Clustal-W.  Identical  amino  acids  are  in  red  with  yellow-shaded  box.  Green  shading 
represent amino acids that are similar. Bold letters represent amino acids that differ in both 
sequences. The highly conserved N-terminal domain is indicated by the dashed box.  Chapter 4     171 
Figure 4.15b shows the autoradiograph for Hsp90 expression in B. pahangi 
and C. elegans with actin as a loading control. A band of ~83 kDa was detected 
in  both  species  by  Western  blot  using  an  antibody  raised  to  recombinant  B. 
pahangi Hsp90. The autoradiograph was then scanned and band densities were 
obtained using FlourChem
TM IS 5500 software. This analysis showed that Hsp90 is 
expressed  at  a  relatively  higher  level  in  B.  pahangi  compared  to  C.  elegans 
Hsp90 (p<0.05). 
Previous results showed that soluble GA competes with ATP beads to bind 
to Hsp90. In C. elegans, Hsp90 failed to bind GA but retained its ability to bind 
ATP  (David  et  al.,  2003). To  address  this  issue,  I compared  the  ability  of  B. 
pahangi and C. elegans Hsp90 to bind ATP using γ phosphate immobilised ATP as 
previously described (Grenert et al., 1997; Soti et al., 2003). Worm lysates were 
incubated with ATP beads for 60 min at room temperature. The resin was then 
pelleted  and  washed  with  buffer  and  analysed  by  SDS PAGE  and  Western 
blotting. Figure 4.16 shows that both B. pahangi and C. elegans Hsp90 bind to 
ATP beads. The results presented are based on three independent experiments.  
 
 
 Chapter 4     172 
 
 
 
Figure 4.15: Hsp90 is more highly expressed in B. pahangi than in C. elegans. 
 
a) Coomassie blue stained gel of B. pahangi (Lane 1) and C. elegans (Lane 2) adult worm 
extracts. Mr presents the molecular weight marker. 
b) Hsp90 expression levels of B. pahangi (Lane 1) and C. elegans (Lane 2) with actin as a 
loading  control.  Equal  amount  of  proteins  were  analysed  by  SDS-PAGE  and  Western 
blotting. Proteins were transferred to NCP using standard methods, blocked overnight in 5% 
dried milk in PBS/0.5% Tween 20 and then the blot probed with 1:5000 dilution of the B. 
pahangi anti-Hsp90 antibody. Bound antibody was detected using a 1:10,000 dilution of anti-
rabbit  IgG.  The  blot  was  developed  using  the  Pierce  Super  Signal  West  Pico 
chemiluminescence kit.           
c)  The  graph  shows  the  expression  levels  of  Hsp90  for  B.  pahangi  and  C.  elegans  as 
detected using the B. pahangi anti-Hsp90 antibody. The autoradiograph was scanned for 
densities using FlourChem
TM IS-5500 software. Hsp90 expression is significantly higher in B. 
pahangi  compared  to  C.  elegans.  The  data  represent  the  mean  ratio  of  Hsp90/actin  ± 
standard deviation from three different experiments.  
B. pahangi 2.2138 ± 0.9138 
B. pahangi Hsp90 vs C. elegans Hsp90   * p = 0.0010 
C. elegans 0.7155 ± 0.1033 
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Figure 4.16: B. pahangi and C. elegans Hsp90 bind to ATP beads. 
 
Autoradiograph  shows  the  comparison  of  B.  pahangi  (Lane  1)  and  C.  elegans  (Lane  2) 
Hsp90 binding to ATP beads. 500 µg of worm lysates were incubated with 100 µl of ATP 
beads for 60 min at room temperature, pelleted and washed with buffer and bound proteins 
were analysed by 10% SDS-PAGE and Western blotting which was blotted and probed with 
1:5000 dilution of the B. pahangi anti-Hsp90 antibody. Bound antibody was detected using a 
1:10,000 dilution of anti-rabbit IgG conjugated to HRP. The blot was developed using the 
Pierce Super Signal West Pico chemiluminescence kit. 
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4.3  Discussion 
The  development  of  a  compound  with  macrofilaricidal  activity  has  long 
been  a  goal  of  the  World  Health  Organisation  (WHO).  Current  treatment  of 
filariasis  is  largely  dependent  on  treatment  with  drugs,  such  as 
diethylcarbamazine or ivermectin, which kill the Mf but not the adult worm. The 
only novel chemotherapeutic target currently under development for the filarial 
nematodes is the Wolbachia endosymbiont (Hoerauf, 2008; Supali et al., 2008). 
Wolbachia  are  present  in  most  of  the  human  filariae  and  were  shown  to  be 
important for worm fertility and survival (Debrah et al., 2007; Hoerauf et al., 
2008).  Previously,  Hsp90  was  identified  as  a  possible  target  in  B.  pahangi 
(Devaney et al., 2005). Inhibition of B. pahangi Hsp90 by GA not only kills the Mf 
but also kills the adult worm. Thus Hsp90 might be a useful target for lymphatic 
filariasis. The aim of this Chapter was to further characterise B. pahangi Hsp90.   
Results in this Chapter show that Hsp90 is expressed in all B. pahangi life 
cycle stages analysed, at a similar level. However, in the pull down assay, only 
adult stage Hsp90 was observed to bind to GA, not Hsp90 from the L3 and Mf. 
The inability to detect Hsp90 binding to GA beads could perhaps reflect a lack of 
sensitivity of the assay, or alternatively may suggest that Hsp90 from Mf and L3 
is processed in such way that it fails to bind to GA. Nothing is currently known 
about co chaperones in B. pahangi and whether they may be required for Hsp90 
to bind to GA. These data were surprising as GA kills Mf, suggesting that it can 
bind to Mf Hsp90.  
  In  many  eukaryotes,  Hsp90  is  induced  after  heat  shock  or  following 
exposure to stress. However, in this Chapter, Hsp90 expression was not strongly 
induced by heat shock or GA treatment in B. pahangi. These results correlate Chapter 4     176 
well  with  previous  studies  on    B.  pahangi  hsp90  by  (Thompson  et  al.,  2001) 
where it was shown that hsp90 mRNA levels were minimally induced following 2 
h of heat shock (1.2–1.5 fold). In contrast, studies in C. elegans using in situ 
hybridisation showed that under stress conditions, daf 21 mRNA was expressed 
all over the body of C. elegans while under normal conditions, daf 21 is localised 
to the germline of adult C. elegans (Inoue et al., 2003). This suggested that daf 
21 mRNA was up regulated by heat shock. The difference between the results of 
that study using in situ hybridisation and the results presented here may relate 
to the different methods used.    
Hsp90 was detected in the ES products of adult B. pahangi but not in the 
ES  products  of  Mf.  ES  products  contain  molecules  shed  from  the  parasite 
surface as well as those secreted from the pharyngeal glands, excretory system 
etc. These results suggest that the secreted Hsp90 might be stage specific but 
the  reason  why  Hsp90  is  secreted  in  adult  ES  products  of  Brugia  remains 
unknown. The first discovery of extra cellular Hsp90 was reported by Ullrich et 
al (1986) in mouse tumour cells. Hsp90 has been identified at the cell surface 
of  other  cancer  cells  where  it  was  shown  to  be  involved  in  cell  motility, 
invasion  and  metastasis  (Eustace  et  al.,  2004;  Sidera  et  al.,  2004).  Adult 
filarial worms secrete many bio active molecules (Hewitson et al., 2008), and 
it is possible that Hsp90 may be required for the activity of some of these.  
Attempts were made to identify Hsp90 client proteins/co chaperones using 
two  different  methods.  The  first  method,  using  a  modified  GA biotin  binding 
assay, did not identify any potential Hsp90 associated proteins due to the non 
specific binding observed in the assay. Attempts were made to overcome this 
problem  but  were  not  successful  in  increasing  the  specificity  of  binding. Chapter 4     177 
However, the original studies by (Neef et al., 2010), showed that this technique 
was able to detect and identify heat shock factor 1A (HSF1A) associated proteins 
from human and yeast using HSF1A biotin beads.    
The second method used a proteomic analysis. Following exposure to GA, 
Hsp90 complexes undergo a conformational change and as a result the client 
proteins  are  released  from  the  complexes  and  subject  to  degradation.  The 
rationale of this method was that client proteins would therefore be degraded 
following  exposure  of  worms  to  GA.  Thus  it  might  be  possible  to  identify 
proteomic  differences  between  GA treated  and  control  worms.  In  the  DIGE 
analysis, a total of 75 proteins (3.8%) were observed to differ in expression level 
between the groups. Of these, only 14 (0.7%) showed a reduction in expression 
following GA treatment but unfortunately it was not possible to identify these 
because  of  equipment  failure.  Without  knowing  the  identity  of  any  of  these 
differentially expressed proteins, it is difficult to draw any conclusion from this 
experiment. It was, however, surprising that so few proteins showed a reduced 
expression following exposure of adult B. pahangi to GA.  The second analysis 
was carried out using a much less sensitive technique and, not surprisingly, few 
differences  were  observed.  Of  the  five  proteins  down regulated  following  GA 
treatment,  most  were  structural  proteins.  Of  these  tropomyosin  and  myosin 
regulatory light chain 1, appeared in both the up regulated and down regulated 
list. The reason for this are not clear but it may be that proteolytic fragments of 
tropomyosin  were  detected  in  the  GA treated  group.  Because  of  lack  of 
sensitivity of this method, only a single experiment was carried out.  
A  study  by  (Tsaytler  et  al.,  2009)  using  complementary  proteomic 
approaches  also  identified  several  Hsp90  protein  partners  with  structural Chapter 4     178 
functions e.g. myosin 9, Filamin A, actin etc. In C. elegans, tropomyosin in the 
muscle  wall  was  suggested  to  be  essential  as  it  is  required  for  the  late 
development  of  C.  elegans  (Kagawa  et  al.,  2007).  Until  recently,  UNC 45,  a 
muscle specific protein, was one of the few targets of Hsp90 which had been 
experimentally validated in C. elegans (Barral et al., 2002). According to Barral 
et al (2002), a direct interaction between UNC 45 and Hsp90 occurs as UNC 45 
contains  a  tetratricopeptide  repeat  domain  that  binds  to  the  C terminal  of 
Hsp90.  However,  further  investigations  are  needed  for  an  improved 
understanding of the role of Hsp90 in the regulation of the cytoskeleton and 
contractile  activity.  Furthermore,  different  methods  need  to  be  adopted  to 
identify Hsp90 client proteins in B. pahangi.  
A  recent  study  identified  Hsp90  interacting  proteins  in  bacteria 
(Shewanella oneidensis, Shewanella frigidimarina and Psychrobacter frigidicola) 
that  live  at  different  temperatures,  using  immunoprecipitation  followed  by  a 
proteomic  approach  (Garcia Descalzo  et  al.,  2010).  Many  of  the  proteins 
identified were involved in energy metabolism such as isocitrate lyase, succinyl 
CoA synthetase, alcohol dehydrogenase etc. It was hypothesised that Hsp90 and 
its  interacting  proteins  may  play  a  role  in  adaptation  to  cold  environments. 
Echeverria et al (2010) also identified Hsp90/p23 client proteins in Toxoplasma 
gondii  using  a  similar  co immunoprecipitation  approach.  These  had  multiple 
functions such as glycolysis, ATP production, protein synthesis, chaperones and 
foldases,  kinases  and  phosphatases.  These  studies  help  explain  why  Hsp90  is 
essential  in  most  organisms  and  suggest  that  the  application  of  an 
immunoprecipitation approach to B. pahangi might yield more data. Chapter 4     179 
In  this  Chapter,  the  binding  of  B.  pahangi  Hsp90  to  GA  was  further 
explored. One area of interest was to investigate the amount of Hsp90 that was 
available for GA binding. Results in this Chapter show that only a small amount 
of Hsp90 binds to GA, approximately 6.31% of the cellular Hsp90. It is possible 
that the amount of GA bound to beads is a limiting factor in these experiments. 
However, this seems unlikely as by the fifth pull down no binding was observed. 
Alternatively the low amount of Hsp90 bound to GA beads may reflect steric 
hindrance between bead bound GA and soluble Hsp90, or alternatively it may be 
an accurate reflection of the amount of Hsp90 that can bind GA. If correct, the 
results suggest that it might be necessary to inhibit only a small percentage of 
total Hsp90 to kill the worm. 
The B. pahangi lysate was also subjected to competition assays with GA, 
ATP  and  novobiocin.  Free  soluble  GA  was  shown  to  inhibit  the  binding  of  B. 
pahangi Hsp90 to GA beads in a dose dependent manner. On the other hand, in 
the ATP binding assay, soluble GA was also shown to compete for binding of 
Hsp90 to ATP beads which suggests that ATP and GA share the same binding site 
in B. pahangi Hsp90. These results are consistent with the findings of Grenert et 
al  (1997)  where  they showed that  100 200  nM GA  is  enough  to  block  50%  of 
chicken Hsp90 binding to GA beads. Since the amount of GA derivatised to resin 
is not known and may vary from batch to batch, these values reflect relative IC50 
values.  
  Novobiocin, a coumarin type antibiotic inhibits Hsp90 functions in a very 
different manner to GA and radicicol. Novobiocin was shown to bind to the C 
terminal  domain  of  Hsp90,  a  different  binding  site  from  GA.  Several  point 
mutations in the N terminus of chicken Hsp90 did not affect novobiocin binding Chapter 4     180 
and the N terminus failed to bind novobiocin beads (Marcu et al., 2000a). Many 
previous studies  have shown that  novobiocin affects the interaction  of Hsp90 
with its client proteins (Marcu et al., 2000a; Katschinski et al., 2002; Haendeler 
et al., 2003; Yun et al., 2004; Allan et al., 2006). The binding of B. pahangi 
Hsp90  to  GA  beads  was  shown  to  be  competed  by  excess  novobiocin.  It  is 
noteworthy that the concentration of novobiocin required to inhibit binding of B. 
pahangi Hsp90 to GA beads is very high, in the millimolar range. However, this 
reflects  the  concentration  of  novobiocin  required  to  inhibit  Hsp90  binding  in 
mammalian cells (Marcu et al., 2000a) and in B. pahangi where novobiocin at 
concentrations of 200 500  M kills adult worms (Devaney, unpublished).  It has 
been  proposed  that  the  N terminal  and  C terminal  domain  of  Hsp90  interact 
(Yun et al., 2004). Other studies have demonstrated that novobiocin binding may 
alter  the  conformation  of  the  Hsp90  C terminal  domain  leading  to  the 
dissociation of TPR containing co chaperones (Marcu et al., 2000a; Marcu et al., 
2000b; Soti et al., 2003; Wayne & Bolon, 2007). Taken together these results 
support  the  hypothesis  that  an  interaction  occurs  between  domains  in  Hsp90 
which is essential for the chaperoning functions.  
One area that remains to be resolved is the lack of binding of C. elegans 
Hsp90 to GA compared to Brugia. A possible explanation is that B. pahangi and 
C. elegans bear different post translational modifications that affect GA binding. 
It was not possible to directly compare recombinant worm Hsp90 with native 
protein, so a comparison was made between recombinant human Hsp90α with 
native Hsp90 isolated from SkBr3 cells. Hsp90 is extensively modified and these 
modifications are known to impact the Hsp90 chaperone machinery. As reviewed 
previously  phosphorylation,  acetylation  and  other  modifications  of  Hsp90  are 
important  elements  in  regulating  the  Hsp90  chaperone  function  (Scroggins  & Chapter 4     181 
Neckers,  2007).  A  recent  study of  Plasmodium falcifarum  Hsp90  showed  that 
exposure  of  infected  red  blood  cells  to  the  histone  deacetylase  inhibitor, 
Trichostatin A, had a synergetic effect with GA and inhibited malaria growth 
(Pallavi et al., 2010). These studies suggest that the degree of acetylation of 
Hsp90 may affect its ability to bind to GA. However, in this Chapter it was shown 
that  both  rHsp90α  and  native  Hsp90  bound  to  GA,  suggesting  that  post 
translational modifications of human Hsp90 are not essential for Hsp90 to bind to 
GA but might be required for other Hsp90 chaperone functions. Thus, while it 
was not possible to exclude differences in post translational modifications being 
important in GA binding, there was no evidence to support it.  
The  final  result  in  this  Chapter  showed  that  C.  elegans  and  B.  pahangi 
Hsp90 bind ATP similarly even though Hsp90 is expressed at a relatively higher 
level in B. pahangi than in C. elegans. However, the analysis of Hsp90 expression 
level was based on the use of an antibody raised to B. pahangi Hsp90, which may 
have a higher affinity for B. pahangi Hsp90 than for C. elegans Hsp90. However, 
the C terminal domain to which the antibody was raised is very similar between 
B. pahangi and C. elegans as shown in Figure 4.14. The ATP binding assay for 
both nematodes validates previous reports by David et al (2003), where they 
showed that C. elegans Hsp90 binds to ATP but not to GA. C. elegans Hsp90 and 
B. pahangi Hsp90 are highly conserved (91.4% similar and 84.1% identical) with 
only minor substitution amino acids in the N terminal domain. However, these 
substitutions are unlikely to contribute to conformational differences between 
B.  pahangi  and  C.  elegans  that  affect  GA  binding  (Devaney  et  al.,  2005). 
Additionally, the charged region of B. pahangi Hsp90 is longer than C. elegans 
Hsp90. A study in yeast showed that the charged region plays an important role 
in regulating the chaperone function of Hsp90 (Scheibel et al., 1999). In future Chapter 4     182 
studies it may be of interest to examine the role of the charged region in B. 
pahangi Hsp90 in more detail.  
In conclusion, the mystery of why C. elegans Hsp90 fails to bind GA remains 
unsolved. From other studies in this laboratory, there are clear differences in 
the function of Hsp90 in the two nematodes e.g. B. pahangi Hsp90 was unable to 
rescue  a  C.  elegans  daf 21  mutant,  although    the  protein  was  successfully 
expressed  (Gillan  et  al.,  2009).  Thus  despite  a  high  degree  of  sequence 
similarity, Hsp90 appears to be functionally diverse in nematodes. These studies 
differ from results in yeast, where Hsp90 from human or Trypanosoma cruzi can 
complement a yeast hsp90 mutant (Palmer et al., 1995) as can C. elegans hsp90 
and  human  hsp90β  (Piper  et  al.,  2003)  despite  significantly  lower  levels  of 
identity (60.5% and 60.3%, respectively). According to Gillan et al (2009) the 
overall  degree  of  sequence  similarity  may  not  be  a  good  measure  of  Hsp90 
function. Given the interaction between the different domains of Hsp90, it may 
be  important  to  look  outside  the  N terminal  domain  and  also  to  attempt  to 
identify client  proteins/co chaperones  which  may  differ  significantly  between 
these two nematodes.            
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5  Hsp90 and drug resistance 
5.1  Introduction 
To date, there are no data on the possible involvement of Hsp90 in drug 
resistance  in  nematodes.  In  this  chapter,  I  investigated  the  hypothesis  that 
Hsp90  may  have  a  role  in  drug  resistance  in  nematodes  using  anthelmintic 
resistant  and  susceptible  worms.  As  reviewed  in  the  Introduction,  Hsp90  was 
shown to be involved in drug resistance in tumour cells and fungi. In fungi, the 
emergence of azole resistance was suggested to be associated with Erg11 (an 
enzyme in the cytochrome P450 family which is involved in the biosynthesis of 
ergosterol)  and  calcineurin.  Calcineurin  belongs  to  the  protein  phosphatase 
family  and  was  identified  as  an  Hsp90  client  protein,  involved  in  regulating 
numerous responses to membrane stress (Cowen & Lindquist 2005; Cowen et al., 
2006; Singh et al., 2009). In contrast, in some tumour cells, P gp was suggested 
to be involved in the drug resistance mediated by Hsp90β (Betram et al., 1996). 
Thus the question arises: could Hsp90 have a role in anthelmintic resistance in 
nematodes?  
Gastrointestinal nematode infections can cause great losses in revenue due 
to  decreased  livestock  production  and  animal  death.  Additional  losses  are 
suffered due to sub clinical effects of parasite infection. It is estimated that the 
cost of controlling gastrointestinal nematode infection is between US$220 to 500 
million in Australia (Emery & Wagland, 1991; McLeod, 1995). In the UK itself, the 
cost of treatment and losses for the sheep industry reach around £84 million 
annually  (Nieuwhof  &  Bishop,  2005).  The  most  common  method  to  control 
gastrointestinal  nematode  infection  is  by  anthelmintic  treatment.  However, Chapter 5        185 
inconsistent treatment, excessive use and overdose of drugs have caused a new 
problem to arise, drug resistance.  
Anthelmintics are separated into several classes based on their chemical 
structure and mode of action. To date, three groups of anthelmintic are widely 
used, namely the benzimidazoles, imidazothiazoles and macrocylic lactones. The 
most  widely  used  and  available  anthelmintics  belong  to  the  benzimidazole 
group. Benzimidazoles were introduced to the market in 1961 beginning with 
thiabendazole followed by albendazole and fenbendazole. Anthelmintics of the 
imidazothiazole tetrahydropyridimine  group  were  introduced to  the  market  in 
1968. The most widely used are levamisole, pyrantel and morantel. Levamisole 
is a nicotinic receptor agonist (Aceves et al., 1970; Aubry et al., 1970) with a 
selective action on nematode receptors. The third group of anthelmintics are 
the  macrocyclic  lactones  such  as  ivermectin,  moxidectin  and  abemectin. 
Macrocyclic lactones were introduced in the early 1980s and since then have 
become  effective  anthelmintics  for  combating  gastrointestinal  nematode 
infections.  
Anthelmintic resistance is a major problem that threatens the livestock 
industry  throughout  the  world,  especially  in  countries  with  hot  and  humid 
climates. Such climates provide ideal conditions for the development of free 
living  stages  of  nematode  parasites  on  pasture.  Several  recent  investigations 
have demonstrated a progressive spread of anthelmintic resistance, mainly in 
nematode populations of sheep (Sargison  et  al., 2005). This problem  became 
worse  when  the  first  multiple  drug  resistance  cases  were  reported  in  H. 
contortus from South Africa (Van Wyk et al., 1999), Malaysia (Chandrawathani et 
al.,  2003)  and  the  United  States  (Mortensen  et  al.,  2003).  Anthelmintic Chapter 5        186 
resistance  is  present  in  a  population  when  there  is  a  greater  frequency  of 
individuals  within  a  population  which  are  able  to  tolerate  an  anthelmintic 
compared  to  a  normal  population  (Prichard  et  al.,  1980).  Several  reviews  on 
possible mechanisms of anthelmintic resistance have been published over the 
last few years (Kaplan, 2004; Jabbar et al., 2006). Since anthelmintics kill the 
majority of susceptible nematodes, the next generation will consist largely of 
offspring of the resistant nematodes (Le Jambre, 1985). If the character that 
provides  resistance  is  controlled  by  a  single  major  gene,  then  the  resistant 
population  will  build  up  very  rapidly  (Le  Jambre,  1985)  and  this  trait  is 
inheritable. 
In  the  work  described  in  this  Chapter,  Hsp90  levels  were  compared  in 
anthelmintics susceptible and resistant worms. The first group studied were field 
isolates  of  the  Trichostrongylid  species,  Teladosargia  circumcincta. 
Trichostrongylid  nematodes  are  highly  prevalent  in  grazing  animals  and  have 
developed resistance to anthelmintics. Two UK isolates were compared; Tci5 is 
resistant to all classes of broad spectrum anthelmintics (Bartley et al., 2005), 
while Tci2 is susceptible to all of these drugs.  
The second group of nematodes compared were Caenorhabditis elegans 
strains that were derived from mutagenesis screens. In these studies, C. elegans 
is exposed to a mutagen and worms are selected by their ability to grow on drug 
(Driscoll  et  al.,  1989,  Dent  et  al.,  2000).  The  strains  used  were  C.  elegans 
CB3474 and DA1316. C. elegans CB3474 is resistant to benzimidazole compounds 
via mutations in the ben 1 gene which encode β tubulin isotype 1 (Driscoll et al., 
1989).  C.  elegans  DA1316  is  an  ivermectin resistant  strain  which  contains 
mutations in avr 14, avr 15 and glc 1, each of which encode glutamate gated Chapter 5        187 
chloride  channel  (GluCl)  sub units  and  exhibits  high  level  resistance  to 
ivermectin (Dent et al., 2000).  
Finally, a third group of C. elegans were studied; these were wild type N2 
worms which had been continually grown on increasing levels of ivermectin and 
selected  for  their  ability  to  survive  and  reproduce  on  drug  (James  &  Davey, 
2009). These worms were continuously passaged on increasing concentration of 
ivermectin. IVM 6 worms were resistant to ivermectin at 6 ng/ml, while IVM 10 
worms were resistant to 10 ng/ml. Both strains also showed cross resistance to 
moxidectin and to other anthelmintics such as levamisole and pyrantel. 
The first aim of the studies described in this Chapter was to determine 
whether  Hsp90  expression  levels  were  altered  in  anthelmintic  resistant 
nematodes. Secondly, experiments were undertaken using the RNAi approach to 
knock down hsp90 levels in C. elegans ivermectin resistant worms, to determine 
whether Hsp90 is involved in resistance in these worms.  
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5.2  Results 
5.2.1 Hsp90 expression levels in drug resistant nematodes are 
not significantly different compared to susceptible 
nematodes 
5.2.1.1  T. circumcincta isolates – resistance acquired by natural selection 
in the field 
The two T. circumcincta isolates used in this study were obtained from 
the  Moredun  Research  Institute,  Edinburgh,  UK.  T.  circumcincta  extract  was 
prepared as described previously in Materials and Methods (Section 2.1.3) and 
equal  amounts  of  protein  extracts  (2 4   g)  were  analysed  by  SDS PAGE  and 
Western  blotting.  Figure  5.1a  shows  a  Coomassie  blue  stained  gel,  while  the 
corresponding  autoradiograph  is  shown  in  Figure  5.1b.  In  this  experiment  B. 
pahangi extract was used as a control for the antibody and actin was used as a 
loading control. The autoradiograph shows that there was no difference in Hsp90 
expression levels in the T. circumcincta Tci5 isolate (Lane 2) compared to the T. 
circumcincta Tci2 isolate (Lane 3). The autoradiograph was scanned and band 
densities were quantified using  using  FluorChem
TM  IS 5500  software.  Based  on  the 
Hsp90/actin  ratio  a  graph  was  plotted.  The  expression  level  of  Hsp90  in  the  T. 
circumcincta Tci5 isolate was similar to the Tci2 isolate (Tci5 0.9586 ± 0.0461, 
Tci2 0.7542 ± 0.0318)(p>0.05).          Chapter 5        189 
 
 
 
Figure 5.1: Analysis of Hsp90 expression levels in anthelmintic susceptible and resistant T. 
circumcincta   
 
a)  Coomassie  blue  staining  of  approximately  equal  amounts  of  protein.  Mr  represents 
molecular  marker,  B.  pahangi  (Lane  1),  T.  circumcincta  Tci5  isolate  (Lane  2)  and  T. 
circumcincta isolate Tci2 (Lane 3).  
b) Equal amounts of soluble extract of B. pahangi (Lane 1), T. circumcincta Tci5 (Lane 2) and 
Tci2 (Lane 3) were analysed by Western blotting using the B. pahangi anti-Hsp90 antibody at 
1:5000 dilution followed by 1:10,000 dilution of HRP-labelled anti-rabbit IgG (Sigma). Bound 
antibody was detected by chemiluminescence using Super Signal ® West Pico Kit. Anti-actin 
was used as the loading control and B. pahangi extract was used as a positive control. 
c)  Graph  shows  the  Hsp90  expression  levels  in  T.  circumcincta  resistant  and  susceptible 
isolates. Hsp90 expression was higher in the T. circumcincta Tci5 isolate compared to the T. 
circumcincta  Tci2  isolate  but  the  difference  was  not  significant  between  the  two  isolates 
(p>0.05).    Graph  presented  here  shows  the  mean  ±  standard  deviation  of  three  different 
experiments. 
T. circumcincta Hsp90 Tci5 vs Tci2, p = 0.0809    Chapter 5        190 
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5.2.1.2  C. elegans resistant strains – resistance acquired by mutagenesis 
C. elegans  CB3474  is  a  strain  which  shows  resistance  to  benzimidazole 
compounds via a mutation in the ben 1 gene (Driscoll et al., 1989). C. elegans 
DA1316 is a strain which contains mutations in three separate genes, all of which 
are required for high level resistance to ivermectin (Dent et al., 2000). Both 
strains were selected in mutagenesis screens. Levels of Hsp90 were compared in 
these mutant worms and in wild type N2 worms by Western blotting. Figure 5.2a 
shows  a  Coomassie  blue  stained  gel  of  the  soluble  extracts,  with  the 
corresponding  autoradiograph  shown  in  Figure  5.2b.  The  autoradiograph  was 
scanned  and  band  densities  were  quantified  using  FluorChemTM  IS 5500 
software. The graph in Figure 5.2c shows  Hsp90 expression levels in C. elegans 
N2, C. elegans CB3474 and C. elegans DA1316.The expression levels of Hsp90 in 
C. elegans N2 was similar compared to the mutant worms (N2 1.3181± 0.0361, 
CB3474 1.1471± 0.0412, DA1316 1.2853± 0.0685)(p>0.05).  
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Figure 5.2: Analysis of Hsp90 levels in C. elegans drug resistant strains 
 
a)  Coomassie  blue  stained  gel  of  soluble  extracts  of  C.  elegans  N2  (Lane  1),  C.  elegans 
CB3474 (Lane 2) and C. elegans DA1316 (Lane 3). Mr represents the molecular weight marker. 
b)  Autoradiograph  of  Hsp90  expression  levels  in  susceptible  and  resistant  C.  elegans. 
Extracts were loaded exactly as in Panel a. C. elegans N2 (Lane 1), C. elegans CB3474 (Lane 2) 
and C. elegans DA1316 (Lane 3).  Actin was used as a loading control.  
c) The expression level of Hsp90 based on Hsp90/Actin ratio as quantified using FluorChem
TM 
IS-5500  software.  Graph  presented  here  shows  the  mean  ±  standard  deviation  of  three 
different experiments. 
C. elegans N2 vs C. elegans CB3474, p = 0.0809  
C. elegans N2 vs C. elegans DA1316, p = 0.6625  
C. elegans CB3474 vs C. elegans DA1316, p = 0.0809 
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5.2.1.3  C. elegans ivermectin-resistant strains – acquired by selection on 
drug 
In some cases, nematode tolerance to drug can be induced by continuous 
exposure  to  drug  in  the  laboratory.  In  this  case,  wild type  N2  worms  were 
adapted to culture with ivermectin at 6 ng/ml or 10 ng/ml. Hsp90 expression 
levels were compared in  C. elegans  N2,  C. elegans  IVM 6 and IVM 10 worms. 
Figure 5.3a shows a Coomassie blue stained gel of the extracts while Figure 5.3b 
shows the corresponding autoradiograph of Hsp90 expression levels in ivermectin 
resistant  and  susceptible  worms.  The  autoradiograph  was  scanned  and  band 
density was quantified  using  FluorChem
TM  IS 5500  software  and  graph  was  plotted 
based on Hsp90/actin ratio. The graph in Figure 5.3a indicates that the expression 
level of Hsp90 in C. elegans N2 was similar compared to the IVM 6 and IVM 10 
worms  (N2  2.3657±0.1774,  IVM 6  1.9683±  0.4080  and  IVM 10  1.9104± 
0.0668)(p>0.05).  
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Figure 5.3: Analysis of Hsp90 expression levels in C. elegans N2 and ivermectin resistant 
worms 
 
a) Coomassie blue stained gel of soluble extracts of adult stage of C. elegans N2, C. elegans 
IVM-6 and C. elegans IVM-10. 30 adult worms were directly solubilised in 30 µl SDS-PAGE 
sample cocktail by boiling for 3 min. 5 µl of sample extract was loaded onto the gel for the 
analysis.  
b) Autoradiograph of Hsp90 expression levels as detected using the B. pahangi anti-Hsp90 
antibody. C. elegans N2 (Lane 1), C. elegans IVM-6 (Lane 2) and C. elegans IVM-10 (Lane 3). B. 
pahangi anti-Hsp90 antibody was used at 1:5000 dilution followed by 1:10,000 dilution of HRP-
labelled anti-rabbit IgG (Sigma). Bound antibody was detected by chemiluminescence using 
Super Signal ® West Pico Kit. Actin was used as a loading control (Mr weight ~42 kDa). 
c)  The  expression  level  of  Hsp90  based  on  the  Hsp90/actin  ratio  as  quantified  using 
FluorChem
TM IS-5500 software. Graph presented here shows the mean ± standard deviation of 
three different experiments.  
C. elegans N2 vs C. elegans IVM-6, p = 0.3827  
C. elegans N2 vs C. elegans IVM-10, p = 0.0809 
C. elegans IVM-16 vs C. elegans IVM-10, p =  0.6625 Chapter 5        196 
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5.2.2 Optimising the conditions for hsp90(RNAi)  
C. elegans is a useful model for parasitic nematodes, because defining the 
function of genes of interest in parasitic species can be difficult due to the lack 
of  appropriate  knock out  approaches  or  suitable  functional  assays  (Britton  & 
Murray,  2006).  In  this  section  C.  elegans  wild type  worms  were  used  in 
preliminary hsp90(RNAi) experiments to optimise RNAi conditions, prior to using 
this approach to investigate the possible role of Hsp90 in drug resistance.       
5.2.2.1  Investigating the effect of temperature and time of feeding on the 
efficiency of RNAi 
In  the  initial  experiments,  wild type  N2  worms  were  fed  on  a  300  bp 
hsp90(RNAi)  construct  described  previously  (Section  2.3.2.5).  RNAi  was 
conducted  at  different  temperatures  or  for  different  time  periods,  as  both 
variables can affect the intake of the construct and the efficiency of the RNAi. 
The aim of these experiments was to obtain a reduction in Hsp90 levels, while 
maintaining the viability of the worms. L4 of wild type N2 were fed on the 300 
bp hsp90(RNAi) construct for 6 h, 12 h or 24 h at 20
oC. 30 worms were then 
solubilised in 30  l SDS PAGE sample cocktail and analysed by Western blotting. 
Figure 5.4a shows the autoradiograph of Hsp90 expression levels after different 
feeding duration. At 6 h, there was a small but insignificant increase in Hsp90 
expression in RNAi treated worm compared to the control group (Lane 1 and 
Lane 2)(p>0.05). However, after 12 h of feeding there was a small reduction in 
Hsp90 expression level in RNAi treated worms compared to the control group 
(Lane 3 and Lane 4)(p>0.05), with a further reduction after 24 h of feeding (Lane 
5  and  Lane  6)(p<0.05).  In  these  experiments,  Hsp90  levels  were  reduced  by Chapter 5        198 
approximately  42%  after  24  h  feeding  on  the  hsp90(RNAi)  construct.  Thus 
subsequent RNAi experiments were carried out at 24 h.  
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Figure 5.4: Different RNAi feeding periods affect Hsp90 expression levels. 
 
a) Wild-type N2 L4 worms were fed on the hsp90(RNAi) construct for 6, 12 and 24 h. Control 
worms were fed on empty vector under identical conditions. 6 h-Control (Lane 1), hsp90(RNAi) 
(Lane 2), 12 h-Control (Lane 3), hsp90(RNAi)(Lane 4), 24 h-Control (Lane 5), hsp90(RNAi) (Lane 
6).  All experiments were carried out at 20
oC. Equal volumes of extract (5 µl) were loaded onto 
a 10% gel and analysed by SDS-PAGE and Western blotting as described previously.  
b)  Hsp90  expression  levels  following  hsp90(RNAi)  at  20
oC  after  different  feeding  times. 
Results are expressed as ratio of Hsp90/actin in RNAi treated worms compared to controls.  
All values represent the mean ± standard deviation of three experiments. All percentages are 
expressed relative to the appropriate control, which was set to 100%.  
6 h-106.24% ± 8.87, 12 h-90.70% ± 22.55, 
 24 h-58.35% ± 2.47, 
Control vs 6 h feeding on the hsp90(RNAi) construct, p = 0.311 
Control vs 12 h feeding on the hsp90(RNAi) construct, p = 0.576 
*Control vs 24 h feeding on the hsp90(RNAi) construct, p = 0.001 
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In  the  next  experiments,  worms  were  fed  on  the  300  bp  hsp90(RNAi) 
construct for 24 h at different incubation temperatures of 16
oC, 20
oC or 25
oC. 
Temperature  was  shown  to  influence  the  effectiveness  of  RNAi  in  previous 
studies (Kamath et al., 2003). Figure 5.5a shows the autoradiograph of Hsp90 
expression levels of wild type N2 after 24 h feeding on the 300 bp hsp90(RNAi) 
construct  at  16
oC,  20
oC  or  25
oC.  The  autoradiograph  was  then  scanned  to 
quantify Hsp90 expression levels using FlourChem
TM IS 5500. Figure 5.5b shows 
the graph of Hsp90 expression levels after feeding on the 300 bp hsp90(RNAi) 
construct  for  24  h  at  different  temperatures.  Hsp90  expression  levels  were 
reduced  at  all  temperatures  tested.  However,  the  greatest  reduction  was 
observed at 25
oC (49.84% ± 3.82), followed by 20
oC (40.48% ± 3.03) and 16
oC 
(9.64%  ±  7.30).  The  reduction  in  Hsp90  expression  was  significantly  different 
from the controls at 20
oC and 25
oC (p<0.05) but not at 16
oC.   Chapter 5        202 
 
 
 
Figure 5.5:  hsp90(RNAi) was more efficient at higher temperature.  
 
a) Autoradiograph of wild-type N2 Hsp90 expression levels after 24 h feeding on the 300 bp 
hsp90(RNAi)  construct  at  different  incubation  temperatures.  16
oC-Control  (Lane  1),  300  bp 
hsp90(RNAi)  (Lane  2),  20
oC-Control  (Lane  3),  hsp90(RNAi)  (Lane  4),  25
oC-Control  (Lane  5), 
hsp90(RNAi)  (Lane  6).    30 worms  were  solubilised  in  30  µl  SDS-PAGE  sample  cocktail  by 
boiling  and  equal  volumes  (5  µl)  were  loaded  onto  a  10%  gel  and  analysed  by  Western 
blotting.   
b)  Hsp90  levels  after  24  h  feeding  on  the  300  bp  hsp90(RNAi)  construct  at  different 
temperatures.  Results  are  expressed  as  the  ratio  of  Hsp90/actin  RNAi  treated  worms 
compared  to  controls.  All  values  represent  the  mean  ±  standard  deviation  of  three 
experiments. All percentages are expressed relative to the appropriate control, which was set 
to 100%. 
16
o C-90.35% ± 7.30, 20
oC- 58.51% ± 3.03, 25
oC-50.16% ± 3.82 
Control vs RNAi treated at 16
oC, p = 0.168 
* Control vs RNAi treated at 20
oC, p = 0.02 
* Control vs RNAi treated at 25
oC, p = 0.02 
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5.2.2.2  Feeding on the 300 bp hsp90(RNAi) construct affects the growth of 
wild-type N2 and produces a phenotype  
For the next hsp90(RNAi) experiment, L4 were fed at 20
oC for 24 h on the 
300  bp  hsp90(RNAi)  construct.  Three  worms  were  then  transferred  onto 
triplicate fresh NGM plates spotted with OP50 and were left for 24 h to let the 
worm lay eggs. The next day, the numbers of eggs were scored. Figure 5.6 shows 
the fertility of wild type N2 after feeding on empty vector or on the 300 bp 
hsp90(RNAi) construct. The Po wild type N2 grown on the 300 bp hsp90(RNAi) 
plates had a smaller brood size (58 ± 27) compared to Po wild type N2 grown on 
control plates (control group 223 ± 12)(p<0.05). These experiments confirmed 
that knock down of Hsp90 affects the fertility of wild type N2 worms.  
In addition, other phenotypes were observed in Po RNAi treated worms. 
Figure 5.7 shows the Po worms after 24 h feeding on control plates or on the 
hsp90(RNAi) construct. Control worms appeared normal (Figure 5.7a) while some 
hsp90(RNAi) worms developed a protruding vulva (Figure 5.7b) and a ‘bagging 
effect’ in which eggs hatched and the larvae were released in the body of the 
worm (Figure 5.7c). The F1 generation of control worms were normal (Figure 
5.8a), while a protruding vulva was observed in many hsp90(RNAi) worms (see 
Figure 5.8b). The F1 with protruding vulva were 100% sterile and showed reduced 
motility. A similar phenotype was previously reported in hsp90(RNAi) knock out 
worms (Gillan et al., 2009) where they reported the wild type N2 F1 generation 
were infertile.     
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Figure 5.6: Egg counts of wild-type N2 after feeding on the 300 bp hsp90(RNAi) construct. 
 
Fewer  eggs  were  produced  in  wild-type  N2  fed  on  the  300  bp  hsp90(RNAi)  construct 
compared  to  the  control  group  fed  on  empty  vector.  N2  were  fed  on  the  hsp90(RNAi) 
construct for 24 h at 20
oC and three worms were transferred onto new NGM plates seeded 
with OP50. Worms were left for a further 24 h at 20
oC and the number of eggs produced was 
counted. 
N2-Control- 223 ± 12 
* N2-RNAi- 58 ± 27 
p = 0.0404 
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Figure 5.7: hsp90(RNAi) phenotypes observed in wild-type N2 after 24 h feeding on the 300 bp 
construct. 
 
a) N2 Po after 24 h feeding on the empty vector. 
b) N2 Po after 24 h feeding on the hsp90(RNAi construct. Arrow shows the protruding vulva.   
c) Po of N2 fed on the hsp90(RNAi) construct showing a ‘bagging effect’. Arrow shows the 
larvae hatched within the body of parent worm.  
Worms were viewed on a Carl Zeiss, Stemin SV 6 microscope and images were captured using 
Canon Powershot G6 software. Final magnification x75.   
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Figure 5.8: hsp90(RNAi) phenotypes observed in wild-type N2 after 24 h feeding on the 300 bp 
construct. 
 
a) F1 of N2 fed on empty vector after 24 h, showing normal development. 
b) F1 of N2 fed on 300 bp hsp90(RNAi) construct. Arrow shows protruding vulva.   
Worms were viewed on a Carl Zeiss, Stemin SV 6 microscope and images captured using 
Canon Powershot G6 software. Final magnification x75.     
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5.2.2.3  A shorter hsp90(RNAi) construct reduced the Hsp90 expression 
levels in C. elegans N2  
The aim of the hsp90 knock down experiments was to reduce the level of 
Hsp90 in an ivermectin resistant strain of C. elegans and to determine whether 
this reduction in Hsp90 level had any effect on sensitivity to drug. For these 
experiments it was important that the reduction in Hsp90 level did not affect 
worm viability. As can be seen in the previous section, the 300 bp hsp90(RNAi) 
construct  produced  a  variety  of  detrimental  phenotypes  in  N2  worms  and 
therefore  was  not  appropriate  for  use  in  these  experiments.  Based  on  these 
observations, the experiments were repeated using a smaller 75 bp hsp90(RNAi) 
construct.  This  construct  was  prepared  by  Dr.  Victoria  Gillan  as  described  in 
Materials and Methods (Section 2.3.2.3). In initial experiments, C. elegans N2 
were  fed  on  the  75  bp  hsp90(RNAi)  construct  at  different  incubation 
temperatures  (16
oC,  20
oC  and  25
o  C)  for  24  h.  After  24  h,  30  worms  were 
solubilised in 30  l SDS PAGE sample cocktail and analysed by Western blotting. 
Figure 5.9a shows the autoradiograph of Hsp90 expression in C. elegans N2 fed 
on the 75 bp hsp90(RNAi) construct compared to control empty vector or the 300 
bp  hsp90(RNAi)  construct  at  different  feeding  temperatures.  Bands  on  the 
autoradiograph were scanned and the reduction in Hsp90 levels was estimated 
based  on  the  Hsp90  to  actin  ratio.  The  reduction  of  Hsp90  levels  was  most 
pronounced in wild type N2 fed on the longer construct at 20
oC or 25
oC (Figure 
5.9, Lane 6 and Lane 9). However, even using the shorter 75 bp hsp90(RNAi) 
construct a reduction in Hsp90 levels was observed at all temperatures (Figure 
5.9b).  No  phenotypes  were  observed  in  wild type  N2  fed  on  the  75  bp 
hsp90(RNAi) construct but the same phenotypes were observed with the 300 bp 
hsp90(RNAi)  construct  as  described  previously.  This  experiment  was  repeated Chapter 5        211 
twice  under  identical  conditions  with  similar  results.  For  the  subsequent 
experiments, the 75 bp hsp90(RNAi) construct was used.  Chapter 5        212 
 
 
 
Figure 5.9: A comparison of Hsp90 expression levels in C. elegans N2 fed on the 75 bp or 300 
bp hsp90(RNAi) constructs at different feeding temperatures. 
 
a) Autoradiograph of Hsp90 levels in C. elegans N2 fed on control empty vector, 75  bp or 300 bp  
hsp90(RNAi) constructs with actin as a loading control at different feeding temperatures (16
oC, 
20
oC and 25
oC) for 24 h. Wild-type N2 fed on control empty vector (Lane 1, 4, 7), wild-type N2 fed 
on the 75 bp (Lane 2, 5 and 8) or the 300 bp RNAi construct (Lane 3, 6 and 9). An equal volume 
of extract was analysed on a 10% gel followed by Western blotting. Proteins were transferred to 
NCP using standard methods, blocked o/n in 5% dried milk in PBS/0.5% Tween 20 and then the 
blot probed with 1:5000 dilution of the B. pahangi anti-Hsp90 antibody. Bound antibody was 
detected using a 1:10,000 dilution of anti-rabbit IgG conjugated to HRP. The blot was developed 
using the Pierce Super Signal West Pico chemiluminescence kit.   
b) Graph shows the wild-type N2 Hsp90 expression levels after feeding on the control empty 
vector, 75 bp or 300 bp construct. The greatest reduction in Hsp90 levels was observed at 20
oC 
or 25
oC in worms fed on the 300 bp hsp90(RNAi) construct. Results represented the mean ± 
standard deviation from two different experiments.                     Chapter 5        213 
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5.2.2.4  Reduction in Hsp90 levels in ivermectin-resistant worms 
In fungi and yeast, reducing Hsp90 levels increased the sensitivity of azole 
resistant strains to drug. In the experiments presented here, the sensitivity of C. 
elegans IVM 10 worms to ivermectin was investigated following hsp90(RNAi) in 
order to ask whether Hsp90 might have a role in ivermectin resistance. Based on 
the hsp90(RNAi) results shown previously, the 75 bp hsp90(RNAi) construct was 
used in all experiments at a temperature of 20
oC for 24 h feeding time. Hsp90 
levels in wild type N2 and IVM 10 worms were analysed by solubilising 30 worms 
in  30   l  SDS PAGE  sample  cocktail  and  analysing  by  Western  blotting.  Figure 
5.10a shows an autoradiograph of Hsp90 expression levels in wild type N2 and 
IVM 10 worms after feeding on the 75 bp hsp90(RNAi) construct. Hsp90 levels in 
both strains were reduced following 24 h of RNAi (Lane 2 and Lane 4) compared 
to control worms (Lane 1 and 3). The Hsp90 reduction levels were estimated 
based on the density values using FlourChem
TM IS 5500 software and a graph was 
plotted.  Figure  5.10b  shows  that  Hsp90  expresson  levels  were  significantly 
reduced in wild type N2 worms (21.64% ± 10.75) and in IVM 10 worms (29.72% ± 
7.17) following 24 h feeding on the 75 bp hsp90(RNAi) construct compared to 
empty vector control for both groups (p<0.05).  
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Figure 5.10: Hsp90  levels  in wild-type  N2  and  IVM-10  resistant worms were reduced  after 
feeding on the 75 bp hsp90(RNAi) construct 
 
a) Autoradiograph shows Hsp90 levels after 24 h of RNAi with actin as a loading control at 
20
oC. Wild-type N2 fed on the empty vector construct (Lane 1), 75 bp construct (Lane 2), IVM-
10 worms fed on the empty construct (Lane 3) and 75 bp construct (Lane 4). 5 µl of each 
sample was loaded onto a 10% gel and analysed by SDS-PAGE and Western blotting. Proteins 
were transferred to NCP using standard methods, blocked o/n in 5% dried milk in PBS/0.5% 
Tween 20 and then the blot probed with 1:5000 dilution of the B. pahangi anti-Hsp90 antibody. 
Bound antibody was detected using a 1:10,000 dilution of anti-rabbit IgG conjugated to HRP. 
For the loading control, anti-actin antibody was used at 1:1000 dilution and bound protein was 
detected using anti-mouse IgG at 1:10,000. The blot was developed using the Pierce Super 
Signal West Pico chemiluminescence kit.      
b) Graph shows the Hsp90 expression levels after feeding on the 75 bp hsp90(RNAi) construct 
based on the integrated density value quantified using FlourChem
TM Is-5500 software. Results 
presented  the  percentage  of  mean  ±  standard  deviation  of  Hsp90/actin  ratio  from  three 
different experiments. The Hsp90 levels of worms fed on the empty vector was set at 100%.    
C. elegans N2 reduction in Hsp90 level vs N2-Control = 21.64 % ± 10.75 
IVM-10 reduction in Hsp90 level vs IVM-10-Control = 29.72 %  ± 7.17 
*N2-Control vs N2-RNAi, p = 0.037 
*IVM-10-Control vs IVM-10-RNAi, p = 0.009 
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In addition, egg production by adult worms was also was analysed in these 
experiments. Three  worms were  placed  onto  each  of three fresh NGM plates 
seeded with OP50 after feeding on the 75 bp hsp90(RNAi) construct or on empty 
vector for 24 h. Plates were incubated at 20
oC for further 24 h. At this point 
worms were removed from the plates and the number of eggs counted. Figure 
5.11 shows the egg production by wild type N2 and IVM 10 worms in a typical 
RNAi experiment. Wild type N2 fed on the empty vector construct produced 245 
± 75 eggs over the 24 h period, compared to 160 ± 64 eggs by worms fed on the 
75  bp  hsp90(RNAi)  construct.  IVM 10  worms  fed  on  the  empty  construct 
produced  186  ±  68  eggs  compared  to  126  ±  43  by  worms  fed  on  the  75  bp 
hsp90(RNAi)  construct.  However,  the  difference  is  not  significant  (p>0.05). 
Further  observation  of  the  F1  generation  feeding  on  the  75  bp  hsp90(RNAi) 
construct  showed  that  the  F1  generation  were  fertile  and  appeared  normal 
compared to the F1 generation feeding on the empty construct. This experiment 
indicated that the reduction in Hsp90 levels by feeding on the 75 bp hsp90(RNAi) 
construct did not significantly affect egg production or worm viability.   
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Figure  5.11:  Egg  production  by  wild-type  N2  and  IVM-10  worms  fed  on  the  75  bp 
hsp90(RNAi) construct. 
 
No significant difference was observed in egg production in wild-type N2 and IVM-10 worms 
fed on the 75 bp hsp90(RNAi) construct compared to controls (p>0.05). Wild-type N2 or IVM-
10 worms were fed on the 75 bp hsp90(RNAi) construct for 24 h at 20
oC. Three worms were 
then transferred onto each of three new NGM plates seeded with OP50. Worms were left for 
further 24 h at 20
oC and the number of eggs counted. Results presented are the mean ± 
standard deviation of eggs produced by wild-type N2 or IVM-10 worms from three different 
experiments.  
N2-Control vs N2-RNAi, p = 0.1904 
IVM-10-Control vs IVM-10-RNAi, p = 0.3827 
N2-Control vs IVM-10-Control, p = 0.6625 
N2-RNAi vs IVM-10-RNAi, p = 0.6625 
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5.2.2.5  Reduction in Hsp90 levels alters the ivermectin-resistant 
phenotype 
Previous results showed that Hsp90 levels were reduced in wild type N2 and 
IVM 10 resistant worms fed on the 75 bp hsp90(RNAi) construct for 24 h at 20
oC. 
However, the RNAi conditions did not affect the growth or the fertility of the 
worms. The aim of this work was to ask whether a reduction in Hsp90 levels 
could alter the ivermectin resistant phenotype of IVM 10 worms. To assess the 
sensitivity of the RNAi treated worm to drug, wild type N2 or IVM 10 worms were 
fed on the 75 bp hsp90(RNAi) construct at 20
oC for 24 h. Then 5 worms were 
transferred to each of 6 wells of a 24 well microtitre plate containing ivermectin 
at different concentrations (0, 1, 5 and 10 ng/ml). OP50 was added to each well 
and the plates were incubated at 20
oC. Worm motility was scored at 24 h and 
again at 48 h as described in Materials and Methods (Section 2.3.2.3). Figure 
5.12a shows the results of the motility assay at 24 h and in Figure 5.12b, the 48 
h  results.  At  24  h,  motility  of  worms  in  all  groups  was  similar  at  all 
concentrations of ivermectin. However by 48 h, wild type N2 worms showed a 
reduced motility which was most apparent at 10 ng/ml ivermectin. In contrast, 
IVM 10  worms  fed  on  empty  vector  maintained  the  tolerance  to  drug,  while 
worms fed on the 75 bp hsp90(RNAi) construct behaved more like the wild type 
N2 control i.e. their motility was compromised in the presence of ivermectin. 
This experiment was repeated three times with similar results. 
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Figure 5.12: A reduction in Hsp90 levels alters the sensitivity of IVM-10 ivermectin-resistant 
worm to drug. 
 
Wild-type N2 or IVM-10 resistant worms were fed on the 75 bp hsp90(RNAi) or on empty vector  
for 24 h at 20
oC, followed by incubation in liquid culture containing ivermectin at different 
concentrations (0, 1, 5 and 10 ng/ml) at 20
oC for 24 h or 48 h . After 24 h (Panel a) or 48 h 
(Panel  b)  the  motility  of  the worms  was  scored.  Graph  presented  here  shows  the  mean  ± 
standard deviation of three different experiments.  
Worm motility was scored based on the activity of the worms in liquid containing different 
concentrations of ivermectin at 24 h and 48 h. The scoring system for the motility assay is 
shown below.  
Activity  Score 
Thrashing 
Slow 
Paralysed 
Dead 
3 
2 
1 
0 
   
   
30 worms for each concentration of drug were scored individually. The score then converted 
to a numerical value and expressed as a percentage of the maximum score (90 = 30 worms x 
3).  
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The data shown in Figure 5.12 is presented in more detail in Figure 5.13. At 
24 h there was little difference overall in the motility of wild type N2 and IVM 10 
worms fed on the 75 bp hsp90(RNAi) construct. However, two groups showed a 
small  but  significant  difference  in  motility  between  RNAi  and  empty  vector 
controls  (p<0.05)(Figure  5.13a).  The  first  group  was  wild type  N2  incubated 
without ivermectin and the  second was IVM 10 worms  incubated in  10 ng/ml 
ivermectin.  In  both  cases,  there  was  a  reduction  in  motility  in  RNAi treated 
worms.  
At  48  h,  wild type  N2  worms  incubated  in  increasing  concentrations  of 
ivermectin  showed  a  progressive  reduction  in  motility,  irrespective  of  RNAi 
treatment or not, except for those incubated in the highest concentration of 
ivermectin  (10  ng/ml)(Figure  5.13b).  In  this  group  there  was  a  significant 
difference between the motility of RNAi treated worms compared to controls. 
No differences were observed in IVM 10 worms incubated without drug or with 
drug  at  1  ng/ml,  irrespective  of  RNAi  treatment.  However,  at  higher 
concentrations  of  ivermectin  (5  and  10  ng/ml),  a  significant  difference  was 
observed between control and RNAi treated IVM 10 worms. The motility of the 
RNAi  group  was  significantly  reduced  compared  to  the  control  empty  vector. 
These  results  indicate  that  reducing  Hsp90  levels  in  IVM 10  resistant  worms 
alters the sensitivity of the worms to high levels of ivermectin. 
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Figure 5.13: Motility assays of wild-type N2 and IVM-10 worms following hsp90(RNAi). 
 
Wild-type N2 or IVM-10 ivermectin resistant worms were fed on the 75 bp hsp90(RNAi) or on 
empty vector construct for 24 h at 20
oC, followed by incubation in liquid culture containing 
ivermectin  at different  concentrations  (0, 1,  5  and 10 ng/ml)  at 20
oC  for  24  h or  48  h.  The 
motility of the worms scored after 24 h or 48 h. Graph presented here shows the mean ± 
standard deviation of three different experiments.  
a)  24 h 
*N2-Control vs N2- RNAi at 0 ng/ml, p = 0.0087 
N2-Control vs N2-RNAi at 1 ng/ml, p = 0.0557 
N2-Control vs N2-RNAi at 5 ng/ml, p = 0.0714 
N2-Control vs N2-RNAi at 10 ng/ml, p = 0.5582  
IVM-10-Control vs IVM-10- RNAi at 0 ng/ml, p = 0.3155  
IVM-10-Control vs IVM-10-RNAi at 1 ng/ml, p = 0.5881 
IVM-10-Control vs IVM-10-RNAi at 5 ng/ml, p = 0.1387 
*IVM-10-Control vs IVM-10-RNAi at 10 ng/ml, p = 0.0451 
b) 48 h 
N2-Control vs N2-RNAi at 0 ng/ml, p = 0.2103 
N2-Control vs N2-RNAi at 1 ng/ml, p = 0.7475  
N2-Control vs N2-RNAi at 5 ng/ml, p = 0.3700 
*N2-Control vs N2-RNAi at 10 ng/ml, p = 0.0315 
IVM-10-Control vs IVM-10-RNAi at 0 ng/ml, p = 0.3674 
IVM-10-Control vs IVM-10-RNAi at 1 ng/ml, p = 0.8037 
*IVM-10-Control vs IVM-10-RNAi at 5 ng/ml, p = 0.0435 
*IVM-10-Control vs IVM-10-RNAi at 10 ng/ml, p = 0.046 
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5.3  Discussion  
Drug  resistance  is  already  a  serious  problem  in  nematode  parasites  of 
livestock and also is also a growing issue in human health e.g. in onchocerciasis 
(Boussinesq, 2008). While treatment still relies upon the use of anthelmintics, 
there  is  a  need  to  understand  the  mechanisms  of  drug  resistance.  Recently, 
Hsp90 was suggested to mediate drug resistance in fungi (Cowen & Lindquist, 
2005; Singh et al., 2009). In this Chapter, the possible role of Hsp90 in mediating 
anthelmintic resistance was investigated by comparing Hsp90 levels in resistant 
and susceptible nematodes. Furthermore, in RNAi experiments, levels of Hsp90 
were reduced in order to determine whether a reduction in Hsp90 levels could 
alter the response of drug resistant worms to ivermectin.     
The  most  direct  approach  to  study  anthelmintic  resistance  is  by  the 
comparative analysis of resistant and susceptible parasites isolated directly from 
the field. The T. circumcincta isolate, Tci5 was characterised by Bartley et al 
(2005)  and  shown  to  be  resistant  to  the  three  broad  spectrum  anthelmintic 
groups. In contrast, the Tci2 isolate is susceptible to all anthelmintic groups. The 
T.  circumcincta  Tci5  and  Tci2  isolates  were  compared  but  no  significant 
difference was observed in Hsp90 levels. Next Hsp90 levels were compared in 
two C. elegans strains where resistance was acquired by mutagenesis, namely C. 
elegans  CB3464  and  DA1316.  The  CB3464  strain  is  resistant  to  benzimidazole 
compounds, while the DA1316 strain shows a high level of resistant to ivermectin 
(Dent et al., 2000). Again, no difference in Hsp90 levels was observed between 
these  worms  and  wild type  N2  controls.  These  assays  were  conducted  in  the 
absence of drug pressure. In future studies it would be interesting to compare 
Hsp90 levels in the presence of the relevant drug, to rule out the possibility that Chapter 5        226 
drug exposure induces increased expression of Hsp90. Finally, Hsp90 levels were 
compared in ivermectin resistant C. elegans where resistance was acquired by 
continuous passage on plates containing drug. These worms were resistant to 
ivermectin at 6 ng/ml or 10 ng/ml. According to James & Davey (2009), IVM 6 
worms show a 4.5 fold difference and IVM 10 worms a 19 fold difference in IC50 
sensitivity to ivermectin compared to wild type N2 worms. In that study they 
also showed that resistance might be associated with increased expression of 
drug  pumps such as  mrp 1 and  pgp 1. These worms are not only resistant  to 
ivermectin  but  also  showed  a  cross resistance  to  moxidectin,  levamisole  and 
pyrantel but not to albendazole (James & Davey, 2009). However, no difference 
was observed in Hsp90 levels between IVM 6, IVM 10 and wild type N2 worms. 
C. elegans was shown to be a useful model to study parasitic nematodes 
(Blaxter,  1998;  Gilleard,  2004).    Using  RNAi  to  knock down  or  to  reduce  the 
expression  of  certain  genes  can  result  in  an  observable  phenotype.  Results 
presented in this Chapter show that feeding C. elegans with E. coli expressing 
dsRNA  (300  bp  hsp90(RNAi)  construct)  reduced  the  Hsp90  levels  by 
approximately 40% and produced a phenotype. The cessation of egg production 
and a protruding vulva was observed in P0 worms and in the progeny suggesting 
that Hsp90 is required during oogenesis or embryogenesis. The RNAi study by 
Piano et al (2000) shows that injection of C. elegans with hsp90 dsRNA results in 
an  embryonic  lethal  phenotype  in  the  progeny  and  the  cessation  of  egg 
production in hermaphrodite worms. Gillan et al (2009) showed that the progeny 
of  wild type  N2  fed  on  hsp90(RNAi)  were  infertile  and  had  reduced  motility. 
These results indicate that Hsp90 is important in worm fertility and viability. 
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constuct, a shorter construct was used in subsequent experiments. Worms fed on 
the 75 bp hsp90(hsp90) construct did not show any obvious phenotype but Hsp90 
levels were reduced.  
In the initial RNAi experiments, IVM 6 worms were used but no affect on 
tolerance to ivermectin was observed when Hsp90 levels were reduced using the 
75 bp hsp90(RNAi) construct (data not shown). As IVM 10 worms are significantly 
more resistant to ivermectin, the experiments were repeated using this strain. 
hsp90(RNAi)  was  carried  out  and  C.  elegans  N2  and  IVM 10  worms  were 
subjected  to  a  drug  cytotoxicity  assay  as  described  in  Materials  and  Methods 
(Section  2.3.2.2)  on  NGM  plates  containing  ivermectin  at  increasing 
concentrations (1, 5 or 10 ng/ml ivermectin). However, in all cases, the RNAi 
treated  worms  crawled  off  the  drug  plates.  This  experiment  was  repeated 
several times with the same results (data not shown). It remains unclear why the 
RNAi treated  worms  should  crawl  off  the  plates,  but  it  is  possible  that  a 
reduction  in  Hsp90  levels  affects  the  ability  of  C.  elegans  to  sense  food,  or 
perhaps more likely induces an aversion response of the worm to ivermectin. In 
C.  elegans  hsp90  was  shown  to  be  required  for  regulation  of  specific 
chemosensory  behaviours  (Birnby  et  al.,  2000;  Morley  &  Morimoto,  2004). 
Consequently  to  overcome  this  problem,  worms  were  subjected  to  a  motility 
assay in liquid culture containing ivermectin with OP50 as a food source. In the 
RNAi experiments, reducing Hsp90 levels in IVM 10 ivermectin resistant worms 
significantly altered  the sensitivity  to ivermectin but only at 5 and 10  ng/ml 
ivermectin. It was noteable that only 10 14% of wild type N2 worms survived 
after 48 h on 10 ng/ml ivermectin, while more than 63% of control IVM 10 worms 
survived this concentration of drug. In contrast, the survival of the IVM 10 worms 
following RNAi was severely compromised. While the results presented in this Chapter 5        228 
Chapter do not indicate how a reduction in Hsp90 levels affects the response to 
ivermectin, these results do support the hypothesis that Hsp90 may be involved 
in tolerance of high concentration of ivermection.  
The best explanation of how Hsp90 mediates drug resistance comes from 
studies on yeast (Cowen & Lindquist, 2005; Singh et al., 2009). In azole resistant 
yeast,  resistance  was  suggested  to  be  associated  with  calcineurin,  an  Hsp90 
client  protein.  According  to  Fox  &  Heitman  (2002),  calcineurin  acts  as  a 
regulator for cell cycle progression, morphorgenesis and virulence. Hsp90 binds 
to the catalytic subunit of calcineurin keeping it stable and poised for activation 
(Imai  et  al.,  2000;  Kumar  et  al.,  2005).    In  the  presence  of  azoles,  Hsp90 
regulates membrane  responses that  are vital for cells to  survive. Importantly 
Cowen & Lindquist (2005) showed that the response of azole resistant yeast to 
drug was altered by genetic or chemical inhibition of Hsp90 and that inhibition 
of  calcineurin  function  by  Cyclosporin  A  or  FK506  (inhibitor  of  calcineurin) 
phenocopied Hsp90 inhibition. Thus, Hsp90 potentiates drug resistance in yeast 
via calcineurin.   
There are also several reports that suggest that Hsp90 may have a role in 
drug resistance in tumour cells (Betram et al., 1996; Davies et al., 2002; Xing et 
al.,  2008).  For  example,  Xing  et  al  (2008)  showed  that  activation  of  the 
phosphatidylinositol 3 kinase (PI-3K/Akt2) pathway has a crucial role in inducing 
resistance  to  docetexal  in  ovarian  and  breast  cancer  cells.  The  PI-3K/Akt2 
pathway  has  been  shown  to  be  important  in  promoting  cell  proliferation  and 
inhibiting cell death. Most importantly, Akt is a serine threonine kinase and an 
Hsp90 client protein, forming a complex with Hsp90 (Sato et al., 2000). Thus, it 
suggests that in some cancer cells, activation of PI-3K/Akt2 pathway which is Chapter 5        229 
modulated by Hsp90, is important in docetexal resistance (Xing et al., 2008). In 
another  study  in  cancer  chemotherapy,  drug  resistance  was  suggested  to  be 
associated with P gp and Hsp90β (Betram et al., 1996). Hsp90β was shown to be 
co precipitated along with P gp. P gp is a member of the ATP binding cassette 
transporter family encoded by the gene MDR1 and previously implicated in the 
multi drug  resistance  phenotype  (Ueda  et  al.,  1987).  The  results  suggest  an 
intracellular  co operation  between  Hsp90β  and  P gp  and  the  involvement  of 
Hsp90β  in  multi drug  resistant  colon  carcinoma  (Betram  et  al.,  1996).  In 
addition, a study by Liu et al (1999) showed that reducing Hsp90 levels using 
antisense RNA increased the sensitivity of human gastric and hepatic cancer cells 
to drugs compared to parental cells, which again indicates a possible role of 
Hsp90 in resistance to chemotherapeutic agents in tumour cells.        
 
In conclusion, the role of Hsp90 in acquired drug resistance in nematodes 
deserves further study. The mechanisms of anthelmintic resistance in nematodes 
are  not  are  properly  understood  but  are  likely  to  be  complicated.  The 
contribution  of  Hsp90  to  drug  resistance  might  be  a  general  mechanism  that 
relates the cellular stress response with the stress induced by drug exposure. 
Future  investigation  of  the  composition,  structure  and  function  of  Hsp90 
complexes  in  nematodes  may  unlock  new  possibilities  for  the  treatment  of 
anthelmintic resistant nematodes. 
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6  General discussion 
The  exposure  of  any  living  cell  or  organism  to  environmental  stress, 
including  elevated  temperature,  chemical  or  oxidative  stress,  results  in  the 
synthesis of proteins known as heat shock proteins (Hsps). Hsps are among the 
most highly conserved of all proteins and are present in most eukaryotic and 
prokaryotic organisms. Consequently the study of Hsps has been of much interest 
in  biology.  Hsp90,  the  focus  of  this  thesis,  is  an  essential  highly  conserved 
protein, which is present in most organisms tested.  
Hsps in host-parasite interactions: What do we know?   
The role of Hsps in host parasite interactions has received considerable 
attention from both clinical and biological perspectives. From the host point of 
view,  Hsps  expressed  by  invading  parasites  are  potent  antigens  that  induce 
immune responses (Polla, 1991; Kaufmann, 1992; Maresca et al., 1994). Thus, 
according to Newport (1991), parasite Hsps are potentially useful in generating 
vaccines. From the parasite point of view, the synthesis of Hsps may represent a 
cellular defense mechanism that favours adaptation of the parasite to different 
environments throughout its life cycle (Tsuji et al., 1997).  
Parasites that are transmitted to mammalian hosts from the environment 
or from a vector undergo profound changes in temperature during the transition 
to these hosts (with internal temperatures of 37
oC or above). The induction of 
Hsps  commonly  accompanies  this  transition.  Numerous  studies  have 
demonstrated the developmental regulation of Hsp expression in parasites (Van 
der Ploeg et al., 1985; Devaney & Lewis, 1993; Ernani et al., 1993; Neumann et 
al.,  1993;  Hartman  et  al., 2003);  expression  differs  throughout  the  life cycle Chapter 6        232 
both  quantitatively  and  in  the  types  of  Hsps  induced.  For  example  Brugia 
pahangi requires two hosts to complete its life cycle and the temperature shift 
experienced by Mf from 37
o C in the mammalian host to 28
o C in the mosquito is 
a requirement for development to proceed (Devaney & Lewis, 1993). According 
to Jecock & Devaney (1992), different types of Hsps are expressed in the Mf and 
the  L3  of  B.  pahangi.  Their  observations  show  that  a  range  of  Hsps  were 
expressed  in  Mf  at  37
o  C  and  repressed  after  transfer  to  28
o  C.  The  most 
abundant  proteins  identified  were  small  Hsps  and  these  were  shown  to  be 
synthesised only in Mf at 37
oC (Devaney et al., 1996). In contrast, in the L3, the 
expression of Hsps is temporary and corresponds with the transition from the 
mosquito to the mammalian host. These studies show that in the Mf and the L3 
of B. pahangi, the transmission between hosts is complemented by alterations in 
gene expression and that temperature induces the expression of certain genes.   
For parasitic species that do not involve a vector in their life cycle, the 
free living  stage  occurs  in  water  or  soil.  Hsp  expression  accompanies  the 
transition  from  the  environment  into  the  definitive  host.  In  Haemonchus 
contortus, Hsp20 was identified and shown to be constitutively expressed in the 
L3, early L4 and adult stages (Hartman et al., 2003). It was proposed that the 
presence  of  Hsp20  in  the  L3  may  indicate  that  this  protein  plays  a  role  in 
preparation for the transition from pasture to mammalian host (Hartman et al., 
2003). It was also suggested that the presence of Hsp20 in the adult worm may 
be due to its expression in eggs, as an early adaptation to cold shock when eggs 
are  passed  out  of  the  host  onto  the  pasture.  Thus,  many  Hsps  appear  to  be 
expressed in parasites to co incide with environmental transitions. In contrast to 
these findings, Hsp90 is expressed constitutively throughout the B. pahangi life Chapter 6        233 
cycle. This presumably relates to the fact that some Hsps also play important 
roles under normal conditions of growth.   
Why is there a difference amongst nematodes in GA-binding? 
Much  of  the  work  described  in  this  thesis  was  concerned  with 
understanding why some nematode Hsp90s bind to GA, while others do not. The 
variability in GA binding may relate to differences in nematode life cycles and 
the  environments  in  which  they  live.  Nematodes  are  a  remarkably  successful 
group  within  the  Animal  Kingdom.  While  most  nematodes  are  free living, 
parasitic  species  play  a  significant  role  in  regulating  the  productivity  of  wild 
populations,  and  impact  negatively  on  human  agriculture  as  well  as  human 
health. Nematodes are abundant and have successfully adapted to nearly every 
habitat from marine to fresh water, from the polar region to the tropics, as well 
as the highest to the lowest of elevations.  
The  contradictory  affinity  of  Hsp90  from  Caenorhabditis  elegans  and  B. 
pahangi for GA is interesting, given the degree of conservation between the two 
proteins. The first report on the failure of C. elegans Hsp90 to bind to GA came 
from David et al (2003), with similar results reported by Devaney et al (2005). C. 
elegans  is  a  free living  nematode  that  resides  in  clade  V  of  the  nematode 
phylogeny together with important parasitic nematodes such as H. contortus, 
Teladosargia circumcincta, Heligmosomoides polygyrus etc. The ecology of these 
species is very diverse. According to Kiontke & Sudhaus (2006), the actual niche 
of C. elegans in the environment remains unknown. In the wild, C. elegans is 
usually found as a stress resistant dauer form, which is non feeding. The study 
by  David  et  al  (2003)  demonstrated  that  C.  elegans  is  insensitive  to  GA 
treatment  as  exposure  to  high  concentration  of  GA  did  not  produce  any Chapter 6        234 
phenotype. A recent study by Taldone et al (2010) validated this finding using a 
sensitive fluorescence polarisation assay in which GA also failed to bind to C. 
elegans Hsp90. Analysis of hsp90 sequences from a range of nematode species 
demonstrated  three  separate  lineages  for  hsp90  sequences  which  correlated 
with the ability to bind GA (Him et al., 2009). However, in that study, no direct 
relationship between amino acid substitutions in Hsp90 and GA binding ability 
was observed. These data suggest that the evolution of hsp90 may correlate with 
key functions other than the ability to bind GA.  
Darwin  argued  that  natural  selection  causes  traits  that  aid  survival  to 
become more common, while traits that hinder survival become rare. Over many 
generations,  successful  random  changes  are  filtered  by  natural  selection  and 
retained. In this way an organism can adapt to its environment. C. elegans might 
be adapted to survive exposure to GA in soil. Interestingly, Hsp90 from parasitic 
species that have free living larvae in the environment also failed to bind GA, 
while Hsp90 from those species that are protected from the environment by an 
egg shell or are permanently parasitic, did bind to GA. The results presented in 
this thesis therefore support the ‘adaptation theory’ as proposed by David et al 
(2003).  
Alternatively  there  are  additional  explanations  that  may  explain  the 
different sensitivity of B. pahangi and C. elegans to GA. While C. elegans Hsp90 
fails to bind to GA, it retains its ability to bind to ATP. Although differences 
were observed in the level of expression of Hsp90 in B. pahangi and C. elegans, 
both proteins bound to ATP beads in binding assay. However, studies using more 
sophisticated approaches would be necessary to ascertain whether the ATPase 
activity of B. pahangi and C. elegans Hsp90 differs. In addition, Hsp90 is known Chapter 6        235 
to be modified significantly, by phosphorylation, acetylation and glycosylation 
(Chiosis et al., 2004; Scroggins and Neckers, 2007; Scroggins et al., 2007; Yang 
et al., 2008). These post translational modifications alter its activity in a range 
of  assays.  A  recent  study  on  Plasmodium  falciparum  Hsp90  showed  that 
differences  in  acetylation  affected  sensitivity  to  GA  (Pallavi  et  al.,  2010). 
However  to  date,  very  little  is  known  of  the  modifications  of  Hsp90  in 
nematodes.  In  this  thesis,  no  evidence  was  produced  that  post translational 
modifications are associated with the ability of human Hsp90 to bind to GA, but 
further studies are required to determine the role of such modifications in GA 
binding in nematodes.  
Could Hsp90 be a new target for filarial worms?  
Previous studies by Devaney et al (2005) on B. pahangi showed that GA 
treatment not only kills the Mf but also kills the adult worms in vitro. Both 
male and female worms are susceptible to GA. In addition, the production of 
Mf  by  adult  was  inhibited  within  24  h  of  exposure  to  the  drug.  While,  the 
mechanism by which GA kills the worm is unknown, these results indicate that 
inhibition of Hsp90 activity may represent a novel target for chemotherapy of 
filariasis. The results in Chapter 4 show that only a small amount of cytosolic 
Hsp90 bound to GA in the pull down assays. This may suggest that inhibition of 
a small proportion of Hsp90 is sufficient to kill the worms. By analogy with its 
effects on mammalian cells, GA most likely kills filarial parasites by disrupting 
interactions  between  Hsp90  and  key  client  proteins  that  are  required  for 
viability.  Consequently  attempts  were  made  to  identify  client  proteins  of 
Hsp90 in adult B. pahangi using a proteomic approach. While key proteins of 
Hsp90 have been identified in mammalian cells and yeast, fewer interactions Chapter 6        236 
have been identified in nematodes. In C. elegans, 68 proteins are predicted to 
interact  with  Hsp90  (www.wormbase.org),  but  mostly  of  these  interactions 
have not been experimentally validated. In this thesis, several proteins were 
identified in the proteomic analysis, but these were mostly structural proteins. 
Although  the  2D gel  analysis  did  not  provide  a  list  of  possible  Hsp90  client 
protein, further studies should be carried out using the more sensitive DIGE 
method. Recent studies in other organisms have used a similar approach to 
successfully  identify  a  range  of  client  proteins  or  co chaperones  of  Hsp90 
(Tsayler et al., 2009; Garcia Descalzo et al., 2010). Hsp90 was shown to be 
secreted  in  the  ES  product  of  Brugia  malayi  (Kumari  et  al.,  1994)  and  B. 
pahangi (this thesis). It would be interesting in future studies to compare the 
ES  proteome  of  adult  worms  cultured  with  or  without  GA  to  investigate 
whether any ES products are dependent upon Hsp90 for their activity.   
Does Hsp90 mediate drug resistance in nematodes?  
The  role  of  Hsp90  in  anthelmintic  resistance  remains  unresolved.  In 
fungi, Hsp90 was shown to be involved in drug resistance. Hsp90 was suggested 
to act as a capacitor of phenotypic variation, buffering genetic variation in 
Drosophila melanogaster (Rutherford & Lindquist, 1998; Sollars et al., 2003) 
and Arabidopsis thaliana (Queitsch et al., 2002). These studies demonstrated 
that  challenging  Hsp90  function  by  mutation,  pharmacological  means  or 
environmental stress can produce novel heritable phenotypes. The heritable 
phenotype is passed to the new generation even when Hsp90 levels return to 
normal. Through studies in Drosophila (Rutherford & Lindquist, 1998), a role 
for  Hsp90  in  evolutionary  adaptation  was  proposed.  Hsp90  functions  as  a 
chaperone for mutant proteins, and allows them to act functionally as normal Chapter 6        237 
proteins. These mutations tend to accumulate under the protection of Hsp90. 
When  the  accumulated  mutations  surpass  the  normal  Hsp90  threshold  as  a 
result  of  environmental  stress  or  inhibition  of  Hsp90  function,  various 
mutations were expressed. Therefore, Hsp90 has the capacity to ‘buffer’ the 
expression of mutations and release these in response to environmental stress. 
The exposure of nematodes to anthelmintic presumably represents a stress and 
induction of Hsps may help nematodes survive that stress. However, whether 
Hsp90 may ‘buffer’ genetic changes in nematodes remains unclear. Results in 
this  thesis  suggest  that  Hsp90  might  have  a  role  in  drug  resistance  in  C. 
elegans, but the mechanism by which Hsp90 might function in resistance in 
nematodes remains to be ascertained. 
Conclusion 
The present study presents a comparative analysis of Hsp90 in nematodes 
and investigates its possible role in drug resistance. Although a high degree of 
sequence similarity is observed when comparing Hsp90 amino acid sequences in 
nematodes, it remains possible that subtle differences in Hsp90 sequence may 
confer  differential  sensitivity  to  GA  as  recently  demonstrated  in  the  yeast, 
Humicola  fuscoatra,  where  a  single  conservative  mutation  in  Hsp90  altered 
sensitivity to radicicol (Prodromou et al., 2009). Additionally, defining the Hsp90 
complexes in  B. pahangi  and identifying those which are essential for filarial 
viability may provide additional novel targets for the chemotherapy of filariasis.  
Future  studies  should  consider  the  role  of  client  proteins/co chaperones  in 
Hsp90 activity, the differences in the charged region of Hsp90 and perhaps the 
internal interactions between domains. Further research addressing the possible 
roles of Hsp90 in drug resistance should be carried out. This could be achieved Chapter 6        238 
by implementing more sensitive approaches which may be able to identify novel 
targets  that might be responsible for  acquired drug resistance in  nematodes.      
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Appendix 1: Worm materials 
Nematode  Source 
 
Trichinella spiralis 
Trichuris muris 
 
Dr. C. Lawrence, University of Strathclyde 
Prof. R. Grencis, University of Manchester 
 
Brugia pahangi 
Dirofilaria immitis 
Onchocerca ochengi 
Acanthocheilonema viteae 
Toxocara cati 
Ascaris suum 
Parascaris equorum 
Anisakis simplex 
Pseudoterranova decipiens 
Anguillicola crassus 
 
Veterinary Infection and Immunity, University of Glasgow 
Dr. J. Foster, New England BioLabs 
Dr. B. Makepeace, Liverpool School of Tropical Medicine 
Prof. W. Harnett, University of Strathclyde 
Mr. J. McGoldrick, Vet School, University of Glasgow 
Prof. A. Maule, Queens University Belfast 
Prof. J. Matthews, Moredun Research Institute 
Dr. S. Martin, University of Aberdeen 
Dr. I. Coombs, University of Glasgow 
Dr. I. Coombs, University of Glasgow 
 
Strongyloides ratti 
Panagrellus redivivus 
Globodera rostochiensis 
Globodera pallida 
Prof. M. Viney, University of Bristol 
Prof. A. Maule, Queens University Belfast 
Dr. J. Jones, Scottish Crop Research Institute 
Dr. C. Fleming, Agri Food and Bioscience Institute, Belfast 
 
Caenorhabditis elegans 
Caenorhabditis briggsae 
Oscheius tipulae 
Pristionchus pacificus 
Haemonchus contortus 
Heligmosomoides polygyrus 
Teleodorsargia circumcincta 
Nippostrongylus brasiliensis 
C. elegans Genetics Center 
C. elegans Genetics Center 
C. elegans Genetics Center 
C. elegans Genetics Center 
Prof. D. Knox, Moredun Research Institute 
Prof. R. Maizels, Universitiy of Edinburgh 
Prof. D. Knox, Moredun Research Institute 
Prof. R. Maizels, Universitiy of Edinburgh 
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Appendix 2: Buffers and stock solutions 
2.1  Buffers for use in pull-down assays 
2.1.1 TNES buffer 
TNES contains 50 mM Tric HCl pH 7.4, 100 mM NaCl, 2 mM EDTA, 1% Igepal CA 
630  (SIGMA,  UK)  in  100  ml  ddH2O.  Store  at  room  temperature.  Add  protease 
inhibitor prior to use. 
2.1.2 SkBr3 lysis buffer 
Buffer consists of 50 mM Tris HCl, pH 7.5, 1% NP40, 2 mM EDTA, 100 MM NaCl. 
Store at room temperature. Add protease inhibitor prior to use. 
2.1.3 GA-biotin lysis buffer 
Buffer consists 20 mM HEPES, 5 nM MgCl2, 1mM EDTA, 100 mM KCl, 0.03% NP 40, 
1% Triton X 100. Store at room temperature. Add protease inhibitor prior to use. 
2.1.4 ATP-binding buffer 
Buffer consists of 20 mm HEPES, 50 mM KCl, 6 mM MgCl2, 0.01% NP40, pH 7.4 in 
100 ml total volume. Store at room temperature.  
2.2  SDS-PAGE and Western blotting buffers and 
solutions 
2.2.1 1x SDS-PAGE sample cocktail  
50 mM Tris HCl, pH 6.8, 10% glycerol, 2% SDS, 0.1% Bromophenol blue, 100 mM 
DTT. Aliquot and store at  20
oC before use.       268 
2.2.2 10% (w/v) APS 
Dissolve  1000  mg  ammonium  persulfate  (APS)  with  10  ml  ddH2O.  Aliquot and 
store at  20
oC.  
2.2.3 10% (w/v) SDS 
Dissolve 10 g SDS in 90 ml ddH2O and bring to 100 ml with ddH2O and store at 
room temperature. 
2.2.4 10x SDS-PAGE running buffer, pH 8.3 (makes 1 L) 
Dissolve 30.3 g Tris base, 144.0 g Glycine, and 10.0 g SDS with ddH2O up to 1 L 
of total volume and store at 4
oC before use. Dilute 50 ml of 10x stock with 450 
ml ddH2O for each electrophoresis.  
2.2.5 Western blotting buffer/Transfer buffer (makes 1 L) 
Dissolve 3.03 g Tris base, 42.3 g Glycine, add 200 ml Methanol and ddH2O to 
1000 ml. Store buffer at 4
oC before use. 
2.2.6 1.5 M Tris-HCl, pH 8.8 
Dissolve 27.23 g Tris base in 80 ml ddH2O. Adjust to pH 8.8 with HCl. Bring total 
volume to 150 ml with ddH2O and store at 4
oC. 
2.2.7 0.5 M Tris-HCl, pH 6.8 
Dissolve 6 g Tris base in 60 ml ddH2O. Adjust to pH 6.8 with HCl. Bring total 
volume to 100 ml with ddH2O and store at 4
oC.     269 
2.2.8 Gel formulation (10% SDS-PAGE gel) 
For 10% resolving gel, add 4.1 ml ddH2O, 3.3 ml 30% Acrylamide/Bis, 2.5 ml 1.5 
M Tris HCl pH 8.3, 0.1 ml 10% (w/v) SDS, 50  l 10% (w/v) APS and 5.0  l TEMED. 
For 5% stacking gel, add 5.7 ml ddH2O, 1.7 ml 30% Acrylamide/Bis, 2.5 ml 0.5 M 
Tris HCl pH 6.8, 0.1 ml 10% (w/v) SDS, 50  l 10% (w/v) APS and 10.0  l TEMED. 
2.2.9 5% (w/v) dried milk solution 
Dissolve 2.5 g of dried milk to 50.0 ml PBS/Tween20. Prepare fresh as required.  
2.2.10  Incubation/blocking buffer for Western blotting 
Add 16.0 ml of PBS/Tween20, 4.0 ml of 5% dried milk and 200  l of FCS to give 
total volume 20.0 ml. Prepare within 5 min of use.  
2.2.11  Washing buffer 
Dissolve one pack of PBS (Sigma, UK), 500  l Tween20 in 1 L ddH2O. Store at 4
oC.  
2.3  Staining solutions 
2.3.1 Coomassie blue staining R-250 (makes 2.5 L) 
Dissolve 2.5 g of Coomassie blue in 1.125 L methanol, 1.125 L ddH2O and 250 ml 
acetic acid and keep at room temperature. 
2.3.2 Coomassie blue staining G-250 (makes 500 ml) 
Dissolve 2.5 g of Coomassie blue in 250 ml methanol, 50 ml acetic acid and 200 
ml ddH2O and keep at room temperature.      270 
2.3.3 Destaining solution (makes 1.7 L, 10% acetic acid solution) 
Add 175 ml of acetic acid and 500 ml methanol to 1.025 L of ddH2O and store at 
room temperature.  
2.3.4 Silver staining (Bio-Rad, UK. Cat: 161-0449) 
2.3.4.1  Fixative enhancer solution (makes 400 ml)  
Add  200  ml  methanol,  40  ml  acetic  acid  and  40  ml  fixation  enhancer 
concentrate, 120 ml ddH2O to give total volume of 400 ml. 
2.3.4.2  Staining solution (makes 100 ml) 
Add 35 ml ddH2O, 5.0 ml silver complex solution, 5.0 ml reduction moderator 
solution, 5.0 ml image development reagent and 50 ml development accelerator 
solution. Prepare within 5 min of use.   
2.3.4.3  Stop solution (5% (v/v) acetic acid solution) 
Add 50 ml acetic acid and ddH2O up to 1 L and store at room temperature. 
2.3.5 Ponceau S 
Add 3.0 g of TCA (Trichloroacetic acid) to 100 ml of ddH2O and add 0.2 g of 
Ponceau S. Store at room temperature.     271 
Appendix 3: Proteomic analysis buffers and stock 
solutions 
3.1  Lysis buffer  
Buffer consists of 8 M urea, 4% CHAPS (w/v) and 100 mM Tris base in 25 ml. 
Aliquot and store at  20
oC before use. Add protease inhibitor prior to use.  
3.2  80% acetone 
Add 80 ml acetone to 20 ml ddH2O (v/v). Store at  20
oC before use. 
3.3  Rehydration buffer 
Buffer  consists  6  M  urea,  2  M  thiourea,  4%  CHAPS,  65  mM  DTT  and  trace 
Bromophenol blue. Add 0.5% IPG buffer prior to use. 
3.4  First SDS equilibration buffer solution 
Buffer consists 6 M urea, 75 mM Tris base, 29.3% Glycerol (v/v), 2% SDS (w/v), 
0.002% Bromophenol blue in 200 ml ddH2O. Aliquot and store at  20
oC. Add 100 
mg DDT/10 ml equilibration buffer prior to use.     
3.5  Second SDS equilibration buffer solution 
Buffer consists 6 M urea, 75 mM Tris base, 29.3% Glycerol (v/v), 2% SDS (w/v), 
0.002% Bromophenol blue in 200 ml ddH2O. Aliquot and store at  20
oC. Add 250 
mg iodoacetamine/10 ml equilibration buffer prior to use.       272 
3.6  Gel formulation (12% SDS-PAGE gel) 
For 100 ml solution, add 42.25 ml ddH2O, 31.25 ml 40% Acrylamide/Bis, 25 ml 
1.5 M Tris HCl pH 8.8, 1.0 ml 10% (w/v) SDS, 500  l 10% (w/v) APS and 33  l 
TEMED. Add APS and TEMED just before casting the gel. 
3.7  1% Bromophenol blue stock solution 
Dissolve 100 mg Bromophenol blue, 60 mg Tris base with 10 ml ddH2O. Aliquot 
and store at  20
oC before use.    
Appendix 4: Bacteria and worm culture 
4.1  L-Broth, pH 7.0 (makes 1 L) 
Dissolve 10 g NaCl, 10 g Tryptone and 5 g yeast to 800 ml ddH2O and bring the 
total volume to 1 L. Sterilise by autoclaving and store at room temperature. 
4.2  L-Broth agar 
Add 7.5 g agar to 500 ml L Broth and sterilise by autoclaving and store at room 
temperature.  
4.3  NGM agar 
Add  3  g  NaCl,  17  g  agar,  2.5  g  Peptone  to  975  ml  of  ddH2O.  Sterilise  by 
autoclaving, cool flask to 55
oC for 15 min. Then add 1.0 ml of 1 M CaCl2, 1.0 ml 
of 5 mg/ml cholesterol in ethanol, 1.0 ml of 1 M MgSO4 , 25 ml of 1 M KH2PO4. 
Store at 4
oC.     273 
4.4  Cholesterol-free NGM 
Add  3  g  NaCl,  17  g  agar,  2.5  g  Peptone  to  975  ml  of  ddH2O.  Sterilise  by 
autoclaving, cool flask to 55
oC for 15 min. Then add 1.0 ml of 1 M CaCl2, 1.0 ml 
of 1 M MgSO4 , 25 ml of 1 M KH2PO4. Store at 4
oC. 
4.5  RPMI-1640 medium for B. pahangi culture 
Add 1 ml 50% glucose, 100 units/ml streptomycin, 100  g/ml penicillin to 100 ml 
RPMI 1640 with containing 5 mM glutamine, 25 mM HEPES (Invitrogen, UK. Cat: 
52400 017). Incubate at 37
oC before use.   
4.6  Ivermectin stock solution 
Dissolve 1 mg ivermectin with 1.0 ml of DMSO to give 1 mg/ml concentration. 
Pipette  100   l  and  add  to  10.0  ml  DMSO  to  give  a  final  concentration  of  10 
 g/ml. Store at  20
oC before use.     
4.7  Ivermectin plates 
Add 500  l 25 mg/ml water soluble cholesterol (Sigma, UK. Cat: C1145 250MG) 
to 500 ml of cholesterol free NGM. For 10 ng/ml plates (5 x 10 ml), add 50  l 10 
 g/ml ivermectin to 50 ml NGM to give final concentration of 10 ng/ml. Add 30 
 l 10  g/ml ivermectin to 50 ml NGM to give final concentration of 6 ng/ml. 
Store plate at room temperature.      274 
2Appendix 5: Other buffers and solutions 
5.1  Bleach solution (makes 10 ml) 
Add 625  l 4 M NaOH, 1500  l sodium hypochlorite to 7875  l of ddH2O. Prepare 
fresh as required.   
5.2  M9 buffer (makes 1 L) 
Dissolve 3 g KH2PO4, 6 g Na2HPO4, 5 g NaCl, 1 ml MgSO4 in ddH2O and bring up to 
1 L and sterilise by autoclaving and store at room temperature. 
5.3  50% (w/v) glucose stock 
Dissolve 50 g of sucrose to 80 ml ddH2O. Bring up volume to 100 ml with ddH2O 
and store at room temperature.  
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Appendix 6: MASCOT Search Results  
6.1 Down-regulated 
6.1.1 1a - Tropomyosin 
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6.1.2 1b - Myosin regulatory light chain 1  
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6.1.3 1c - Actin-depolymerising factor 1 
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6.1.4 - Actin-depolymerising factor 1 
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6.1.5 - DJ-family protein 
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6.2 Similar in both groups 
6.2.1 2a - Small heat shock protein 
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6.2.2 2b - Alkali myosin light chain 
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6.2.3 2c - Thioredoxin 
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6.2.4 2d - Small heat shock protein 
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6.2.5 2e - Tropomyosin 
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6.3 Up-regulated 
6.3.1 3a - Myosin regulatory light chain 1 
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6.3.2 3b – Tropomyosin 
 
 